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1.1. Burnout
We all experience stress at work now and then. However, a large number 
of employees experience chronic stress at work (Parent-Thirion, Fernández 
Macías, Hurley, & Vermeylen, 2007). For many of them this chronic stress 
eventually causes health problems resulting in no longer being able to fulfill 
task demands or, worse, in sick leave (Donald et al., 2005; Parent-Thirion et 
al., 2007). Since Freudenberger (1974) coined the term in the mid-1970s, 
this phenomenon is often labeled as burnout. Burnout may be best defined 
as a work-related chronic syndrome characterized by three main symptom 
dimensions: exhaustion, cynicism towards work, and reduced professional 
efficacy (Cordes & Dougherty, 1993; Maslach, Schaufeli, & Leiter, 2001; 
Schaufeli & Enzmann, 1998). Of these three dimensions exhaustion is usually 
the most prominent symptom. Furthermore, individuals with burnout often 
report depressive feelings, cognitive problems, sleep disturbances, anxiety, 
rumination, anger, muscle pain, and gastrointestinal and cardiovascular 
complaints (e.g., Bakker et al., 2000; Belcastro, 1982; Hoogduin, Schaap, & 
Methorst, 2001; Melamed et al., 1999; Schaufeli, Bakker, Hoogduin, Schaap, 
& Kladler, 2001; Schaufeli & Enzmann, 1998; Shirom, 2005; Taris, 2006).
Epidemiologic studies show that the number of employees with burnout 
complaints has increased over the last years. In the Netherlands, for 
example, the percentage of employees who reported burnout complaints 
ranged between 8 and 10 percent of the working population at the end of the 
20th century (Smulders, Houtman, Van Rijssen, & Mol, 2013). In 2014, this 
percentage increased to almost 15 % (Hooftman, Mars, Janssen, De Vroome, 
& Van den Bossche, 2014). In most European countries this percentage 
is even higher, especially in the eastern European countries (Eurofound, 
2012; Milczarek, Schneider, & González, 2009; Smulders et al., 2013). It 
is important to emphasize that these percentages concern employees who 
report burnout symptoms. They do not involve clinically diagnosed burnout 
patients. Although exact numbers about the prevalence of clinical burnout 
are lacking, it is estimated that approximately 4 % of the working population 
suffer from a clinical burnout (Maske, Riedel-Heller, Seiffert, Jacobi, & Hapke, 
2014; Schaufeli & Van Dierendonck, 2000).
Determining the percentage of employees with clinical burnout is difficult 
because burnout is not an officially defined diagnosis in the Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric 
Association, 2013), and is only mentioned without diagnostic criteria in the 
International Classification of Diseases (10th ed.; ICD-10; World Health 
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Organisation, 2010). These are the two nomenclatures that are most widely 
used by clinicians for the diagnosis of mental disorders. Consequently, and also 
due to financial reimbursement issues (e.g., in many countries, treatment for 
burnout is not compensated by insurance companies (McCormack & Cotter, 
2013; Schaufeli, Leiter, & Maslach, 2009)), diagnoses like major depressive 
disorder, adjustment disorder, undifferentiated somatoform disorder, (vital) 
exhaustion, or neurasthenia are used instead of burnout diagnoses (e.g., 
Kaschka, Korczak, & Broich, 2011). In the Netherlands, for example, a 
burnout diagnosis is commonly based on the DSM-5 criteria for diagnosing 
an undifferentiated somatoform disorder, with the addition that the cause of 
the symptoms is work-related (e.g., Hoogduin et al., 2001; Van Dam, Eling, 
Keijsers, & Becker, 2013).
An important reason why burnout is not included in the DSM-5 and is only 
mentioned (without diagnostic criteria) in the ICD-10, is due to its symptomatic 
overlap with some other mental disorders (e.g., Kaschka et al., 2011), in 
particular with some depressive disorders (e.g., Schaufeli & Enzmann, 1998). 
However, even though the symptomatology of burnout overlaps to some 
extent with other psychopathologies, there is ample literature indicating 
that burnout is a separate entity that can be distinguished from those other 
psychopathologies, on both a psychological and (neuro-)biological level (e.g., 
Ahola et al., 2005; Bakker et al., 2000; Brenninkmeyer, Van Yperen, & Buunk, 
2001; Glass & Mcknight, 1996; Leiter & Durup, 1994; Shirom, 2005; Toker, 
Shirom, Shapira, Berliner, & Melamed, 2005; Van Luijtelaar, Verbraak, Van den 
Bunt, Keijsers, & Arns, 2010). For example, in two large confirmatory factor 
analytic studies Bakker et al. (2000) and Leiter and Durup (1994) provided 
convincing evidence for the discriminant validity of burnout and depression. 
More specifically, Bakker et al. (2000) found support for the often postulated 
notion that depression is characterized by a generalization of an individual’s 
feelings across all domains of life, whereas burnout is work-specific rather 
than all-encompassing. Regarding (neuro-)biological differences, Toker et 
al. (2005), for example, showed in a large study among 1563 employees 
that burnout, depression, and anxiety are differentially associated with 
microinflammation biomarkers. Furthermore, Van Luijtelaar et al. (2010), 
based on their EEG study of burnout patients, concluded that the observed 
EEG pattern in burnout patients differs from that of both depressive and 
chronic fatigue patients.
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1.2. Burnout and cognitive functioning
Employees with burnout often complain about major cognitive problems, such 
as an inability to concentrate and impaired memory (e.g., Weber & Jaekel-
Reinhard, 2000). For example, they often report issues with focusing during 
meetings or when reading, and difficulties in recalling information.
Although impaired cognitive functioning can have a devastating impact on a 
person’s private as well as professional life, it was not until 2005 that researchers 
started to empirically study these self-reported cognitive problems in burnout 
(Sandström, Rhodin, Lundberg, Olsson, & Nyberg, 2005; Van der Linden, 
Keijsers, Eling, & Van Schaijk, 2005). The results of the earlier studies revealed 
that these self-reported cognitive problems were indeed accompanied by 
actual cognitive impairments, as measured with cognitive-neuropsychological 
tests (e.g., Öhman, Nordin, Bergdahl, Birgander, & Neely, 2007; Österberg, 
Karlson, & Hansen, 2009; Rydmark et al., 2006; Sandström et al., 2005; 
Van der Linden et al., 2005). The pattern of results of these impairments 
seemed to indicate that burnout is particularly associated with compromised 
executive functioning (i.e., a set of higher-order cognitive processes that 
regulate other cognitive sub-processes), and that individuals with burnout 
have fewer difficulties with more lower-order cognitive processes, such as 
processing speed (Sandström et al., 2005; Van der Linden et al., 2005).
These initial studies provided a proper first insight into the relationship between 
burnout and cognitive functioning, but had some important limitations:
i. Most fundamentally, the way in which burnout was defined varied 
widely between the studies and lacked specificity in some studies.
ii. In the previous studies a large number of cognitive functions were 
assessed with a broad variety of cognitive-neuropsychological tests, 
limiting the comparability between studies.
iii. In many of the earlier studies it was not controlled for important potential 
confounding variables, such as comorbidity of other psychopathologies, 
like depressive disorders.
iv. In the vast majority of former studies a cross-sectional research design 
was employed, precluding clear conclusions about developmental 
issues.
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1.3. Burnout and cortisol
It has often been hypothesized that impaired cognitive functioning of individuals 
with burnout may be related to the prolonged period of stress that these 
individuals experience (e.g., Österberg et al., 2009; Sandström et al., 2011). 
This hypothesis seems plausible since burnout is a stress-related condition (e.g., 
Cordes & Dougherty, 1993; Maslach et al., 2001), and there is ample evidence 
that prolonged periods of stress can have a detrimental impact on the brain. In 
this framework, the hippocampus and the prefrontal cortex –brain structures 
that are responsible for memory consolidation and executive functioning, 
respectively– are most widely studied (e.g., Arnsten, 2009; Lupien & Lepage, 
2001, respectively). The hypothalamic-pituitary-adrenal axis (HPA axis) is 
believed to underlie the relationship between stress and cognitive functioning. 
This neuroendocrine system plays a major role in the regulation of stress 
reactions. Specifically, the hormone cortisol, the release of which is regulated by 
the HPA axis and which is considered to be a main stress hormone, is assumed 
to mediate the relationship between stress and cognitive functioning. It seems 
that high as well as low levels of cortisol can have a negative impact on cognitive 
functioning (Lupien, Maheu, Tu, Fiocco, & Schramek, 2007). Accordingly, 
studying cortisol levels may provide valuable information about the biological 
underpinnings of burnout.
The relationship between burnout and cortisol has been examined in some 
previous studies. However, the results of these studies are inconsistent and 
sometimes even contradictory. In some studies burnout was found to be related 
with lower-than-normal levels of cortisol (e.g., Marchand, Juster, Durand, & 
Lupien, 2014; Sonnenschein et al., 2007), whereas other studies showed that 
burnout was associated with elevated cortisol levels (e.g., De Vente, Olff, Van 
Amsterdam, Kamphuis, & Emmelkamp, 2003; Melamed et al., 1999). Moreover, 
there is also research in which burnout was found to be unrelated to any 
deviation in cortisol (e.g., Grossi, Perski, Evengård, Blomkvist, & Orth-Gomér, 
2003; Mommersteeg, Heijnen, Verbraak, & Van Doornen, 2006).
Basically the same four limitations as those which may account for the mixed 
findings regarding the relationship between burnout and cognitive functioning 
might be held responsible for the inconclusiveness in the existing burnout-
cortisol literature. These limitations are:
i. The large variety of operationalizations of burnout and its lack of specificity;
ii. Heterogeneity and limited reliability of the cortisol assessment;
iii. Important potential confounding variables which were not controlled for;
iv. The lack of longitudinal research designs.
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1.4. Aim of this dissertation
Against this background, the main aim of this dissertation is twofold:
1. a)  Provide a better understanding of cognitive functioning associated
          with burnout (cross-sectional approach);
b) Gain more insight into the course of cognitive functioning in 
     relation to burnout (longitudinal approach);
2. a) Provide a better understanding of cortisol levels associated with 
          burnout (cross-sectional approach);
   b) Gain more insight into the course of cortisol levels in relation to
          burnout (longitudinal approach).
To these aims, we studied both the burnout-cognition and burnout-cortisol 
relationships by adopting research designs that enabled us to overcome the main 
limitations of previous studies: i) large differences in the operationalization of 
burnout and its lack of specificity, ii) heterogeneity (and restricted reliability) of 
the outcome measures, iii) not controlling for important potential confounders, 
and iv) the lack of longitudinal research designs.
To address the first limitation (i.e., large differences in the operationalization 
of burnout and its lack of specificity), we studied cognitive functioning and 
cortisol levels in both a large group of clinically diagnosed burnout patients as 
well as in a large group of employees who reported symptoms of a burnout 
but who were not diagnosed as such and were still working. In addition, we 
included a healthy control group. We carefully selected our participants and 
described our selection criteria very clearly. With regard to the second limitation 
(i.e., heterogeneity and restricted reliability of the outcome measures), we 
systematically assessed both cognitive functioning and cortisol levels. Cognitive 
functioning was measured both subjectively, by a well-validated questionnaire, 
and objectively, by well-validated cognitive tests that measured executive 
functioning as well as more general cognitive processes. Additionally, we 
drew upon a new approach by looking into the subjective costs associated 
with cognitive tests performance. The rationale behind this is that adequately 
upholding (cognitive test) performance can come at larger costs (Hockey, 2013; 
Kurzban, Duckworth, Kable, & Myers, 2013; Meijman & Mulder, 1998). In order 
to obtain a full, valid, and reliable assessment of cortisol levels, we measured 
the diurnal cortisol pattern during two days. Hereto, we collected six salivary 
cortisol samples during two consecutive non-working days. We collected 
the cortisol samples on non-working days to make sure that the sampling 
conditions were equal between the groups. This is deemed relevant because 
research has shown that cortisol levels are generally higher on workdays than 
Chapter 1 General introduction
14 15
1
on days off work (e.g., Kunz-Ebrecht, Kirschbaum, Marmot, & Steptoe, 2004; 
Langelaan, Bakker, Schaufeli, Van Rhenen, & Van Doornen, 2006; Schlotz, 
Hellhammer, Schulz, & Stone, 2004). In the vast majority of previous studies on 
the relationship between burnout and cortisol, however, the cortisol sampling 
procedure took place during workdays. This most likely affected the results of 
those studies in which the burnout group consisted of clinical burnout patients 
who were (largely) not working (i.e., on sick leave), and in which the control 
group comprised healthy participants who were working during the sampling 
procedure. The third limitation (i.e., not controlling for important potential 
confounders) was tackled by excluding participants with comorbid mental 
disorders, especially those with mood and anxiety disorders. Furthermore, in 
our analyses we statistically controlled for potentially important confounding 
variables. Finally, to address the fourth limitation (i.e., the lack of longitudinal 
research designs) and in order to study the course of cognitive functioning and 
cortisol levels in relation to burnout, we performed two longitudinal studies.
1.5. Outline of this dissertation
In Chapter 2, a longitudinal study is presented in which we examined cognitive 
functioning of clinically diagnosed burnout patients both shortly after they 
were diagnosed with burnout and after a 10-week period during which they 
were treated for their burnout symptoms. On both test occasions, cognitive 
functioning of these patients was compared with a healthy control group. We 
examined cognitive functioning by measuring self-reported cognitive problems 
as well as cognitive test performance. Cognitive test performance was 
systematically assessed by including tests that measure the three most basic 
executive functions, namely, updating, inhibition, and switching.
Based on the results of the research described in Chapter 2, Chapter 3 presents 
a study in which we examined burnout in relation to cognitive functioning in 
more detail. In addition to a sample of clinically diagnosed burnout patients and 
healthy controls, we also examined a sample of non-clinical burnout individuals, 
consisting of individuals who reported to have symptoms of burnout, but 
were not clinically diagnosed and were not seeking help for these symptoms. 
Furthermore, these three groups were not only compared on the performance 
on cognitive tests assessing the three most basic executive functions, but also on 
the performance on tests that specifically assessed more lower-order cognitive 
processes. To obtain a full picture of cognitive functioning we also collected 
information about the subjective costs associated with the performance on the 
cognitive tests.
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To improve our knowledge about the biological underpinnings of burnout, in 
Chapter 4 a study is described in which we examined cortisol levels in relation 
to burnout. Hereto, we examined the cortisol levels of the same three groups 
as described in Chapter 3, that is, a clinical burnout, a non-clinical burnout, 
and a healthy control group. In order to get an appropriate range of cortisol 
indices, including different measures of the cortisol awakening response (CAR) 
and several day-curve measures, salivary cortisol was collected six times a 
day during two consecutive non-workdays.
In our last study, described in Chapter 5, we aimed to provide more insight 
into the longitudinal course of both cognitive functioning and cortisol levels in 
relation to burnout. To this end, we reexamined the three groups (i.e., clinical 
burnout, non-clinical burnout, and healthy control group) that we reported on 
in the studies described in Chapter 3 and Chapter 4, after a 1.5 years period. 
In-between the first and second examination, the patients of the clinical 
burnout group received psychological treatment aimed at reducing burnout 
symptoms in those individuals.
Finally, Chapter 6 provides a summary and discussion of our empirical 
findings regarding cognitive functioning and cortisol levels in relation to 
burnout. Furthermore, strengths and limitations of the studies reported in this 
dissertation are described, followed by recommendations for future research. 
Finally, some practical implications are put forward and an overarching 
conclusion is provided.

CHAPTER 2
Burned out cognition: Cognitive functioning 
of burnout patients before and after a 
period with psychological treatment
This chapter appeared as:
Oosterholt, B. G., Van der Linden, D., Maes, J. H. R., Verbraak, M. J., & Kompier, 
M. A. J. (2012). Burned out cognition: Cognitive functioning of burnout 
patients before and after a period with psychological treatment. Scandinavian 
Journal of Work, Environment & Health, 38(4), 358-369. 
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2.1. Abstract
Many employees with burnout report cognitive difficulties. However, the 
relation between burnout and cognitive functioning has hardly been empirically 
validated. Moreover, it is unknown whether the putative cognitive deficits in 
burnout are temporary or permanent. Therefore, the purpose of the study was 
to answer two related questions: (i) Is burnout associated with self-reported 
cognitive difficulties and with deficits in a specific and well-defined set of 
executive functions? (ii) Do these putative self-reported cognitive difficulties 
and deficits in executive functioning in burnout diminish after a 10-week 
period with cognitive behavioral therapy? Sixteen employees with burnout 
were compared with sixteen matched healthy employees on self-reported 
cognitive difficulties and tests measuring the basic executive functions, 
namely, updating, inhibition, and switching, on two test occasions. The 
interval between the test occasions was ten weeks, during which the burnout 
individuals received cognitive behavioral therapy. On the first test occasion, 
and relative to healthy individuals, individuals with burnout reported more 
cognitive difficulties and showed deficits in the “updating” function. No group 
differences were found regarding the “inhibition” and “switching” functions, 
although individuals with burnout generally responded slower than healthy 
individuals on the latter test. Even though after the ten-week treatment 
period individuals with burnout revealed positive changes regarding burnout 
symptoms, general health, and self-reported cognitive difficulties, no evidence 
was found for improved cognitive test performance. These findings suggest 
that either (i) burnout leads to permanent cognitive deficits, (ii) subjective 
burnout complaints reduce faster than deficits in cognitive test performance, 
or (iii) cognitive deficits are a cause rather than a consequence of burnout.
Chapter 2 Burned out cognition
18 19
2
2.2. Introduction
Epidemiological studies have shown that a relatively large number of 
employees experience high and chronic levels of stress at work (Packham 
& Webster, 2009; Parent-Thirion et al., 2007). For a relevant proportion of 
these employees, their stress complaints become so severe that they are no 
longer able to maintain adequately their job performance or, worse, they drop 
out of work (Donald et al., 2005; Moreau et al., 2004; Parent-Thirion et al., 
2007). To date, the majority of research on such employees’ complaints has 
been conducted under the label of burnout: a work-related chronic affective 
state, characterized by emotional exhaustion, depersonalization, and reduced 
personal accomplishment (Cordes & Dougherty, 1993; Maslach et al., 2001; 
Schaufeli & Enzmann, 1998). Even though burnout is not included in the most 
recent version of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR; American Psychiatric Association, 2000), numerous studies 
have shown that it is a useful concept in describing the major characteristics 
of many employees with work-related chronic stress complaints.
Early burnout research mainly focused on its antecedents, its impact on a 
person’s attitudes and health, and its organizational consequences (Toker et 
al., 2005). Recent studies also indicate that individuals with burnout often 
complain about impaired cognitive functioning, such as reporting attentional 
and memory problems (e.g., Maslach et al., 2001). This is not surprising 
given that burnout may be considered a stress-related syndrome (Cordes & 
Dougherty, 1993), and there is ample evidence that sustained stress can have 
detrimental effects on neuronal structures involved in cognitive functioning, 
such as the hippocampus and the prefrontal cortex (e.g., Arnsten, 2009; 
Toker et al., 2005). More specifically, there is substantial literature indicating 
that the association between stress and impaired cognitive functioning may 
be mediated by chronically elevated levels of glucocorticoids (e.g., cortisol), 
which in turn may lead to a reduction in total brain weight (Coburn-Litvak 
et al., 2004) and, more specifically, to atrophy of the hippocampus (Lupien 
& Lepage, 2001; McEwen, 1998) and the prefrontal cortex (McEwen, 2005).
Remarkably, however, the hypothetical relationship between clinical burnout 
and cognition has hardly been empirically validated using objective measures. 
To the best of our knowledge, to date there are only seven studies in which this 
relationship has been examined (Öhman et al., 2007; Österberg et al., 2009; 
Rydmark et al., 2006; Sandström et al., 2011; Van der Linden et al., 2005; 
Wahlberg et al., 2009). The results of these studies suggest that subjective 
cognitive complaints of individuals with burnout are linked to actual cognitive 
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deficits, as measured with cognitive neuropsychological tests. The pattern of 
these deficits seems to indicate that burnout is particularly accompanied by 
compromised executive functioning, and individuals with burnout have less 
difficulty with more automatic cognitive processes.
The term executive functioning refers to a set of higher-order cognitive 
processes that regulate other cognitive sub-processes (Miyake et al., 2000). 
Importantly, executive functions are widely held to be mediated by a neuronal 
circuitry that involves prefrontal cortical areas (e.g., D’Esposito et al., 1995). 
As opposed to more automatic cognitive processes, executive functions 
are responsible for the voluntary regulation of thought and action (Miller & 
Cohen, 2001). For example, these functions enable an individual to respond 
appropriately to novel, changing, or complicated tasks or situations (Norman 
& Shallice, 1986).The literature describes a wide range of executive functions 
(e.g., Chan, Shum, Toulopoulou, & Chen, 2008), including working memory, 
verbal reasoning, task switching, cognitive flexibility, abstract thinking, 
inhibition, sequencing, planning, rule acquisition, and problem-solving.
Minor deficits in executive functions can have a devastating impact on a 
person’s private as well as professional life. For example, individuals may be 
unable to respond adequately in social contexts, structure tasks, or maintain 
their usual performance. Given the importance of executive functioning, the 
objective of this study was to add further knowledge to the sparse literature 
on the relationship between burnout and cognitive functioning. Previous 
studies addressing this issue focused on a variety of executive functions 
that were assessed with various cognitive neuropsychological tests. In this 
study, however, we aimed at examining the relationship between burnout 
and cognitive functioning more systematically. Specifically, we concentrated 
on three basic types of executive functions, namely, updating and monitoring 
of working memory representations (“updating”), inhibition of prepotent 
responses (“inhibition”), and switching between tasks or mental sets 
(“switching”). In line with Miyake et al. (2000), our motive in assessing these 
specific functions was that there is a relatively large consensus that these 
are basic executive functions, which can be clearly and precisely described 
(in contrast to other more higher-level constructs of executive functioning, 
such as planning or abstract thinking) and can be operationalized in relatively 
simple, well-studied, and validated cognitive tasks. Furthermore, these three 
executive functions are considered to be involved in the performance of other 
more complex executive functioning tests.
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To this end, we compared a group of employees with burnout against a 
matched healthy control group to assess their performance on a well-chosen 
set of executive-functioning tests. The burnout group was carefully selected 
so as to preclude the comorbidity with mood and anxiety disorders. This 
enabled a relatively pure assessment of the relationship between burnout 
and cognition. A further characteristic of the individuals in the burnout group 
was that they received cognitive behavioral therapy (CBT) according to a 
treatment protocol for burnout, which is commonly used in the Netherlands 
(Keijsers et al., 2004). This therapy was not specifically directed at alleviating 
cognitive complaints, but rather that these individuals with burnout received 
a treatment over a period of about ten weeks that gave us the opportunity 
to establish any possible changes in cognitive performance as a result of the 
treatment and/or the lapse of time. Specifically, we acquired data concerning 
burnout symptoms, physical and mental complaints, and both subjective 
and objective cognitive performance, using a set of standard questionnaires 
and executive functioning tests prior to and after the treatment period. We 
expected burnout symptoms and physical and mental complaints to improve 
in the course of the treatment period, but the question of interest was whether 
or not cognitive performance (subjective and/or objective) would also show 
any improvements. Such improvements are to be expected only if the 
prolonged stress, held to underlie the burnout symptoms, did not result in any 
permanent brain damage and/or when cognitive deficits are a consequence 
rather than a cause of burnout.
In sum, the purpose of this study was to answer two related questions: (i) Is 
burnout associated with self-reported cognitive difficulties and with deficits in 
a specific and well-defined set of executive functions? (ii) Do these possible 
self-reported cognitive difficulties and deficits in executive functioning in 
burnout diminish after a 10-week period with CBT?
2.3. Method
2.3.1. Participants
In total 32 employees, 16 diagnosed with burnout and 16 matched healthy 
controls, participated in this study. The participants in the burnout group were 
selected on the basis of their diagnosis, established by professional clinical 
psychologists from HSK Group. HSK Group is a major mental healthcare 
organization in the Netherlands, with several offices across the country. 
The participants with burnout, who were referred by general practitioners, 
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were recruited from three HSK Group offices where they were diagnosed 
and received CBT for their burnout. Although burnout is not classified in the 
DSM-IV-TR, in the Netherlands a burnout diagnosis is commonly based on the 
DSM-IV-TR criteria for diagnosing an undifferentiated somatoform disorder 
with the addition of work-related causes. This procedure was also used for the 
burnout diagnosis in our study. Even though the symptomatology of burnout 
overlaps with several other psychological disorders such as depression and 
anxiety disorders, it has been suggested that burnout is a distinct construct 
(Ahola et al., 2005). Therefore, an exclusion criterion for participation was 
current fulfillment of DSM-IV-TR criteria for any other axis I or II disorder. At 
the onset of the study, 7 of the 16 burnout participants were on sick leave 
due to their burnout, 5 continued working but worked fewer hours than before 
their burnout diagnoses, and 4 were still working the same number of hours 
as before the diagnoses. At the time of the second testing session, three 
individuals were on sick leave, nine worked less, and four worked the same 
number of hours compared to before their burnout. On both the first and the 
second testing session, two individuals in the burnout group were treated with 
psychotropic drugs.
Control group participants were recruited in the same part of the Netherlands 
as burnout group participants, from several different companies. The 16 
healthy controls who participated in our study were matched to the burnout 
group according to the demographic characteristics of gender, age, level of 
education, and contractual working hours per week (based on the working 
hours of individuals with burnout before their diagnosis) (see Table 2.1. for 
detailed information). None of these participants received treatment for 
psychiatric disorders. In addition, participants in the control group were 
screened by means of the Dutch translation (Overbeek, Schruers, & Griez, 
1999) of the Mini-International Neuropsychiatric Interview 5.0.0 (Sheehan 
et al., 1998) and were excluded if they fulfilled the criteria of any DSM-IV-TR 
axis I disorder assessed with this interview. One participant in the control 
group used a psychotropic drug on the first and second testing sessions. At 
the time of both measurements, all participants in this group were actively 
employed. In the burnout as well as the control group, the majority of the 
participants were working in the education, health, government, or industrial 
sectors.
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Table 2.1. Sample characteristics
Burnout group Control group
M SD Range M SD Range p
Age (years) a 40.21 10.23 27–57 41.16 11.03 26–57 .801
Level of educationb 3.69 .60 2–4 3.50 .63 2–4 .492
Work hours/weekc 36.00 4.32 24–40 34.59 8.24 16–48 .551
n % n % p
Sex 
Men 8 50 8 50 1.002
Women 8 50 8 50 1.002
Note. aParticipants’ age at the onset of the study. bLevel of education was measured in terms 
of a participant’s highest level of education completed, ranging from 1 to 4, primary school to 
university degree, respectively. cParticipants’ contractual working hours per week. 1Based on an 
ANOVA test. 2Based on Pearson’s chi-square test.
2.3.2. Materials
2.3.2.1. Self-reports
Utrechtse Burnout Scale. The severity of burnout symptoms was measured 
with the Utrechtse Burnout Scale (Schaufeli & Van Dierendonck, 2000), 
which is the Dutch adaptation of the widely used Maslach Burnout Inventory 
(Maslach, Jackson, & Leiter, 1996). We used the version for general professions 
(Utrechtse Burnout Scale-A), which contains 15 questions to be answered on a 
7-point Likert scale (0 = “never”, 6 = “every day”). The questionnaire consists 
of three subscales: emotional exhaustion, depersonalization, and personal 
accomplishment. Sample items are, respectively, “I feel mentally exhausted 
by my job”, “I doubt about the usefulness of my job”, and “I know well how 
to solve problems in my job”. The individuals with burnout who were on sick 
leave during the first and/or second testing session were instructed to fill 
in the items of the Utrechtse Burnout Scale questionnaire according to how 
they would feel if they were working at that moment. For practical research 
purposes, Brenninkmeijer and Van Yperen (2003) proposed that individuals 
can be classified high in burnout when they have a high score (> 2.19) on 
emotional exhaustion and a high score (> 1.99) on depersonalization or a low 
score on personal accomplishment (< 3.67). Measured with Cronbach’s alpha, 
the internal consistencies of the subscales were respectively, .88, .69, and .83.
Symptom Checklist-90-Revised. We used the Dutch adaptation (Arrindell & 
Ettema, 2003) of the Symptom Checklist-90-Revised (SCL-90-R), a multi-
dimensional questionnaire that assesses physical and mental complaints 
(Derogatis, 1977). The SCL-90-R is commonly applied by psychiatrics and 
psychologists to monitor psychiatric and psychological treatment. The 90 items 
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in this questionnaire describe different physical and psychological complaints, 
for which one has to indicate the extent to which he/she encounters them on 
a 5-point Likert scale (1 = “not at all”, 5 = “extremely”). The Dutch SCL-90-R 
consists of 8 subscales, which measure the primary symptom dimensions of 
anxiety (10 items), agoraphobia (7 items), depression (16 items), somatization 
(12 items), insufficiency (9 items), sensitivity (18 items), hostility (6 items), 
and sleeplessness (3 items), and an additional subscale (9 items). The sum 
of the scores on the subscales is referred to as the psychoneuroticism score, 
which is the equivalent of the Global Severity Index (English version). The 
mean psychoneuroticism score of the Dutch population is 118 (Arrindell & 
Ettema, 2003). Cronbach’s alpha of this questionnaire was .95.
Cognitive Failure Questionnaire. A Dutch translation of the Cognitive Failure 
Questionnaire (Broadbent, Cooper, Fitzgerald, & Parkes, 1982) was used to 
assess the participants’ self-reported cognitive functioning. This questionnaire 
consists of 25 items, which assess cognitive failures in daily life. The items can 
be answered on a 5-point Likert scale (0 = “never”, 4 = “very often”). Sample 
items are “Do you read something and find you have not been thinking about 
it and must read it again?”, “Do you find yourself suddenly wondering whether 
you’ve used a word correctly?”, and “Do you find you forget appointments?” 
Research has shown that individuals with impaired executive functions exhibit 
many of the cognitive failures in daily life as assessed with the Cognitive 
Failure Questionnaire (Robertson, Manly, Andrade, Baddeley, & Yiend, 1997). 
Cronbach’s alpha was .92.
2.3.2.2. Cognitive tests
To examine the relationship between burnout and executive functioning, we 
focused on the aforementioned three types of functions: updating, inhibition, 
and switching. These functions were measured by three well-validated tests, 
each tapping specifically into one of the three target functions.
2-Back Task. To assess updating, we used a 2-Back Task (Kirchner, 1958), 
consisting of 197 letters, displayed one by one in the centre of the screen. 
Participants were instructed to push a button on a button-box when the 
present letter was similar to the letter that had appeared two stimuli previously 
(target rate was 32.5 %). Stimuli consisted of the letters b, d, g, p, t, and v, 
which were displayed quasi-randomly in both capital and small letters (for a 
correct response no distinction was made between capital and small letters). 
Stimulus duration was fixed at 450 ms with an inter-stimulus interval of 750 
ms. The test lasted approximately four minutes. Performance was assessed by 
the mean number of correct responses.
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Sustained-Attention-to- Response Test. The Sustained-Attention-to-Response 
Test (SART; Robertson et al., 1997) was used to measure inhibition. The 
present version consisted of digits, ranging from 1–9, that were sequentially 
displayed in a quasi-random order in the centre of the screen. Participants 
were instructed to push a button on a button-box each time a digit appeared 
on the screen, except when the digit was a “3”, which occurred in 11.1 % of the 
cases. A total of 225 digits, each with a duration of 250 ms, was presented. The 
interval between digits was set at 850 ms. Completion of the test took about 
four minutes. The main performance measure in the SART is the number of 
inhibition errors, in which a participant presses the button when a “3” appears 
on the screen.
Matching Task. Switching was assessed with the Matching Task (Poljac et al., 
2010), a variant of the task-switching paradigm, as originally developed by 
Jersild (1927). In this test, four different geometric figures (a circle, a hexagon, 
a square, and a triangle), displayed in the colors blue, green, red, or yellow 
were used as stimuli. On each trial, a colored reference figure was shown in the 
upper half of the screen, and four colored match figures were displayed in the 
lower half of the screen. Participants were instructed to match the reference 
figure to one of the match figures according to shape or color. The color-shape 
combination of the figures was shown randomly with two restrictions. First, 
the four match figures were not allowed to have the same shape or color. 
Second, the reference and the match figures were not allowed to match in 
both shape and color. The type of task, matching according to shape or form, 
was randomly chosen and indicated by a cue that was displayed for 1000 ms. 
Matching was performed by pushing one of the four buttons on the keyboard 
which corresponded to one of the four match figures in the lower half of the 
screen. The response–stimulus interval was set at 700 ms. The test consisted 
of 31 task runs, each consisting of on average six trials (range 4–8 trials). 
During one single task run, no task switch – that is matching according to color 
or shape – occurred. Half of all task runs consisted of “switch” runs, in which 
the type of task differed from the previous run. The other half consisted of 
“repetition” runs, in which the type of task was identical to the previous run. The 
duration of the test was approximately six minutes. Besides general reaction 
time, the most important dependent variable in this task is the switch cost: 
the difference in reaction time on the first trial between switch and repetition 
runs. Error and no-response trials and trials that directly followed such trials 
were not included in the analysis. Just like the first entire task run, a task run, 
which followed a task run in which all trials were errors, was excluded from the 
analysis (for more detailed information about this task, see Poljac et al., 2010).
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2.3.3. Procedure
All participants were tested twice. Testing of the burnout group occurred 
before or after the participant’s regular appointment with the psychologist in 
a quiet room at one of the three offices of the mental healthcare organization. 
For half of the participants with burnout (n = 8), the first test session was 
conducted before their treatment started. Four participants had already 
received one therapy session before they were tested the first time, and 
four participants had already received two therapy sessions. However, all 
participants with burnout were tested for the first time within 3 weeks after 
they were diagnosed with burnout. After the first test session, all burnout 
individuals were treated during a period of approximately 10 weeks (range 
8–17), wherein they received an average of 11 sessions (range 7–13) of CBT 
before they were tested a second time. A therapy session lasted 45 minutes. 
Treatment was provided by professional clinical psychologists according to 
a treatment protocol for burnout (Keijsers et al., 2004) that is commonly 
used in the Netherlands. Basic components of this treatment are reduction of 
complaints, cognitive therapy, and relapse prevention. If necessary, additional 
therapy modules can be chosen. After this period of psychological treatment 
(treatment had not been finished for any of the participants), participants 
were tested a second time. This follow-up measurement was scheduled after 
ten therapy sessions because the mental healthcare organization regularly 
evaluates its patients’ progress after this number of sessions. Similar to the 
participants in the burnout group, approximately 10 weeks (range 8–14) 
after the first test session, the participants in the control group were tested 
a second time. The healthy controls were tested at their homes or at the 
university in a quiet setting.
During each test session, participants completed the different questionnaires 
and then the three cognitive tests. The latter were provided in a 
counterbalanced order across participants, but for each participant, the 
order of the tests was similar in the first and second session. All tests were 
computerized and conducted on a laptop with a 15-inch screen. Participants 
were placed approximately 50 cm in front of the computer screen. The tests 
were introduced with written instructions on the screen as well as verbally 
explained by the experimenter. Participants were instructed to respond as 
quickly and accurately as they could by pushing the required button with their 
dominant hand. The participant had a short practice session (approximately 
30 s) before initiation of each test. In advance, participants were informed 
by letter that the purpose of the study was to investigate the effects of mood 
on cognition. Participants were asked not to consume any caffeine on the 
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examination day. The Ethical Committee of the Faculty of Social Sciences at 
the Radboud University Nijmegen in the Netherlands approved the study.
2.3.4. Statistical analyses
Statistical analyses were performed using SPSS for Microsoft Windows, version 
17.0 (SPSS, Inc, Chicago, IL, USA). Inspection of the data revealed that the 
outcome measures were approximately normally distributed. An alpha level of 
.05 was used for all statistical analyses, and the results were based on two-
tailed tests.
To examine whether burnout is associated with self-reported cognitive 
difficulties and with deficits in executive functioning, all outcome measures 
on the first test session, except performance on the Matching Task, were 
analyzed with a univariate analysis of variance (ANOVA). Performance on the 
Matching Task was statistically evaluated using a 2 × 2 mixed design ANOVA 
with “run type” (switch versus repetition) as within-subject factor and “group” 
(burnout versus control) as between-subject factor.
To examine whether possible self-reported cognitive difficulties and deficits 
in executive functioning during burnout diminish after a 10-week period with 
CBT, we used a repeated measures ANOVA. All outcome measures, except 
performance on the Matching Task, were tested with a 2 × 2 ANOVA, with 
“group” (burnout versus control) as between-subject factor and “time” (first 
versus second test session) as within-subject factor. The Matching Task 
performance was tested with a 2 × 2 × 2 mixed repeated measures ANOVA, 
with “run type” (switch versus repetition) and “time” (first versus second 
test session) as within-subject factors, and “group” (burnout versus control) 
as between-subject factor. Where necessary, interaction effects were further 
qualified by independent samples and paired samples t-tests.
2.4. Results
The results are presented in two main sections. First, results are reported that 
are relevant for determining whether burnout is associated with self-reported 
cognitive difficulties and with deficits in executive functioning (in Table 2.2. 
referred to as research question 1). Second, results are presented that are 
relevant for determining whether possible self-reported cognitive difficulties 
and deficits in executive functioning in burnout diminish after a 10-week 
period with CBT (in Table 2.2. referred to as research question 2).
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2.4.1. Burnout and cognitive functioning
2.4.1.1. Self-reports
Analysis of the Utrechtse Burnout Scale revealed that the burnout group had 
significantly higher scores on the emotional exhaustion and depersonalization 
subscales and a marginally significantly lower score on the personal 
accomplishment subscale than the healthy control group (for statistics, see 
Table 2.2.). Analysis of the SCL-90-R and the Cognitive Failure Questionnaire 
scores revealed that, compared to healthy individuals, individuals with 
burnout reported significantly more physical and mental complaints and more 
cognitive failures.
2.4.1.2. Cognitive tests
Compared to the control group, the burnout group had a significantly lower 
number of correct responses in the 2-Back Task, but the groups did not differ in 
number of inhibition errors in the SART (see Table 2.2. for statistics). Analysis 
of the reaction times of the first trials of each task run of the Matching Task 
revealed significant main effects of run type (switch versus repetition) and 
group but no significant interaction effect. As usually found in these kinds of 
tasks (Monsell, 2003), the main effect of run type was due to the average 
reaction time of both groups being significantly faster after a task repetition 
than after a task switch. However, the main group effect implied that, 
independent of run type, individuals in the burnout group reacted significantly 
slower than individuals in the control group. The absence of a run type × 
group interaction reflected the absence of a significant difference in switch 
cost between the two groups.
2.4.2. Changes after a 10-week period with cognitive 
behavioral therapy
2.4.2.1. Self-reports
Analysis of the Utrechtse Burnout Scale emotional exhaustion subscale 
revealed significant main effects of group and time and a significant group × 
time interaction (see Table 2.2.). Follow-up independent t-tests showed that 
before and after the 10-week period, individuals in the burnout group reported 
significantly more emotional exhaustion than individuals in the control group 
(t(1, 30) = -5.95, p = .00; t(1, 30) = -3.84, p = .00, respectively). However, 
follow-up paired t-tests revealed that individuals with burnout showed a 
relatively strong and significant decrease in emotional exhaustion from 
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the first to second measurement (t(1, 15) = 2.64, p = .02), whereas the 
control group did not differ significantly over time (t(1, 15) = .00, p = 1). 
Analysis of the depersonalization subscale revealed a significant main effect 
of group indicating that, overall, the burnout group scored significantly higher 
on depersonalization than the control group. There was, however, neither 
a significant main effect of time nor significant group × time interaction, 
implying respectively, that the average depersonalization score of both groups 
did not differ over time, and the difference between individuals with burnout 
and healthy individuals on this measure did not significantly differ on the 
first compared to the second measurement. For the personal accomplishment 
subscale, neither a significant main effects of group and time nor significant 
group × time interaction were found.
Analysis of the SCL-90-R scores revealed significant main effects of group 
and time and a significant group × time interaction. Subsequent t-tests 
indicated that on the first as well as second testing session, individuals in the 
burnout group experienced significantly more physical and mental complaints 
compared to individuals in the healthy control group (t(1, 30) = -5.15, p = 
.00; t(1, 29) = -2.79, p = .01, respectively). Follow-up paired t-tests revealed 
that both the burnout and control group differed significantly over time with 
regard to their complaints (t(1, 14) = 3.29, p = .01; t(1, 15) = 2.21, p = .04, 
respectively). However, individuals with burnout showed a stronger decrease 
in complaints than healthy individuals.
Regarding the Cognitive Failure Questionnaire scores, there were significant 
main effects of group and time as well as a significant group × time interaction. 
Subsequent tests revealed that, on both time points, the burnout group 
reported significantly more cognitive failures than the control group (t(1, 30) 
= -3.70, p = .00; t(1, 30) = -2.12, p = .04 for the first and second testing 
session, respectively). However, paired t-tests showed that individuals with 
burnout reported significantly fewer cognitive failures on the second compared 
to the first measurement (t(1, 15) = 3.69, p = .00), which was not the case 
for the healthy controls (t(1, 15) = 1.09, p = .29).
In sum, after a 10-week period with CBT, individuals in the burnout group 
were less emotionally exhausted, had less physical and mental complaints, 
and reported less cognitive failures than before this period. However, their 
level of emotional exhaustion and health complaints – though reduced – 
remained higher than those of the control group, just as they, in addition to 
depersonalization, remained high compared to norm scores.
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2.4.2.2. Cognitive tests
Analysis of the number of correct responses in the 2-Back Task revealed 
significant main effects of group and time, but there was no significant 
interaction (for statistics see Table 2.2.). The main effects indicated that, 
overall, the burnout group performed worse than the control group, and that 
the average performance of both groups significantly improved over time. 
The latter result was probably due to a learning effect. The absence of an 
interaction effect indicated that the difference between the groups did not 
significantly differ before compared to after the 10-week period.
With regard to the number of inhibition errors in the SART, we found that 
neither the main effect of group nor the group × time interaction were 
significant. Thus, there was no evidence that the burnout group performed 
worse than the control group. Similarly to the 2-Back Task, we found a main 
effect of time, reflecting better performance on the second compared to the 
first test session, which was presumably caused by a learning effect.
Analysis of the reaction times of the first trial of each task run in the Matching 
Task revealed significant main effects of run type, group, and time, but none 
of the interactions were significant. The main effect of run type indicated that, 
overall, the average reaction times of both groups was significantly slower on 
switch than repetition trials. The main effect of group reflected that, overall 
and irrespective of run type, individuals with burnout were significantly slower 
compared to healthy individuals. Importantly, however, this difference was 
further qualified neither by an interaction between run type and group nor 
an interaction between run type, group, and time. The main effect of time 
revealed that independent of run type, the average reaction time of both 
groups was significantly faster on the second than on the first measurement. 
In line with the improved performance on the SART and the 2-Back Task, this 
was probably due to a learning effect. Yet, the main effect of time was not 
further qualified by a group × time interaction.
In sum, although the performance of both groups improved from the first 
to the second session, which was probably due to a learning effect, the 10-
week period with CBT did not yield clear positive effects on cognitive test 
performance of the burnout individuals.
Chapter 2 Burned out cognition
30 31
2
Ta
b
le
 2
.2
. 
M
ea
ns
 a
nd
 s
ta
nd
ar
d 
de
vi
at
io
ns
 o
f 
th
e 
ou
tc
om
e 
m
ea
su
re
s 
an
d 
th
e 
re
su
lt
s 
of
 t
he
 s
ta
ti
st
ic
al
 a
na
ly
se
s
Fi
rs
t 
te
st
in
g 
se
ss
io
n
S
ec
on
d 
te
st
in
g 
se
ss
io
n
Re
su
lts
 f
or
 r
es
ea
rc
h
qu
es
tio
n 
1
Re
su
lts
 f
or
 r
es
ea
rc
h
qu
es
tio
n 
2
B
ur
no
ut
 g
ro
up
C
on
tr
ol
 g
ro
up
B
ur
no
ut
 g
ro
up
C
on
tr
ol
 g
ro
up
M
S
D
M
S
D
M
S
D
M
S
D
S
ou
rc
e
df
F
p
η2
S
ou
rc
e
df
F
p
η2
U
B
O
S
EE
 s
ub
sc
al
ea
3.
88
1.
40
1.
34
0.
98
3.
01
1.
57
1.
34
.7
5
G
ro
up
30
35
.4
1
.0
0
.5
4
G
ro
up
30
29
.2
9
.0
0
.4
9
Ti
m
e
30
5.
37
.0
3
.1
5
G
×
T
30
5.
37
.0
3
.1
5
D
 s
ub
sc
al
ea
2.
30
1.
55
.7
0
.5
5
2.
22
1.
38
.7
7
.6
6
G
ro
up
30
14
.9
9
.0
0
.3
3
G
ro
up
30
16
.2
6
.0
0
.3
5
Ti
m
e
30
.0
0
.9
5
.0
0
G
×
T
30
.3
4
.5
7
.0
1
PA
 s
ub
sc
al
ea
4.
03
.9
3
4.
69
.9
6
4.
05
.8
0
4.
47
.9
8
G
ro
up
30
3.
88
.0
6
.1
1
G
ro
up
30
3.
19
.0
8
.1
0
Ti
m
e
30
.6
2
.4
4
.0
2
G
×
T
30
.9
1
.3
5
.0
3
S
C
L-
90
-R
a
17
3.
75
41
.9
8
11
4.
00
21
.0
1
13
5.
60
37
.7
5
10
6.
69
14
.1
2
G
ro
up
30
26
.5
6
.0
0
.4
7
G
ro
up
29
20
.9
4
.0
0
.4
2
Ti
m
e
29
15
.1
5
.0
0
.3
4
G
×
T
29
6.
67
.0
2
.1
9
C
FQ
a
48
.6
3
17
.5
2
30
.0
6
9.
81
38
.4
4
15
.7
2
27
.9
4
12
.1
3
G
ro
up
30
13
.6
7
.0
0
.3
1
G
ro
up
30
9.
57
.0
0
.2
4
Ti
m
e
30
13
.2
9
.0
0
.3
1
G
×
T
30
5.
70
.0
2
.1
6
2-
B
ac
k 
Ta
sk
b
34
.5
0
15
.2
8
43
.9
4
7.
59
40
.1
9
12
.4
0
46
.9
4
8.
53
G
ro
up
30
4.
90
.0
4
.1
4
G
ro
up
30
4.
71
.0
4
.1
4
Ti
m
e
30
8.
33
.0
1
.2
2
G
×
T
30
.8
0
.3
8
.0
3
SA
RT
c
10
.0
0
4.
15
9.
94
5.
09
6.
75
4.
63
7.
00
5.
56
G
ro
up
30
.0
0
.9
7
.0
0
G
ro
up
30
.0
0
.9
5
.0
0
Ti
m
e
30
19
.3
1
.0
0
.3
9
G
×
T
30
.0
5
.8
3
.0
0
M
at
ch
in
g 
Ta
sk
R
un
 t
yp
e
30
37
.5
9
.0
0
.5
6
R
un
 t
yp
e
30
62
.2
0
.0
0
.6
8
RT
 s
w
itc
hd
12
36
25
1.
59
10
15
19
0.
52
11
09
22
2.
15
94
7
15
3.
72
G
ro
up
30
9.
69
.0
0
.2
4
G
ro
up
30
8.
86
.0
1
.2
3
RT
 r
ep
et
iti
on
d
10
73
19
5.
71
88
9
12
6.
14
99
3
23
1.
22
83
4
13
8.
62
R
te
×
G
30
.6
0
.4
5
.0
2
Ti
m
e
30
14
.8
8
.0
0
.3
3
R
t×
G
30
.3
6
.5
5
.0
1
R
t×
T
30
1.
01
.3
2
.0
3
G
×
T
30
.9
7
.3
3
.0
3
R
t×
G
×
T
30
.3
3
.5
7
.0
1
N
ot
e.
 E
E 
=
 E
m
ot
io
na
l 
Ex
ha
us
tio
n.
 D
 =
 D
ep
er
so
na
liz
at
io
n.
 P
A
 =
 P
er
so
na
l 
A
cc
om
pl
is
hm
en
t.
 S
C
L-
90
-R
 =
 S
ym
pt
om
 C
he
ck
lis
t-
90
-R
ev
is
ed
. 
C
FQ
 =
 
C
og
ni
tiv
e 
Fa
ilu
re
 Q
ue
st
io
nn
ai
re
. 
SA
RT
 =
 S
us
ta
in
ed
 A
tt
en
tio
n 
to
 R
es
po
ns
e 
Te
st
. 
RT
 =
 R
ea
ct
io
n 
Ti
m
e.
a T
ot
al
 s
co
re
. 
b C
or
re
ct
 r
es
po
ns
es
. 
c I
nh
ib
iti
on
 e
rr
or
s.
 d
Re
ac
tio
n 
tim
es
 in
 m
ill
is
ec
on
ds
. 
e R
un
 t
yp
e.
Chapter 2 Burned out cognition
32 33
2
2.5. Discussion
The aim of this study was twofold. First, we aimed to examine whether burnout 
is associated with self-reported cognitive difficulties and deficits in executive 
functioning, as measured with tests that assess the executive functions 
updating, inhibition, and switching. Second, we wanted to test whether 
these potential self-reported cognitive difficulties and deficits in executive 
functioning in burnout diminish after a 10-week period of CBT.
2.5.1. Burnout and cognitive functioning
Regarding our first aim, we found that, on the first measurement, individuals 
with burnout reported considerably more cognitive failures than healthy 
individuals. This finding is consistent with the results of several previous 
studies on burnout (Öhman et al., 2007; Österberg et al., 2009; Wahlberg et 
al., 2009) and with numerous clinical observations. Interestingly, burnout was 
also associated with impaired performance on two of the three cognitive tests 
(the 2-Back and the Matching tasks). This implicates that the self-reported 
cognitive complaints in burnout can be substantiated with objective difficulties 
in cognitive performance. Whether or not such difficulties resulted from 
specific deficits in executive functioning or, instead, indicate a more general 
cognitive decline is less clear. More specifically, the individuals with burnout 
showed performance deficits on the 2-Back Task, which indicates that they 
had problems with the updating executive function. However, even though 
employees with burnout underperformed compared to healthy individuals on 
the Matching Task, the pattern of deficits seems to indicate a more general 
cognitive decline, that is, an overall reaction time increase instead of specific 
problems with the transition from repetition to switch trials. Thus, switch costs 
were not significantly longer for individuals in the burnout group, suggesting 
that the corresponding and specific executive function (switching) was not 
impaired. Furthermore, the burnout group did not perform significantly worse 
than the healthy controls on the SART, indicating that they were still able to 
inhibit responses adequately.
Our finding that, compared to healthy individuals, individuals with burnout 
generally reacted slower on the Matching Task is in line with results in previous 
studies (Öhman et al., 2007; Österberg et al., 2009; Rydmark et al., 2006; 
Sandström et al., 2005; Van der Linden et al., 2005), in which burnout was found 
to be related with performance deficits in complex speed measures. The result 
that, compared to the healthy controls, the burnout group underperformed 
on the working memory task (updating and monitoring of working memory 
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representations) is also consistent with findings in previous studies (Öhman 
et al., 2007; Rydmark et al., 2006), wherein burnout was associated with 
impairments in working memory processes. However, our findings that 
individuals with burnout did not perform worse than healthy individuals on the 
inhibition and switching tests, is in contrast to the findings of previous studies, 
in which evidence for differences in inhibition (Van der Linden et al., 2005) 
and switching (Öhman et al., 2007) was obtained. These inconsistent results 
might be related to differences in burnout samples between the studies. In 
the present study we explicitly examined burnout patients without a mood or 
anxiety disorder, whereas the other studies assessed a more heterogeneous 
sample in this respect. However, to date, the question concerning the generality 
or specificity of cognitive deficits (i.e., general cognitive decline and/or 
impairments in specific executive functions) in burnout cannot be conclusively 
answered yet.
2.5.2. Changes after a 10-week period with cognitive 
behavioral therapy
As to our second aim, we found that the level of emotional exhaustion (Utrechtse 
Burnout Scale) and the number of physical and mental complaints (SCL-90-R) 
of individuals with burnout significantly and substantially decreased after a 
10-week period of CBT. This suggests that the treatment had a positive effect 
on subjective burnout symptoms as well as on general health complaints. 
Note that as we did not have a waitlist control group (a group of individuals 
with burnout that did not receive treatment), we cannot conclusively answer 
the question whether the improvement was really due to the treatment or 
was (also) an effect of the lapse of time and/or the fact that some individuals 
with burnout were on sick leave or worked only part-time. However, for our 
purposes, this was not crucial. The main focus of this study was whether or 
not the expected reduction in burnout symptoms and more general physical 
and mental complaints were accompanied by a decline in both subjective 
and objective cognitive performance. The results of this study confirmed this 
partially: the self-reported cognitive performance of individuals with burnout 
improved during the 10-week period with CBT. However, although the cognitive 
test performance of both the burnout and the control group improved probably 
due to a general learning effect, we found no direct evidence that the differences 
in cognitive test performance (i.e., number of correct responses in the 2-Back 
Task and general reaction times in the Matching Task) between both groups had 
decreased after the 10-week period. Hence, whatever recovery processes took 
place during the 10-week period with CBT regarding the subjective complaints, 
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we found no proof that the objective cognitive performance of the burned out 
employees improved during that time.
There are several possible explanations for why individuals with burnout still 
underperformed on the cognitive tests compared to healthy individuals on the 
second measurement. One possibility is that the high levels of stress, which are 
associated with burnout, lead to permanent brain changes among individuals 
with burnout and that these changes are mediated by enhanced glucocorticoid 
levels as outlined in the introduction. However, whether glucocorticoids indeed 
play a role in cognitive effects in burnout is currently difficult to establish as 
the results of studies in this research field are mixed. For example, studies 
reported reduced (Österberg et al., 2009; Rydmark et al., 2006), equal (Grossi 
et al., 2003; Mommersteeg, Heijnen, Verbraak, et al., 2006a), and elevated 
(De Vente et al., 2003; Grossi et al., 2005) cortisol levels among individuals 
with burnout compared to healthy individuals. Clearly, more insight into 
potential (neuro)endocrine abnormalities among individuals with burnout, and 
the possible effects of these abnormalities upon cognition and the brain, is 
required. Therefore, future longitudinal studies spanning longer time intervals 
might test individuals with burnout by comparing them to matched healthy 
individuals on both cognitive performance and (neuro)endocrine-system 
functioning. In addition, neuroimaging techniques could be used to examine 
whether brain regions involved in important cognitive processes, such as 
the (dorsolateral) prefrontal cortex and the hippocampus, of individuals with 
burnout deviate from those of healthy individuals.
A second explanation is that the amount of treatment sessions and/or the 
time interval between the first and the second measurement was simply not 
sufficient to bring about major changes in cognitive functioning. Although 
we found supportive evidence pointing to a significant decrease of burnout 
symptoms and general health complaints in the burnout group, the level of 
symptoms and complaints were still high compared to norm scores and still 
significantly higher than those of the control group. In addition, it should be 
kept in mind that treatment of the individuals with burnout had not ended at 
the time of the second measurement. Thus, the burnout group had “become 
better, but not well yet”. Accordingly, we cannot rule out the possibility that 
after a longer period of continued CBT (i.e., more sessions) burnout symptoms 
and general health complaints would have decreased further and/or self-
reported cognitive functioning and cognitive test performance would have 
improved further. Hence, future studies should preferably include more than 
one follow- up measurement and follow individuals with burnout over a longer 
period of time.
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A third explanation is that individuals in the burnout group had already 
experienced cognitive deficits before they developed a burnout. Since 
executive functions are considered to be essential in coping effectively with 
stress (Declerck, Boone, & De Brabander, 2006; Williams, Suchy, & Rau, 
2009), impairments in executive functioning might, at least theoretically, 
play an important role in the development of burnout. Accordingly, when 
confronted with stressors on the job, executive dysfunction might lead to 
inadequate coping strategies that may enhance the probability of developing 
a burnout. Unfortunately, to the authors’ knowledge there are no studies 
yet that have investigated whether impairments in executive (and/or general 
cognitive) functioning precede burnout.
2.5.3. Strengths and limitations
An asset of this study was that the participants in the burnout group were 
selected on the basis of a high-quality burnout diagnosis, as established by 
professional clinical psychologists. Moreover, we only selected participants 
for the burnout group without comorbid disorders. In many previous studies, 
participants in the burnout group consisted of a mix of individuals that may 
have had a comorbid disorder (e.g., a mood and/or anxiety disorder) in addition 
to their burnout diagnosis. A burnout sample without comorbid disorders 
enabled us to carry out a relatively “pure” assessment of the relationship 
between burnout and cognition.
Another strength is that we systematically examined executive functioning. In 
previous studies, a variety of executive functions were assessed with various 
cognitive neuropsychological tests. In this study, however, we closely followed 
the literature and focused on three well-documented and basic types of 
executive functions that we assessed with well-validated tests, each tapping 
specifically into one of the three target functions.
This study also has its limitations. Firstly, it is hard to make clear causal 
inferences from the present data. We treated cognitive functioning as an 
outcome variable influenced by burnout. Our findings that burnout was 
associated with cognitive deficits, however, do not rule out the possibility of 
a reverse causal relation, nor of a bi-directional relationship. In other words, 
cognitive deficits may be both cause and consequence of burnout. Studies with 
more repeated measurements may shed more light on the issue of causality 
in the relationship between burnout and cognitive functioning.
Furthermore, we did not include a waitlist control group. Such a group would 
have enabled us to assess whether the changes that were observed in the 
Chapter 2 Burned out cognition
36 37
2
present burnout group were due to the treatment, the lapse of time, or both. 
Clearly, this study on possible dynamic changes in cognitive performance of 
burnout individuals must be supplemented by further research.
Another limitation is that some of the individuals with burnout already had 
received one or two therapy sessions before their first testing session, which 
may have decreased the chance of finding a therapy effect. However, it is 
not very likely that this influenced the study outcomes, since these first two 
therapy sessions consisted mostly of psychoeducation and the registration of 
complaints.
As caffeine intake may affect cognitive performance (Glade, 2010), we asked 
participants not to consume any caffeine on both test sessions. One might 
argue that withholding participants from their daily caffeine intake may have 
had an effect on their cognitive performance as well. However, in that case, it 
seems implausible that caffeine deprivation would have had a different impact 
in both groups.
Finally, the sample size in our study, though carefully selected and matched, 
was of a relatively small size. However, despite the limited sample size, we 
found several meaningful statistically significant differences between the two 
groups, while at the same time, the large majority of the major null results 
clearly were not due to a lack of statistical power (given the high p-values 
and low η2-values associated with the corresponding analyses). Nevertheless, 
future studies might preferably use larger study samples and more repeated 
measurements to examine burnout and cognitive functioning in relation to 
treatment and time lapse.
2.5.4. Conclusion
Although we found that burnout was associated with self-reported cognitive 
difficulties, relatively slow responding, and impaired executive functioning, we 
did not find evidence that burnout was associated with deficits in all executive 
functions that we assessed. Based on the present results, combined with the 
results of previous studies on the relationship between burnout and cognitive 
functioning, we therefore conclude that the specific nature of cognitive decline 
in burnout is not clear yet.
While evidence was obtained that a 10-week period containing CBT “brought 
about” positive changes in burnout symptoms and general health complaints, 
individuals with burnout only showed improvements with respect to self-
reported cognitive functioning. No evidence was found that individuals with 
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burnout improved regarding their cognitive test performance. Until further 
research provides conclusive evidence, multiple explanations can be given for 
this result.

CHAPTER 3
Cognitive performance in both clinical 
and non-clinical burnout
This chapter appeared as:
Oosterholt, B. G., Maes, J. H. R., Van der Linden, D., Verbraak, M. J. P. M., 
& Kompier, M. A. J. (2014). Cognitive performance in both clinical and non-
clinical burnout. Stress, 17(5), 400-409.
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3.1. Abstract
Relatively little is known about cognitive performance in burnout. The aim of 
the present study was to further our knowledge on this topic by examining, 
in one study, cognitive performance in both clinical and non-clinical burnout 
while focusing on three interrelated aspects of cognitive performance, 
namely, self-reported cognitive problems, cognitive test performance, and 
subjective costs associated with cognitive test performance. To this aim, a 
clinical burnout patient group (n = 33), a non-clinical burnout group (n = 
29), and a healthy control group (n = 30) were compared on self-reported 
cognitive problems, assessed by a questionnaire, as well as on cognitive test 
performance, assessed with a cognitive test battery measuring both executive 
functioning and more general cognitive processing. Self-reported fatigue, 
motivation, effort and demands were assessed to compare the different groups 
on subjective costs associated with cognitive test performance. The results 
indicated that the clinical burnout patients reported more cognitive problems 
than the individuals with non-clinical burnout, who in turn reported more 
cognitive problems relative to the healthy controls. Evidence for impaired 
cognitive test performance was only found in the clinical burnout patients. 
Relative to the healthy controls, these patients displayed some evidence of 
impaired general cognitive processing, reflected in slower reaction times, but 
no impaired executive functioning. However, cognitive test performance of 
the clinical burnout patients was related to larger reported subjective costs. 
In conclusion, although both the clinical and the non-clinical burnout group 
reported cognitive problems, evidence for a relatively mild impaired cognitive 
test performance and larger reported subjective cost associated with cognitive 
test performance was only found for the clinical burnout group.
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3.2. Introduction
Burnout is a reaction to chronic work stress, characterized by three main 
symptom dimensions: exhaustion, cynicism (a distant attitude towards the job), 
and feelings of reduced professional efficacy (Maslach et al., 2001). Related 
to the latter, individuals with burnout often report to experience cognitive 
problems, such as the inability to concentrate and memory impairments (e.g., 
Weber & Jaekel-Reinhard, 2000). To date, few studies have been performed 
to validate the relationship between burnout and cognition using objective 
measures (e.g., Jonsdottir et al., 2013; Oosterholt, Van der Linden, Maes, 
Verbraak, & Kompier, 2012; Österberg et al., 2009; Sandström et al., 2005; 
Van Dam, Keijsers, Eling, & Becker, 2011; Van der Linden et al., 2005). The 
overall pattern of results indicates that the cognitive problems experienced 
in burnout are indeed accompanied by actual cognitive impairments, as 
assessed by a variety of cognitive neuropsychological tests. However, it still 
remains unclear what the exact nature of the putative impairments is (i.e., 
deficits in executive functioning and/or a more general cognitive decline), and 
which specific functions are impaired.
Several factors may underlie the inconclusive results on the relationship 
between burnout and cognition, such as the heterogeneity of the cognition 
assessment tools, potential confounding variables that were not controlled for, 
and the relatively small sample size in some of the previous studies. Perhaps, 
the most fundamental factor may be the way in which burnout is defined in 
earlier research. In some studies the burnout group consisted of individuals 
with a clinical burnout diagnosis (e.g., Jonsdottir et al., 2013; Van Dam et 
al., 2011), whereas in other studies (e.g., Castaneda et al., 2011; Diestel, 
Cosmar, & Schmidt, 2013) a burnout group comprised healthy undiagnosed 
individuals who merely reported burnout symptoms, as assessed by a 
questionnaire. With regard to the diagnosis of clinical burnout, the criteria 
on the basis of which such clinical burnout diagnosis was established are not 
always clear (e.g., Sandström et al., 2005; Van der Linden et al., 2005) and 
differ between studies (e.g., compare Öhman et al., 2007; Oosterholt et al., 
2012). Furthermore, it is not always apparent whether the individuals of a 
clinical burnout group were “real patients” who were actually seeking help 
for their complaints, or were just clinically diagnosed within the context of 
the study (e.g., Österberg et al., 2009; Rydmark et al., 2006). In case of real 
patients, in a large number of studies (e.g., Sandström et al., 2005; Van Dam 
et al., 2013) no information was provided about the time between diagnosis 
and participation in the study. A final key aspect regarding the diagnosis of 
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burnout is comorbidity with other psychopathologies. For example, there is 
ample evidence showing that depression, often comorbid with burnout, is 
related to cognitive dysfunction (e.g., Gotlib & Joormann, 2010). In former 
research, however, patients with comorbid mental disorders were not always 
excluded or the effects of comorbidity were not always controlled for (e.g., 
Rydmark et al., 2006; Van der Linden et al., 2005). In these studies, the 
observed cognitive test performance in burnout patients may possibly have 
been negatively influenced by mental disorders other than burnout.
The aim of the present study was to examine cognitive performance in 
burnout with a design that allowed us to avoid the key limitations of previous 
research. To this aim, we carefully selected a large group of “freshly” clinically 
diagnosed burnout patients without comorbid disorders, so as to preclude the 
effect of other psychopathologies. Additionally, we included a large non-clinical 
burnout group consisting of individuals, who reported to have symptoms of 
burnout, but were not clinically diagnosed and were not seeking help for these 
symptoms. The two different burnout groups were compared with each other 
and with a matched healthy control group on cognitive performance. Cognitive 
performance was assessed subjectively, by a commonly used and validated 
questionnaire, as well as objectively, by a carefully chosen battery of validated 
tests measuring the most important aspects of executive functioning and more 
general cognitive processing. For a full assessment of task performance, it is 
important to also evaluate the involved costs (e.g., Hockey, 2013; Meijman 
& Mulder, 1998). Therefore, to get more insight into cognitive performance 
in burnout, we additionally evaluated the performance on the cognitive tests 
in light of the associated costs. Hereto, we included measures that provided 
information about subjective costs (experienced fatigue, motivation, effort, 
and demands) that went together with performing the cognitive tests.
In summary, the purpose of the present study was to determine how both 
clinical burnout and non-clinical burnout are related to cognitive performance. 
To this end, we focused on three interrelated features of cognitive performance: 
(i) self-reported cognitive problems, (ii) cognitive test performance; and (iii) 
subjective costs associated with cognitive test performance.
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3.3. Method
3.3.1. Participants
The study comprised three different groups of individuals (total N = 92): A 
group of 33 patients with a clinical burnout diagnosis (clinical burnout group), 
a group of 29 individuals reporting symptoms of a burnout, but neither 
diagnosed as such nor seeking help for these symptoms (non-clinical burnout 
group), and a group of 30 healthy controls (control group). Originally, the non-
clinical burnout group consisted of 30 individuals; however, one participant 
was excluded due to logistical problems with data collection. The three groups 
were matched on several demographical characteristics (for more detailed 
information, see Table 3.1.). Furthermore, each group consisted of individuals 
with various occupational backgrounds.
The clinical burnout patients were recruited from HSK Group, a large mental 
healthcare organization with several offices across the Netherlands. From 
three of those offices, located in the eastern part of the Netherlands, patients 
were selected on the basis of their burnout diagnosis. A burnout diagnosis was 
always established by a team of two or three professional clinical psychologists 
and based on an intake procedure in which a structured clinical interview 
was used containing the Dutch translation (Overbeek et al., 1999) of the 
MINI International Neuropsychiatric Interview 5.0.0 (M.I.N.I.; Sheehan et al., 
1998). Since burnout is not officially included in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV-TR; American Psychiatric Association, 
2000), in the Netherlands a burnout diagnosis is usually based on the DSM-
IV-TR criteria for diagnosing an undifferentiated somatoform disorder with 
the addition that the cause of the symptoms is work-related. This procedure 
was also used in our study. To further validate the assessment of a burnout 
diagnosis, patients filled out the Utrecht Burnout Scale (UBOS; Schaufeli 
& Van Dierendonck, 2000; see “Materials” section for more information). 
Although the symptoms of burnout overlap with symptoms of some other 
psychological disorders, in particular depression, there is sufficient evidence 
revealing that burnout is a distinct construct that can be differentiated from 
other psychological disorders (e.g., Ahola et al., 2005; Bakker et al., 2000; 
Glass & Mcknight, 1996; Leiter & Durup, 1994; Shirom, 2005). For this 
reason, patients were excluded from participation in this study if they fulfilled 
the DSM-IV criteria for any other axis I disorder, as assessed with the M.I.N.I., 
or if they met the DSM-IV criteria for an axis II disorder, as determined with 
the Assessment of DSM-IV Personality Disorders (ADP-IV; Schotte & De 
Doncker, 1994). Of the eligible burnout patients, approximately 40 % agreed 
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to participate in the study. Twelve of the 33 participating patients were on 
sick leave due to their burnout, 16 still worked but fewer hours than before 
their burnout diagnosis, and 5 continued working the same number of hours 
as before their diagnosis.
The individuals in the non-clinical burnout group and the control group 
were recruited via local advertisements or social networking. Inclusion of 
individuals in the non-clinical burnout group and the control group was based 
on a screening questionnaire in which several demographical characteristics 
(used to match the different groups; see Table 3.1.), the exhaustion subscale 
of the UBOS and (history of) psychiatric disorders were assessed. Individuals 
with scores on the exhaustion subscale equal to or higher than the cut-off 
point of 2.20 (Schaufeli & Van Dierendonck, 2000) were assigned to the non-
clinical burnout group and individuals with lower scores to the control group. 
Table 3.1. Demographical characteristics
Clinical burnout Non-clinical burnout Control
M SD M SD M SD p
Age 41.91 10.89 37.55 12.55 38.93 11.23 .321
Work hours per weeka* 36.03 6.70 33.12 6.45 31.07 8.54 .031
n % n % n % p
Sex .632
Men 18 54.55 13 44.83 16 53.33
Women 15 45.45 16 55.17 14 46.67
Level of educationb .902
1 0 .00 0 .00 0 .00
2 3 9.09 2 6.90 2 6.67
3 11 33.33 11 37.93 8 26.67
4 19 57.58 16 55.17 20 66.67
Irregular working hours .652
Yes 10 30.30 12 41.38 10 33.33
No 23 69.70 17 58.62 20 66.77
Medicationc
Psychotropic drugs 4 12.12 1 3.45 0 .00 .102
Somatic drugs 5 15.15 4 13.79 2 6.67 .572
Corticosteroids & antihistamines 2 6.06 5 17.24 2 6.67 .262
Contraceptives 6 18.18 5 17.24 4 13.33 .882
Herbal drugs 0 .00 1 3.45 1 3.33 .532
None 19 57.58 15 51.72 23 76.67 .122
Note. aParticipants’ contractual working hours per week. bLevel of education was measured in terms 
of highest level of education completed, ranging from 1 to 4, primary school to university degree, 
respectively. cSince some participants used more than one type of medication: i) separate tests 
were performed for each type of medication, and ii) the sum of the n and the % of the different 
types of medication is larger than the total n of a particular group and 100 %, respectively.
*The clinical burnout group significantly differed from the control group.
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Individuals with a past history of burnout and individuals who had a current 
psychiatric disorder were excluded from participating in the non-clinical 
burnout group and the control group.
3.3.2. Materials
3.3.2.1. Self-reports
Utrechtse Burnout Scale. The UBOS (Schaufeli & Van Dierendonck, 2000), which 
is the Dutch adaptation of the Maslach Burnout Inventory (MBI; Maslach et al., 
1996), was used to measure burnout symptoms. In this study, the version for 
general professions (UBOS-A; Schaufeli & Van Dierendonck, 2000) was used. 
It contains 15 questions that can be answered on a 7-point Likert scale (0 = 
“never”, 6 = “every day”). The UBOS-A consists of three subscales: exhaustion 
(five items), cynicism (four items), and professional efficacy (six items). Sample 
items are, respectively, “I feel mentally exhausted by my job”, “I doubt about 
the usefulness of my job”, and “I know well how to solve problems in my job”. 
The internal consistencies (measured with Cronbach’s alpha) of the subscales 
were, respectively, .95, .88, and .80.
Symptom Checklist-90-Revised. The Dutch adaptation (Arrindell & Ettema, 2003) 
of the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977) was used 
to determine general physical and psychological complaints. This questionnaire 
contains 90 items divided into nine subscales: Eight subscales which measure 
the primary symptom dimensions of anxiety (10 items), agoraphobia (7 
items), depression (16 items), somatization (12 items), insufficiency (9 items), 
sensitivity (18 items), hostility (6 items), and sleeplessness (3 items), and one 
subscale with additional questions (9 items). Each item can be scored on a 
5-point Likert scale (1 = “not at all”, 5 = “extremely”). The sum of the scores on 
the nine subscales results in a psychoneuroticism score, which is the equivalent 
of the Global Severity Index in the English version. Cronbach’s alpha of this 
questionnaire was .98.
Cognitive Failure Questionnaire. Self-reported cognitive problems were 
assessed with a Dutch translation of the Cognitive Failure Questionnaire (CFQ; 
Broadbent et al., 1982). The CFQ consists of 25 items measuring the frequency 
of everyday cognitive failures. The items can be answered on a 5-point Likert 
scale (0 = “never”, 4 = “very often”). Sample items are “Do you read something 
and find you have not been thinking about it and must read it again?”, “Do you 
find yourself suddenly wondering whether you’ve used a word correctly?” and 
“Do you find you forget appointments?” Cronbach’s alpha was .92.
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Fatigue, motivation, effort, and demands. Fatigue was measured prior to 
and after the cognitive test battery. Furthermore, before the test battery 
participants rated how motivated they were to complete the tests and 
afterwards how much effort they had invested in completing the tests. After 
each cognitive test, participants were asked to score how demanding the test 
had been. All questions were answered on a 10-point Likert scale (1 = “not at 
all”, 10 = “very much”).
3.3.2.2. Cognitive tests
A carefully chosen battery of well-validated tests was employed to measure 
executive functioning as well as more general cognitive processing. In line 
with Miyake et al. (2000), we measured the three most basic and distinctive 
executive functions, namely, updating, inhibition and switching. With respect 
to inhibition, we examined both inhibition of prepotent responses and inhibition 
of irrelevant information (interference control), since these are considered to 
represent two important distinctive types of inhibition, with different neuronal 
substrates (e.g., Nigg, 2000). Verbal memory was assessed as a measure of 
general cognitive processing. Furthermore, some general task performance 
measures (see below) were also used as indicators of general cognitive 
processing.
All cognitive tests were computerized and performed on a laptop with a 15-
inch screen. Participants were seated at a distance of approximately 50 cm in 
front of the laptop screen. A test was introduced with both a written instruction 
on the screen and a verbal explanation by the experimenter. Prior to the 
experimental part of a test, participants practiced each test for approximately 
30 s.
2-Back Task. A variant of the 2-Back Task (Kirchner, 1958) was used to assess 
the updating function. The test consisted of 300 letters, which were presented 
one by one in the center of the screen with a fixed stimulus duration of 450 
ms and a fixed inter-stimulus interval (ISI) of 750 ms. Stimuli consisted of 
the letters b, d, g, p, t, and v, which were displayed in a quasi-random order 
in either capital or small letters. Participants were instructed to press a button 
on a button-box when the displayed letter was similar to the letter which was 
displayed two stimuli earlier (target rate was 33 %). The response time was 
fixed at 1200 ms. The test lasted for about 6 min. The updating function was 
operationalized by the number of correct responses (for a correct response no 
difference was made between capital and small letters).
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STOP-IT. The ability to inhibit prepotent responses was measured with 
STOP-IT (Verbruggen, Logan, & Stevens, 2008), a test based on the stop-
signal paradigm as originally developed by Lappin and Eriksen (1966). The 
test contained 192 trials, in which first a fixation-cross was displayed in the 
center of the screen (for 250 ms), followed by a circle or a square. Stimulus 
duration depended on the individual’s response with a maximum of 1250 
ms. The ISI was fixed at 2000 ms. In 25 % of the trials an auditory stop-
signal (750-Hz, for 75-ms) was presented after the visual stimulus (i.e., a 
circle or a square) appeared on the screen. Participants were instructed to 
quickly push the leftmost button on a button-box when a square appeared, 
and the rightmost button when a circle was presented. However, on the stop-
signal trials, that is, when an auditory signal was presented, participants 
were instructed to withhold their responses. The time between the visual 
stimulus and the auditory stop-signal, i.e., the stop-signal delay, increased or 
decreased depending on whether or not a response on stop-signal trials was 
inhibited. If the participant successfully inhibited a response, the stop-signal 
delay time increased with 50 ms, and if the participant failed to inhibit their 
response, the stop-signal delay time decreased with 50 ms. The initial stop-
signal delay was 250 ms. The duration of the test was approximately 7 min. 
The mean probability of responding on stop-trials, i.e., p(respond/signal), 
and the stop-signal reaction time (SSRT) were used to assess the capability 
to inhibit prepotent responses. Furthermore, the go-trial RT was analyzed as 
a measure of general cognitive processing. For more information about these 
variables, how these variables were calculated (ANALYZE-IT software), and a 
more detailed description of STOP-IT, see Verbruggen et al. (2008).
Flanker Task. A modified version of the Flanker Task (Eriksen & Eriksen, 1974) 
was used to assess participants’ capacity to inhibit irrelevant information. The 
test consisted of 200 trials, each starting with a fixation-cross (250 ms), which 
was directly followed by four flanker arrows without a central target arrow 
(i.e., < <    < <  or  > >    > >). After 450 ms, a congruent or an incongruent 
central target arrow appeared between the second and the third flanker arrow 
for 100 ms. Hence, the following central target arrow combinations were 
used: < < < < <  and  > > > > > (congruent), and < < > < <  and  > > < > 
> (incongruent). The different combinations were presented quasi-randomly 
with equal probabilities. Once the central target arrow appeared, participants 
had a fixed period of 800 ms to respond, which was followed by a 50 ms inter-
trial interval. Participants were instructed to press as quickly as possible the 
leftmost button on a button-box when the central arrow pointed to the left 
and the rightmost button when the central arrow pointed to the right. The test 
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lasted approximately 5 min. Performance on this test was expressed in terms 
of error rates. The congruency effect, which is the variable used to measure 
the ability to inhibit irrelevant information, was assessed by comparing the 
mean error rates on congruent and incongruent trials. Furthermore, the 
overall error rate, measured by the total number of errors on both congruent 
and incongruent trials was used as a measure of general cognitive processing. 
No-response trials and trials with a RT faster than 100 ms were excluded from 
both analyses.
Matching Task. To assess the switching function, the Matching Task (Poljac et 
al., 2010), which is a variant of the task-switching paradigm of Jersild (1927), 
was used. The Matching Task consisted of 31 task runs, each consisting of four 
to eight trials with an average of six trials. In each trial, five colored geometric 
figures were displayed on the screen, one in the upper half and four in the 
lower half. The figures included a circle, hexagon, square, or triangle, colored 
blue, green, red, or yellow. The figure in the upper half of the screen was 
the reference figure and the figures in the lower half were the match figures. 
Participants were instructed to match the reference figure in the upper half 
of the screen as quickly and accurately as possible with one of the match 
figures in the lower half of the screen on the basis of color or form. Matching 
the reference figure with one of the match figures was performed by pressing 
one of four buttons on the keyboard corresponding to one of the four match 
figures. The type of task to be performed, matching according to color or form, 
was indicated with a cue, which was presented for 1000 ms at the beginning 
of each task run. After a 700 ms blank screen, the trials were subsequently 
presented with a maximum duration of 3000 ms, depending on a participant’s 
response. Feedback prompting participants to respond faster was given when 
participants did not respond within 3000 ms. A 250-ms blank screen was 
presented between each trial of a task run as well as after the last trial of a task 
run and the start of the next task run (i.e., the appearance of a cue). The figure 
color-shape combination was randomly determined with two restrictions. First, 
the reference and the match figures were not allowed to match on both shape 
and color. Second, the four match figures were not allowed to have the same 
shape or color. Half of the task runs were programmed to be “switch” runs, 
in which the type of task differed from the preceding run. The other half was 
programmed to be “repetition” runs, in which the type of task was equal to the 
preceding run. The test duration was about 5 min. Since the error rates are 
generally quite low in task-switching paradigms (Steinhauser & Hübner, 2006), 
and also in the matching task (Poljac et al., 2010), performance on this test 
was only measured by the reaction times (RTs). The switch cost, which is the 
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outcome measure of this test that is used to examine the switching function, 
was determined by comparing the mean RT of the first trial of switch runs and 
the first trial of repetition runs. Furthermore, the overall RT, operationalized as 
the mean RT on trial 1 of all task runs (both switch and repetition runs), was 
used as indicator of general cognitive processing. For the calculation of both 
outcome measures, error and no-response trials, and trials with a RT 5100 ms 
were excluded. In addition, for computing the switch cost, trials that directly 
followed error or no-response trials were also excluded as were the task run 
that directly followed a task run in which all trials were errors.
Digit Span Task. A forward Digit Span Task, first described by Jacobs (1887), 
was used as a separate test to assess the general cognitive process of verbal 
memory. The test contained 18 trials, each consisting of a series of digits 
that were presented one by one in the center of the screen. Each digit was 
presented for 450 ms with an ISI of 500 ms. A series of digits could consist 
of the numbers 1 to 9. Because the digits were chosen randomly, a particular 
digit could be presented more than once within a series. Furthermore, the 
number of digits in a series increased, beginning with a series of three digits 
and ending with a series of nine: 1 * 3, 2 * 4, 4 * 5, 4 * 6, 4 * 7, 2 * 8, and 
1 * 9. Participants were instructed to recall the numbers in the order they 
were presented to them. Participants used the number keys on the keyboard 
to type in their response (in a response box that appeared after each series of 
digits). When participants accidentally made a typing error, they could use the 
“backspace” to correct their response, and when satisfied with their response, 
the “enter” key was used to start the next series of numbers. After pressing 
the enter key, it took 1000 ms before the next series of digits was presented. 
The test lasted for about 5 min. The total number of correct recalls was used 
as outcome measure.
3.3.3. Procedure
After participants were recruited, an appointment was made for a test session. 
On average, the patients in the burnout group were tested within 1 month 
after they were diagnosed with burnout (range 4–62 days). A test session took 
place on a weekday and started around 14:00 hr. Testing of the burnout group 
occurred in a quiet room at one of the three offices of the mental health care 
organization. Participants of the non-clinical burnout and the control group 
were tested at their homes or at the university in a quiet room. All participants 
were tested individually. A test session started with the five cognitive tests 
in combination with the questions about fatigue, motivation, effort and 
demands (see “Materials” section for more information). The cognitive tests 
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were presented in a counter-balanced order across the participants. After 
completing the cognitive tests, participants filled out the UBOS, SCL-90-R, 
CFQ, and some questions about demographical characteristics and potentially 
confounding variables. In total, a test session lasted approximately 75 min. 
All participants gave informed consent and the study was approved by the 
Ethical Committee of the Faculty of Social Sciences at the Radboud University 
Nijmegen in the Netherlands.
3.3.4. Statistical analyses
Demographical characteristics were analyzed using a one-way univariate 
analysis of variance (ANOVA) and Pearson’s chi-square test (when necessary 
with Monte Carlo correction) (see Table 3.1. for the specific analysis/test used 
for each demographical characteristic). Fatigue scores prior to and after the 
cognitive test battery were analyzed with a 2 × 3 mixed design ANOVA with 
Time (prior to versus after) as within-subject factor and Group (clinical burnout 
versus non-clinical burnout versus control) as between-subject factor. All 
other self-reported data were statistically evaluated using one-way univariate 
ANOVA. The outcome measures of the cognitive tests, except those of the 
Matching and Flanker Task, were analyzed with one-way univariate ANOVA. 
The data of the Matching and Flanker Task were analyzed using a 2 × 3 mixed 
design ANOVA with Run type (switch versus repetition) as within-subject factor 
for the Matching Task and Trial type (congruent versus incongruent) as within-
subject factor for the Flanker Task, and for both tasks Group (clinical burnout 
versus non-clinical burnout versus control) as between-subject factor. Since 
the Flanker Task data of one participant of the non-clinical burnout group were 
not stored due to technical computer problems, the analysis of the Flanker 
Task was based on a N = 91 (see df2 column in Table 3.3).
For all outcome measures, within-group outliers were replaced with the group 
mean + or − three standard deviations. After replacing the outliers (five 
in total), inspection of the data revealed that, except for the scores of the 
Flanker Task, the scores of the other outcome measures were approximately 
normally distributed. Prior to the analysis, the scores of the Flanker Task were 
log10-transformed to improve normality (on raw data, without replacement of 
outliers). All statistical results were based on two-tailed tests using an alpha 
level of .05. Partial eta-squared (η2) was used as an effect size estimate. When 
a statistically significant overall group effect was obtained, pair-wise group 
comparisons were made using Fisher’s Protected Least Significant Different 
(FPLSD) post-hoc tests. All statistical analyses were performed with SPSS for 
Microsoft Windows, version 20.0 (SPSS, Inc., Chicago, IL).
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3.4. Results
3.4.1. Demographical characteristics
Table 3.1. displays the demographical characteristics of the three groups. The 
groups did not significantly differ on age, level of education, sex, working 
irregular working hours, and intake of medication.
3.4.2. UBOS, SCL-90-R, and CFQ
Analysis of the UBOS scores revealed a significant overall main effect of Group 
on all three subscales (see Table 3.2. for the statistics). Post-hoc tests showed 
that all three groups differed significantly from each other on all subscales, 
except for a marginally significant difference (p = .072) between the non-
clinical burnout group and the control group on the professional efficacy scale 
(all other p’s < .01). On all three subscales, the non-clinical burnout group 
scored in between the clinical burnout group and control group. The results of 
the analyses of the SCL-90-R and the CFQ scores yielded a significant overall 
main effect of Group for both measures. Post-hoc tests revealed the same 
pattern of results for both outcome variables: individuals in the clinical burnout 
group reported significantly more physical and psychological complaints, and 
more cognitive problems than individuals in the non-clinical burnout group, 
who in turn reported significantly more physical and psychological complaints, 
and more cognitive problems than the healthy controls (all p’s < .01).
3.4.3. Cognitive tests
Analysis of the Matching Task data revealed a significant main effect of Run 
type (F(1, 89) = 61.46, p < .001, η2 = .41) and a significant overall main 
effect of Group, but no significant interaction effect between these factors (see 
Table 3.3. for the statistics). The significant main effect of Run type showed 
that, irrespective of Group, individuals reacted significantly slower on switch 
trials than on repetition trials, which was an expected result due to the design 
of the test. Post-hoc tests of the overall main effect of Group indicated that, 
independent of Run type, the individuals in the clinical burnout group reacted 
significantly slower than the healthy controls (p = .016) and marginally slower 
than the individuals in the non-clinical burnout (p = .051), who did not differ 
from the healthy controls. The insignificant interaction effect between Run 
type and Group reflected the absence of a significant difference in switch cost 
between the three groups. The performance on the 2-Back Task, Flanker Task, 
STOP-IT, and Digit Span Task did not significantly differ between the groups.
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3.4.4. Fatigue, motivation, effort, and demands
The analysis of the fatigue scores revealed a significant main effect of Time 
(F(1, 89) = 68.57, p < .001, η2 = .44) and a significant overall main effect of 
Group, but a non-significant Time × Group interaction effect (see Table 3.4. for 
the statistics). The significant main effect of Time indicated that, irrespective 
of Group, individuals were significantly more fatigued after than prior to the 
cognitive test battery. Post-hoc tests of the significant overall main effect of 
Group showed that, independent of Time, all groups differed significantly from 
each other: on average the clinical burnout patients reported to be significantly 
more fatigued compared with the individuals in the non-clinical burnout 
group, who in turn reported to be significantly more fatigued compared with 
the healthy controls (all p’s < .05). Yet, the non-significant interaction effect 
between Time and Group indicated that the increase in fatigue from prior to, 
to after the cognitive tests did not differ between the groups. As depicted in 
Table 3.4., motivation to complete the cognitive tests was high for each group, 
and did not significantly differ between the three groups. However, analysis of 
the effort scores revealed a marginally significant overall main effect of Group. 
Post-hoc tests showed that the clinical burnout patients had a significantly 
higher score on reported effort than both the healthy controls (p = .045) and 
the non-clinical burnout participants (p = .033), which did not differ from each 
other. Although burnout patients reported the highest specific test demand 
scores on all tests, analysis of these scores revealed a significant overall main 
effect of Group only for the STOP-IT test. Post-hoc test indicated that the 
burnout group rated the STOP-IT test as more demanding compared with both 
the control group (p = .005) and the non-clinical burnout group (p = .018). 
In addition, the analysis of the mean test demand scores yielded a marginally 
significant overall main effect of Group. Post-hoc tests showed that, averaged 
across the five cognitive tests, individuals with clinical burnout rated the tests 
as significantly more demanding than the healthy controls (p = .021).
3.4.5. Confounding variables analysis
To control for potential confounding effects, we re-analyzed all outcome 
measures of the various cognitive tests with analysis of covariance, using 
the following variables as covariates: fatigue, motivation, invested effort, 
test demands (specific and mean), use of medication, intake of coffee, 
time of awakening, and hours of sleep. The results of these analyses did 
not substantially deviate from the results of the primary analyses and let to 
identical conclusions (detailed results are available from the first author on 
request).
Chapter 3 Cognitive performance in both clinical and non-clinical burnout
54 55
3
Ta
b
le
 3
.4
. 
G
ro
up
 m
ea
ns
 a
nd
 s
ta
nd
ar
d 
de
vi
at
io
ns
, 
an
d 
th
e 
re
su
lts
 o
f 
th
e 
st
at
is
tic
al
 a
na
ly
si
s 
of
 t
he
 f
at
ig
ue
, 
m
ot
iv
at
io
n,
 e
ff
or
t,
 a
nd
 d
em
an
ds
 s
co
re
s
C
lin
ic
al
 b
ur
no
ut
N
on
-c
lin
ic
al
 b
ur
no
ut
C
on
tr
ol
M
S
D
M
S
D
M
S
D
Eff
ec
t
df
2
F
p
η2
Fa
tig
ue
M
ea
na
*
6.
62
1.
29
5.
17
1.
92
4.
03
2.
05
G
ro
up
89
16
.9
6
.0
0
.2
8
D
iff
er
en
ce
b
1.
73
1.
93
1.
93
2.
07
1.
67
2.
17
T×
G
89
.1
3
.8
7
.0
0
M
ot
iv
at
io
n 
8.
42
1.
17
8.
86
1.
13
8.
57
1.
38
G
ro
up
89
1.
00
.3
7
.0
2
Eff
or
t
9.
42
.8
0
8.
93
.8
4
8.
97
1.
03
G
ro
up
89
3.
01
.0
5
.0
6
D
em
an
ds
2-
B
ac
k 
Ta
sk
8.
58
1.
42
8.
52
1.
21
8.
25
1.
51
G
ro
up
89
.4
8
.6
2
.0
1
S
TO
P-
IT
**
7.
21
1.
36
6.
21
1.
88
6.
03
1.
65
G
ro
up
89
4.
83
.0
1
.1
0
Fl
an
ke
r 
Ta
sk
7.
42
1.
86
7.
10
1.
82
6.
53
1.
59
G
ro
up
89
2.
04
.1
4
.0
4
M
at
ch
in
g 
Ta
sk
6.
49
1.
94
6.
00
1.
79
5.
73
1.
78
G
ro
up
89
1.
35
.2
6
.0
3
D
ig
it 
S
pa
n 
Ta
sk
7.
64
1.
73
7.
62
1.
59
7.
50
1.
68
G
ro
up
89
.0
6
.9
4
.0
0
M
ea
nc
7.
46
.8
5
7.
09
1.
18
6.
81
1.
27
G
ro
up
89
2.
78
.0
7
.0
6
N
ot
e.
 T
 =
 T
im
e.
 G
 =
 G
ro
up
.
a M
ea
n 
fa
ti
gu
e 
sc
or
e 
pr
io
r 
to
 a
nd
 a
ft
er
 t
he
 c
og
ni
ti
ve
 t
es
t 
ba
tt
er
y.
 b
D
iff
er
en
ce
 s
co
re
 b
et
w
ee
n 
fa
tig
ue
 p
ri
or
 t
o 
an
d 
af
te
r 
th
e 
co
gn
iti
ve
 t
es
t 
ba
tt
er
y.
 c M
ea
n 
de
m
an
d 
sc
or
e 
of
 t
he
 f
iv
e 
co
gn
iti
ve
 t
es
ts
.
* A
ll 
gr
ou
ps
 s
ig
ni
fic
an
tly
 d
iff
er
ed
 f
ro
m
 e
ac
h 
ot
he
r. 
**
Th
e 
cl
in
ic
al
 b
ur
no
ut
 g
ro
up
 s
ig
ni
fic
an
tly
 d
iff
er
ed
 f
ro
m
 b
ot
h 
th
e 
co
nt
ro
l g
ro
up
 a
nd
 t
he
 n
on
-c
lin
ic
al
 
bu
rn
ou
t 
gr
ou
p.
Chapter 3 Cognitive performance in both clinical and non-clinical burnout
56 57
3
3.5. Discussion
Since relatively little is known about cognitive performance in burnout, the 
aim of the present study was to further examine cognitive performance in both 
clinical and non-clinical burnout. To this aim, we focused on three interrelated 
features of cognitive performance, namely, self-reported cognitive problems, 
cognitive test performance, and subjective costs associated with performing 
the cognitive tests.
The results showed that the clinical burnout group reported to experience 
significantly more cognitive problems compared with the control group, which 
is in line with previous studies (e.g., Öhman et al., 2007; Oosterholt et al., 
2012; Österberg et al., 2009). More interestingly, we also found self-reported 
cognition (CFQ) to be significantly different between both burnout groups, that 
is, the individuals in the clinical burnout group rated their cognition as being 
significantly worse than the individuals in the non-clinical burnout group did. 
These findings are in line with previous work of Van der Linden et al. (2005), 
and reflect the same pattern of results as we found for the level of burnout 
symptoms (UBOS) and general physical and psychological complaints (SCL-
90-R) that the three different groups experienced. We found, however, only 
partial support that self-reported cognitive problems in burnout co-occur with 
objective performance impairments as assessed with cognitive tests. More 
specifically, our cognitive test results indicated that the clinical burnout group 
significantly underperformed the control group and marginally significantly 
underperformed the non-clinical burnout group on one of the five cognitive 
tests, whereas cognitive test performance of the individuals of the non-clinical 
burnout group did not differ compared with that of the healthy controls on any 
of the other tests.
The impaired cognitive test performance observed in the clinical burnout 
patients reflected a general slowing in RT. That is, the clinical burnout patients 
showed slower overall RTs during the Matching Task (an indicator of a decline in 
more general cognitive processing; see also Oosterholt et al., 2012), however, 
no other performance differences on this and the other cognitive tests were 
found that reflected deficits in any of our assessed executive functions 
(updating, inhibition, and switching). These results are in line with the study 
of Österberg et al. (2009), in which clinical burnout was also found to be only 
related to slower performance during a single speed test. However, in most 
of the other studies on cognitive performance in clinical burnout patients, 
deficits in executive functioning were found in this group of patients as well. 
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Especially the updating function, which is also often referred to as working 
memory, is a type of executive functioning that has repeatedly been found to 
be impaired in this patient population (e.g., Jonsdottir et al., 2013; Öhman et 
al., 2007; Oosterholt et al., 2012; Rydmark et al., 2006).
A factor that may have contributed to the relatively mild cognitive test 
performance impairment in our clinical burnout sample could be that we only 
included patients without comorbid mental disorders. As noted earlier, in 
previous studies, patients with comorbid mental disorders were not always 
excluded, or the effects of comorbidity were not always controlled for. As a 
result, the findings of these previous studies could be an overestimation of 
the degree in which clinical burnout is related to cognitive test performance 
impairment, since, for example, it is relatively well-established that depression 
is related to impairments in executive functioning (e.g., Gotlib & Joormann, 
2010). Furthermore, since it is often proposed that burnout patients do 
not form a homogeneous group and that there exist subtypes of burnout 
patients (e.g., Tops et al., 2007; Van Dam et al., 2013), it could well be 
that heterogeneity with respect to our and previous burnout samples may 
have contributed to the degree in which burnout was found to be related to 
cognitive test performance impairment.
The absence of any cognitive test performance impairment in the non-
clinical burnout group is inconsistent with the results of three previous 
studies, in which non-clinical burnout was found to be associated with: (i) a 
more general cognitive decline (Van der Linden et al., 2005), (ii) deficits in 
executive functions (Diestel et al., 2013), and (iii) even better performance on 
tasks that measured executive functioning (Castaneda et al., 2011). Clearly, 
more research is needed to draw any firm conclusions about cognitive test 
performance in individuals with non-clinical burnout.
With regard to reported fatigue prior to and after the cognitive test battery, 
we found that, as expected, the three groups significantly differed from each 
other (with the clinical burnout group showing the highest fatigue scores, 
followed by the non-clinical burnout group and the control group), and that 
all groups were significantly more fatigued after compared to prior to the 
cognitive test battery. Yet, this increase in fatigue did not differ significantly 
between the groups. Concerning reported motivation to perform, prior to 
the cognitive test battery, all groups were equally (and highly) motivated 
to complete the tests. However, we obtained evidence indicating that after 
test completion, clinical burnout patients reported that they had invested 
more effort in completing the tests, and rated the tests as more demanding 
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relative to individuals in the non-clinical burnout and control groups. These 
findings suggest that adequate test performance in clinical burnout comes at 
a relatively large “cost”. It might be possible that if this cost exceeds a critical 
value, more significant cognitive test performance impairments emerge. This 
suggestion further implies that when clinical burnout patients, and perhaps 
also individuals with a non-clinical burnout, are challenged to a larger extent 
(e.g., use of longer and/or more (complex) tests) they might eventually fail 
(to an even larger extent) to uphold test performance, especially since mental 
fatigue appears to affect performance even more on such tests (e.g., Holding, 
1983; Lorist et al., 2000; Van der Linden, Frese, & Meijman, 2003). This line 
of reasoning could also provide an explanation for the discrepancy between 
the level of self-reported cognitive problems and the level of cognitive test 
performance impairment that we found in both burnout groups. Accordingly, 
the self-reported cognitive problems reflect the cognitive problems of daily life, 
which putatively are more challenging than those established in the relatively 
short and uncomplicated cognitive tests. Therefore, we recommend that in 
future research, a more challenging cognitive test battery may be used to test 
cognitive performance in burnout (both clinical and non-clinical). In light of the 
higher subjective costs that we found to be associated with the performance 
on the cognitive tests in clinical burnout patients, a further interesting aspect 
to investigate would be to examine the process of recovery in burnout after 
cognitive test performance. It could well be that individuals with burnout 
(symptoms) need more time to recover after completing a cognitive test 
battery, for example, from fatigue and/or stress, than do healthy individuals. 
In future studies one might consider to examine whether burnout is related to 
a longer recovery time, for example, by measuring the recovery process (both 
subjectively and objectively) immediately after, in the evening after, or even 
the day after performance on, preferably a challenging, cognitive test battery.
3.5.1. Strengths and limitations
An asset of the present study is that we included both a clinical and a non-
clinical burnout group in order to investigate cognitive performance in burnout. 
Furthermore, our clearly described selection criteria and high-quality burnout 
diagnosis of the patients of the clinical burnout group can be regarded as a 
strong feature. Moreover, we only selected burnout patients without comorbid 
mental disorders, such as depression, which enabled us to carry out a 
relatively “pure” assessment of the relation between burnout and cognition. 
Another asset of this study is the relatively large sample size compared with 
the samples sizes in most of the previous studies.
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Despite these strengths, our study has some limitations as well. For example, 
one might argue a diagnosis of burnout with a comorbid depression is not rare, 
and thus excluding patients with a comorbid depressive disorder may limit 
the generalizability of our results. This could have led to an underestimation 
of the degree in which we found clinical burnout to be related to cognitive 
test performance impairment. Furthermore, the cross-sectional design of 
the study makes it hard to draw any causal inferences. Although we found 
some evidence in cognitive impairment is positively related to the severity 
of burnout, on the basis of our data we cannot conclude that cognitive 
impairment is the result of burnout. To be more precise, we cannot exclude 
beforehand the possibility that cognitive impairment leads to the development 
of burnout (reverse causal relationship), or that burnout is both a cause and a 
consequence of cognitive impairment (bi-directional relationship).
3.5.2. Conclusion
Clinical burnout patients reported more cognitive problems than did 
individuals with non-clinical burnout, who in turn reported more cognitive 
problems relative to healthy controls. Evidence for, a relatively mild, impaired 
cognitive test performance was only found for clinical burnout patients. This 
impaired cognitive test performance was reflected in a general slowing in RT, 
indicating a decline in more general cognitive processing instead of deficits in 
executive functioning. However, cognitive test performance of clinical burnout 
patients was related with larger reported subjective costs. Future research 
should preferably focus on the relationship between subjective and objective 
aspects of cognitive functioning in subcategories of burnout, preferably using 
challenging cognitive tests and diverse (objective and subjective) measures 
of recovery after task performances.

CHAPTER 4
 Burnout and cortisol: Evidence for a lower 
cortisol awakening response in both 
clinical and non-clinical burnout
This chapter appeared as:
Oosterholt, B. G., Maes, J. H. R., Van der Linden, D., Verbraak, M. J. P. M., & 
Kompier, M. A. J. (2015). Burnout and cortisol: Evidence for a lower cortisol 
awakening response in both clinical and non-clinical burnout. Journal of 
Psychosomatic Research, 78(5), 445-451.
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4.1. Abstract
Although the relationship between burnout and cortisol levels has been 
examined in previous studies, the results are mixed. By adopting a design 
in which we attempted to overcome important limitations of earlier research, 
the purpose of the present study was to improve the understanding of the 
biological underpinnings of burnout and to further the knowledge about the 
relationship between burnout and cortisol. A clinical burnout patient group 
(n = 32), a non-clinical burnout group (n = 29), and a healthy control group 
(n = 30) were compared on burnout symptoms, physical and psychological 
complaints, and on cortisol levels. In order to examine a broad range of cortisol 
indices, including different measures of the cortisol awakening response (CAR) 
and several day-curve measures, salivary cortisol was collected six times a 
day during two consecutive non-workdays. As expected, the clinical burnout 
group reported more burnout symptoms, and physical and psychological 
complaints than the non-clinical burnout group, which in turn reported more 
burnout symptoms and physical and psychological complaints than the healthy 
control group. With regard to cortisol levels, we found that until 30 min after 
awakening, the CAR of both the clinical and the non-clinical burnout group 
was lower compared with the healthy control group. Furthermore, there was 
some evidence that the decline of cortisol during the day was smaller in the 
non-clinical burnout group than in the healthy control group. The results of 
the present study provide support for lowered cortisol in both clinical and non-
clinical burnout.
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4.2. Introduction
Burnout is a work-related chronic stress syndrome characterized by exhaustion, 
cynicism (a distant attitude towards the job), and feelings of reduced 
professional efficacy (e.g., Maslach et al., 2001). Since burnout is generally 
the result of a prolonged period of stress, it is often hypothesized that the 
hypothalamic–pituitary–adrenal axis (HPA axis), a part of the neuroendocrine 
system involved in the regulation of reactions to stress, may be disturbed in 
individuals with burnout (e.g., De Vente et al., 2003; Melamed et al., 1999; 
Mommersteeg, Keijsers, Heijnen, Verbraak, & Van Doornen, 2006; Pruessner, 
Kirschbaum, Meinlschmid, & Hellhammer, 2003). As the major output of 
the HPA axis is the stress hormone cortisol, cortisol levels are believed to 
differ in individuals with burnout relative to the levels in healthy individuals. 
Specifically, whereas acute stress leads to increased cortisol levels, a general 
notion is that chronic stress, which is usually the case in burnout, can lead 
to a ‘breakdown of the HPA axis’ resulting in decreased cortisol levels (e.g., 
Fries, Hesse, Hellhammer, & Hellhammer, 2005; Gunnar & Vazquez, 2001; 
McEwen, 1998).
The results of previous studies on the relationship between burnout and 
cortisol, however, do not always fit with this line of reasoning. Although, for 
example, Sonnenschein et al. (2007) and Marchand et al. (2014) indeed 
found burnout to be related to reduced levels of cortisol, Melamed et al. 
(1999) and De Vente et al. (2003), on the other hand, found evidence for 
elevated levels of cortisol. In addition, some studies (e.g., Grossi et al., 2003; 
Mommersteeg, Heijnen, Verbraak, et al., 2006a) failed to find any cortisol 
deviations in burnout. For a more comprehensive review of the literature, see 
Danhof-Pont, Van Veen, and Zitman (2011).
Several factors may underlie these mixed findings, such as heterogeneity in 
the assessment of cortisol, potential confounding variables which were not 
controlled for and the relatively small sample size in some of the previous 
studies. Yet perhaps the most important and fundamental factor might be the 
large variety of operationalizations of burnout that are used in earlier research. 
That is, in some studies, the burnout group comprised clinically diagnosed 
burnout patients (e.g., Mommersteeg, Heijnen, Kavelaars, & Van Doornen, 
2006; Österberg et al., 2009), whereas in other studies (e.g., Marchand et al., 
2014; Moya-Albiol, Serrano, & Salvador, 2010a), the burnout group consisted 
of healthy undiagnosed individuals who were solely selected on the basis of a 
high score on a burnout questionnaire (i.e., reporting symptoms of a burnout). 
In addition to the latter, the type of burnout questionnaire which was used for 
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this purpose also varied (e.g., compare Bellingrath, Weigl, & Kudielka, 2008; 
Melamed et al., 1999). Also, the criteria used for diagnosing a clinical burnout 
are not always clear (e.g., Moch, Panz, Joffe, Havlik, & Moch, 2003; Sandström 
et al., 2011) and differ between studies (Grossi et al., 2005; compare e.g., 
Mommersteeg, Keijsers, et al., 2006). Furthermore, in a large number of 
studies in which a clinical burnout sample was examined, no information was 
provided about the time between the diagnosis of burnout and participation in 
the study, or the time between diagnosis and participation was relatively long 
(e.g., De Vente et al., 2003; Sertoz et al., 2008). This may be problematic 
because treatment or maturation effects might have interfered. A final and 
key aspect with regard to the diagnosis of clinical burnout is the comorbidity 
of other mental disorders. Specifically, although there is substantial evidence 
indicating that, for example, mood and anxiety disorders have an effect on 
cortisol (i.e., elevated cortisol levels; e.g., Abelson, Khan, Liberzon, & Young, 
2007; Herbert, 2013), in former research, burnout patients with comorbid 
mental disorders were not always excluded, and/or the effects of comorbidity 
were not always controlled for (e.g., Moch et al., 2003; Sandström et al., 2011). 
In these studies, the observed cortisol levels in burnout patients may possibly 
have been influenced by mental disorders other than burnout. Finally, a factor 
potentially affecting the validity of the observed cortisol levels in previous 
studies is the day on which the cortisol samples were collected. Research has 
shown that cortisol levels are generally higher on workdays than on days off 
work (e.g., Kunz-Ebrecht et al., 2004; Langelaan et al., 2006; Schlotz et al., 
2004). Yet in almost all previous studies on the relationship between burnout 
and cortisol, the cortisol sampling procedure took place during workdays. This 
may have affected the results of those studies in which the burnout group 
consisted of clinical burnout patients who were (largely) not working (i.e., on 
sick leave) and in which the control group comprised healthy participants who 
were working during the sampling procedure.
The purpose of the present study was to further examine cortisol levels 
in burnout with a design that enabled us to overcome these limitations 
of former research. To this end, we carefully selected a group of recently 
clinically diagnosed burnout patients without comorbid mental disorders, to 
rule out the effect of other psychopathologies. In addition, we included a non-
clinical burnout group consisting of employees who reported to have burnout 
symptoms, but who were not clinically diagnosed as burnout patients and 
were not seeking help for these symptoms. Cortisol levels of both groups were 
compared with a matched control group consisting of healthy employees. In 
order to examine a full range of cortisol indices, including different measures 
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of the cortisol awakening response (CAR) and multiple day-curve measures, 
salivary cortisol was sampled six times a day during two-consecutive non-
workdays. As noted above, we chose to collect cortisol on non-workdays 
to make sure that the sampling conditions were equal between the three 
different employee groups.
In sum, the aim of the present study was to determine how both clinical 
burnout and non-clinical burnout are related to cortisol levels.
4.3. Method
4.3.1. Participants
The sample was part of a larger longitudinal research project, in which both 
cortisol levels and cognitive performance in burnout were studied (see also 
Oosterholt, Maes, Van der Linden, Verbraak, & Kompier, 2014). In total, 
91 employees participated in the present study. Thirty-two had received a 
clinical burnout diagnosis (the clinical burnout group), 29 reported burnout 
symptoms but were neither diagnosed as burnout patients nor seeking help 
for these symptoms (the non-clinical burnout group) and 30 were healthy 
individuals (the control group). Initially, the clinical burnout group and the 
non-clinical burnout group consisted of 33 and 30 participants, respectively. 
However, one participant was excluded from each of these groups due to non-
compliance with the cortisol sampling instructions. One participant did not fill 
out the diary (see Procedure), and one did not sample on two consecutive 
non-workdays. The three groups were matched on several demographical 
characteristics (see Table 4.1. for more detailed information) and consisted 
of employees with various occupational backgrounds. All participants were 
financially compensated for their participation.
The participants in the clinical burnout group were patients from HSK Group, 
a large mental healthcare organization in the Netherlands. Patients were 
selected on the basis of their burnout diagnosis as established by a team 
of two or three professional clinical psychologists. A burnout diagnosis was 
based on an intake procedure in which a structured clinical interview was 
used containing the Dutch translation (Overbeek et al., 1999) of the MINI 
International Neuropsychiatric Interview 5.0.0 (M.I.N.I.; Sheehan et al., 
1998) and the Assessment of DSM-IV Personality Disorders (ADP-IV; Schotte 
& De Doncker, 1994). Since burnout is not officially included in the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV-TR; American Psychiatric 
Association, 2000), in the Netherlands, a burnout diagnosis is usually based 
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on the DSM-IV-TR criteria for diagnosing an undifferentiated somatoform 
disorder with the addition that the cause of the symptoms must be work 
related. This method was also used in the present study. As an additional 
tool to validate the burnout diagnosis, patients filled out the Utrecht Burnout 
Scale (UBOS; Schaufeli & Van Dierendonck, 2000; see Measures section for 
more information). Patients were excluded if they fulfilled the DSM-VI criteria 
for any other axis I or II disorder, as assessed with the M.I.N.I. and the 
ADP-IV, respectively. Approximately 40 % of the eligible burnout patients 
agreed to participate in the study after being contacted by telephone. Of 
the 32 participating patients, 12 were on sick leave due to their burnout, 
15 continued working but worked fewer hours than prior to their burnout 
diagnosis and 5 remained working the same number of hours as before their 
diagnosis.
The participants in the non-clinical burnout group and the control group 
were recruited via local advertisements and social networking. Potential 
participants filled out a screening questionnaire in which several demographical 
characteristics (used to match the different groups; see Table 4.1.), the 
exhaustion subscale of the UBOS and (history of) psychiatric disorders were 
assessed. Individuals with an average score on the exhaustion subscale of 
the UBOS equal to or higher than the cutoff point of 2.20 (Schaufeli & Van 
Dierendonck, 2000) were allocated to the non-clinical burnout group and 
those with scores below the cutoff point to the control group. Individuals with 
a current psychiatric disorder or with a past history of burnout were excluded.
4.3.2. Materials
4.3.2.1. Self-reports
Utrechtse Burnout Scale. Burnout symptoms were assessed with the UBOS 
(Schaufeli & Van Dierendonck, 2000), which is the Dutch adaptation of the 
Maslach Burnout Inventory (MBI; Maslach et al., 1996). The version for 
general professions (UBOS-A; Schaufeli & Van Dierendonck, 2000) was used, 
which contains 15 questions that can be answered on a 7-point Likert scale 
(0 = “never”, 6 = “every day”). The questionnaire consists of an exhaustion, 
a cynicism and a professional efficacy subscale. Cronbach’s alphas of the 
subscales were, respectively, .95, .87 and .78.
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Table 4.1. Demographical characteristics
Clinical burnout Non-clinical burnout Control
M SD M SD M SD p
Age 42.41 10.68 36.90 12.64 38.93 11.23 .171
Work hours per weeka* 36.02 6.85 33.12 6.45 31.07 8.54 .031
n % n % n % p
Sex .572
Men 17 53.13 12 41.38 16 53.33
Women 15 46.88 17 58.62 14 46.67
Level of educationb .882
1 0 .00 0 .00 0 .00
2 3 9.38 2 6.90 2 6.67
3 11 56.25 11 37.93 8 26.67
4 18 34.38 16 55.17 20 66.67
Irregular working hours .692
Yes 10 31.25 12 41.38 10 33.33
No 22 68.75 17 58.62 20 66.77
Tobacco use .612
Yes 7 21.88 4 13.79 7 23.33
No 25 78.13 25 86.21 23 76.67
Medicationc
Psychotropic drugs 3 9.38 1 3.45 0 .00 .262
Somatic drugs 5 15.63 3 10.35 2 6.67 .542
Corticosteroids & antihistamines 2 6.25 5 17.24 2 6.67 .292
Contraceptives 6 18.75 6 20.69 4 13.33 .742
Herbal drugs 0 .00 1 3.45 1 3.33 .542
None 19 59.38 15 51.72 23 76.67 .132
Note. aParticipants’ contractual working hours per week. bLevel of education was measured in terms 
of highest level of education completed, ranging from 1 to 4, primary school to university degree, 
respectively cSince some participants used more than one type of medication: i) separate tests 
were performed for each type of medication, and ii) the sum of the n and the % of the different 
types of medication is larger than the total n of a particular group and 100 %, respectively. 1Based 
on ANOVA. 2Based on Pearson’s chi-square test.
*The clinical burnout group differed significantly from the control group (p = .01).
Symptom Checklist-90-Revised. General physical and psychological 
complaints were assessed with the Dutch adaptation (Arrindell & Ettema, 
2003) of the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977). 
The questionnaire contains 90 items divided into nine subscales: eight 
measuring primary symptom dimensions, and one measuring more general 
symptoms. Each item can be answered on a 5-point Likert scale (1 = “not 
at all”, 5 = “extremely”). The sum of all items results in a psychoneuroticism 
score, which is the equivalent of the Global Severity Index in the English 
version. Cronbach’s alpha of this questionnaire was .98.
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4.3.2.2. Cortisol
Salivary cortisol was collected on two consecutive non-workdays. On both of 
these days, participants individually collected six saliva samples: at awakening, 
30 min after awakening, 60 min after awakening, at 12:00 hr, 17:00 hr and 
22:00 hr. On average, the patients in the burnout group collected the saliva 
samples within one month after they were diagnosed with burnout (range 
7–65 days).
Different, well-validated and commonly used measures of both the CAR and 
the cortisol during the day were used as indices of participants’ cortisol level 
(36.19 nmol/l; see e.g., Nicolson, 2008). The area under the curve with 
respect to ground (AUCG) was computed for the CAR (as a measure of total 
cortisol secretion after awakening; CAR AUCG) as well as for the day (as a 
measure of total cortisol secretion during the day; day AUCG). In addition, the 
AUCG of the CAR was calculated in two ways: based on awakening until 30 min 
after awakening (CAR AUCG 30), and based on awakening until 60 min after 
awakening (CAR AUCG 60). For the computation of the AUCG measures, the 
time-dependent formula was used as described in detail by Pruessner et al. 
(2003). Furthermore, the slope of the CAR (i.e., the increase of cortisol after 
awakening; CAR slope) and the slope of the day (decline of cortisol during 
the day; day slope) were computed. The CAR slope was calculated as the 
difference in cortisol between the second sample of the day (30 min after 
awakening) and the first sample of the day (at awakening). The day slope was 
computed as the difference between the last sample of the day (at 22:00 hr) 
and the first sample of the day (at awakening). Prior to the calculation of the 
different cortisol outcome measures, all samples were individually checked for 
abnormal values. This resulted in the exclusion of one extremely high evening 
value (36.19 nmol/l; see e.g., Nicolson, Storms, Ponds, & Sulon, 1997) from 
a participant in the non-clinical burnout group. Furthermore, only the cortisol 
values of the samples that were collected at 0–5 min after awakening (first 
sample), at 25–35 min after the first sample (second sample), at 25–35 min 
after the second sample (third sample), within 31 min prior to or after 12:00 
hr (fourth sample), within 61 min prior to or after 17:00 hr (fifth sample) and 
within 91 min prior to or after 22:00 hr (sixth sample), were used for the 
calculation of the different cortisol outcome variables. Of the total of 1092 
cortisol samples, 165 samples (15.11 %) were excluded from the analyses: 
eight were missing (.73 %), one was an invalid high value (see above; .09 
%) and 156 were collected outside the set time-limits (14.29 %). For each of 
the six cortisol samples, the correlation between the two days was significant 
and ranged between .23 and .67 (as measured with Pearson’s r). The cortisol 
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outcome measures were calculated separately for each of the two days first. If 
values of both days were available the scores were averaged. Otherwise, the 
value of a single day was used.
4.3.3. Procedure
After participants were recruited, the dates were set for the two consecutive 
non-workdays saliva collection, and an appointment was made for filling out 
the questionnaires. Prior to the saliva collection, participants received detailed 
instructions on how to collect the samples. Specifically, they were instructed 
to clean their lips (if necessary) and to not brush their teeth before sampling, 
and to refrain from eating or drinking (except water) within 45 min before 
collecting a sample. Furthermore, information about variables that are generally 
assumed to affect cortisol levels, such as time of awakening, exact time of 
sampling, intake of medication, caffeine and alcohol consumption, smoking and 
physical activity (e.g., Nicolson, 2008), was registered in the form of a diary. 
The participants collected the saliva samples in 2 ml Eppendorf tubes and kept 
the samples in a refrigerator or freezer until they returned them. Returned 
samples were stored in a freezer at –20 °C until analyzed. The saliva samples 
were analyzed in duplo at the Biochemical Laboratory of the University of Trier 
in Germany by a time-resolved immunoassay with fluorescence detection 
(DELFIA method), as described in detail by Dressendörfer, Kirschbaum, Rohde, 
Stahl, and Strasburger (1992). All participants gave informed consent, and the 
study was approved by the Ethical Committee of the Faculty of Social Sciences 
at the Radboud University Nijmegen in the Netherlands.
4.3.4. Statistical analyses
Both the questionnaires and cortisol data were analyzed with a one-way 
univariate ANOVA, with group (clinical burnout vs. non-clinical burnout vs. 
control) as a between-subject factor. For all outcome measures, within-group 
outliers were replaced with the group mean + or − three standard deviations. 
After replacing the outliers (6 in total), inspection of the data revealed that 
the scores of the outcome measures were approximately normally distributed. 
All tests of statistical significance were based on two-tailed tests using an 
alpha level of .05. When a statistically significant overall group effect was 
obtained, pair-wise group comparisons were made using Fisher’s protected 
least significant different (FPLSD) post hoc tests. Partial eta-squared (η2) was 
calculated as an effect size estimate. All statistical analyses were performed 
with SPSS for Microsoft Windows, version 20.0 (SPSS, Inc., Chicago, IL).
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4.4. Results
4.4.1. Demographical characteristics
The demographical characteristics of the three groups are displayed in Table 
4.1. The results of the analyses of the demographical characteristics revealed 
that the groups did not significantly differ on age, sex, level of education, 
working irregular working hours, tobacco use, and intake of medication.
4.4.2. UBOS and SCL-90-R
For all subscales, the analysis of the UBOS scores yielded a significant overall 
main effect of group (see Table 4.2. for the statistics). Post hoc tests revealed 
that, except for a marginally significant difference (p = .061) between the 
non-clinical burnout group and the control group on the professional efficacy 
scale, the three groups differed significantly from each other on all subscales 
(p’s < .01). On all subscales, the scores of the non-clinical burnout group 
were in between those of the clinical burnout group and those of the control 
group. The results of the analyses of the SCL-90-R scores showed a significant 
overall main effect of group. Post hoc tests indicated that the individuals 
with clinical burnout reported significantly more physical and psychological 
complaints than both the individuals in the non-clinical burnout group and 
the individuals in the control group did (p’s < .001). Furthermore, the non-
clinical burnout group scored significantly higher on physical and psychological 
complaints than the control group did (p = .006).
4.4.3. Cortisol
Figure 4.1. shows, for each of the groups, the raw means and standard errors 
of the cortisol levels on the different time points at the two consecutive non-
work days. Analysis of the CAR AUCG 30 revealed a significant overall main 
effect for group (see Table 4.3. for the statistics). Post hoc tests indicated 
that 30 min after awakening, the CAR of both the clinical burnout group (p = 
.030) and the non-clinical burnout group (p = .020) was significantly smaller 
compared with the CAR of the control group. ANOVA of the day slope revealed 
a marginally significant overall main effect for Group. A post hoc test showed 
that individuals with a non-clinical burnout had a significantly smaller decline 
of cortisol during the day than the healthy controls (p = .027). No significant 
differences were found between the groups for the other cortisol outcome 
measures.
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4.5. Discussion
Although cortisol levels in burnout have been examined in previous studies, the 
results of these studies are inconsistent. By using a design overcoming relevant 
limitations of previous research, the aim of the present study was to get more 
insight in the biological underpinnings of burnout, through the investigation of 
the relationship between burnout and cortisol.
With regard to the results of the self-reports, we found that, as expected, 
patients in the clinical burnout group experienced significantly more burnout 
symptoms (UBOS) compared to individuals in the non-clinical burnout group, 
who in turn reported significantly more burnout symptoms compared with the 
healthy controls. This same pattern of results was obtained for self-reported 
physical and psychological complaints (SCL-90-R).
Regarding the observed cortisol levels, we found that 30 min after awakening, 
and compared with the healthy control group, both the clinical and non-clinical 
burnout group displayed a significantly lower CAR (CAR AUCG 30). These 
findings are in line with those of previous studies of Mommersteeg, Keijsers, et 
al. (2006) and Sonnenschein et al. (2007), and those of Marchand et al. (2014) 
and Moya-Albiol, Serrano, and Salvador (2010b) , in which clinical burnout 
and non-clinical burnout, respectively, were also found to be related with a 
smaller CAR 30 min after awakening. Although there are no other studies that 
specifically assessed the CAR 30 min after awakening in a non-clinical burnout 
sample, there is however also previous research showing clinical burnout to be 
unrelated to any cortisol deviation (Mommersteeg, Heijnen, Kavelaars, et al., 
2006) as well as related to higher cortisol (De Vente et al., 2003) with respect 
to this measure. Besides the effects of the CAR, we found some evidence for 
the slope of the day (day slope) to be significantly smaller in the non-clinical 
(but not in the clinical) burnout group compared with the healthy control group 
4.4.4. Confounding variable analysis
All cortisol outcome measures were re-analyzed with analyses of covariance 
to control for the following potential confounding variables: use of medication 
(for each type of medication separately), smoking, alcohol and caffeine 
intake, physical activity (all coded as dichotomous variables: no/yes), time of 
awakening, sleep duration, sleep quality (1–10), sex and age (all variables were 
self-reported). Controlling for these variables did not substantially change the 
results of the primary analyses and led to identical conclusions (more detailed 
information can be obtained from the first author upon request).
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(with the omnibus test being marginally significant), indicating that this former 
group had a flattened cortisol pattern during the day. There are no comparable 
previous studies in which this measure was assessed.
As regards our results of the CAR 60 min after awakening (CAR AUCG 60), we found 
no differences between the three groups. Nor did we identify any differences in 
the slope of the CAR (CAR slope) and the total secretion of cortisol during the 
day (day AUGG). These findings both fit the results of previous studies (e.g., 
Bellingrath et al., 2008; Ekstedt, Åkerstedt, & Söderström, 2004; Langelaan 
et al., 2006; Mommersteeg, Heijnen, Kavelaars, et al., 2006; Mommersteeg, 
Heijnen, Verbraak, et al., 2006a) and are in contrast with earlier research (e.g., 
De Vente et al., 2003; Grossi et al., 2005).
The results of the present study remained unchanged after statistically 
correcting for potential confounders, such as use of medication, health 
behaviors and sleep indicators. For example, from the literature (e.g., Armon, 
Shirom, Shapira, & Melamed, 2008), it is known that individuals with burnout 
tend to report higher levels of sleep complaints. Although also in this study 
burnout individuals reported a worse sleep quality (1–10 report mark; clinical 
burnout: 6.47; non-clinical burnout: 7.38; healthy controls: 7.93), this 
difference in sleep quality did not play a role in explaining the deviation in 
morning cortisol levels (i.e., CAR AUCG 30).
As already mentioned briefly, a possible explanation for why in some previous 
studies (both studies with a non-clinical and clinical burnout sample), null 
results or increased cortisol levels in burnout were found might be due 
to comorbid depression and/or anxiety, disorders proven to be related to 
elevated cortisol levels (e.g., Abelson et al., 2007; Herbert, 2013). However, 
it should be noted that comorbidity not always explains variance in the 
observed cortisol levels in burnout (e.g., Sjörs, Ljung, & Jonsdottir, 2012). 
Another explanation for the null results found in some earlier clinical burnout 
research may well be that patients in previous studies already had been in 
therapy for a longer period, or that the time interval between diagnosis and 
cortisol sampling was larger than was the case in the present study (for both 
possibilities, often no information is provided in previous research to exclude 
these possibilities). Mommersteeg, Keijsers, et al. (2006), for example, 
found that cortisol levels were lower in patients with burnout than in healthy 
controls directly after diagnosis, but these differences disappeared during 
a period of psychotherapy. In other words, during treatment (or just in the 
course of), it might be that the HPA axis recovers from an initial breakdown 
and that cortisol levels return back to normal. A similar explanation could also 
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account for null results in some previous non-clinical burnout studies. That 
is, if in these studies the period of time between the assessment of burnout 
symptoms and the collection of cortisol was relatively long (again, information 
which is often not provided) maturation effects may occur, which could be 
responsible for the observed null effects.
The present study showed clinical and non-clinical burnout individuals to have 
a similar attenuated cortisol pattern shortly after awakening. This finding 
provides evidence for lowered cortisol in both of these ‘different types’ of 
burnout. It is an interesting, but at present hard to answer, question as to 
what is the clinical relevance of this lower cortisol pattern shortly after waking 
up. Hopefully, future high-quality studies will make it clear whether these 
cortisol results can be replicated and paint a more detailed picture as to what 
these mean for future health and well-being. Furthermore, it is important to 
emphasize that, although we treated clinical and non-clinical burnout as two 
different types of burnout, there may be some overlap between these two 
groups, which is also reflected in the more or less similar cortisol profile in 
both of these burnout groups.
The fact that we found some evidence for the slope of the day to be smaller 
in the non-clinical burnout group only was based on not only a low cortisol 
level in the morning directly after awakening but also on a relatively high 
cortisol level in the evening in this group. Although, at first sight, this high 
(but insignificant) cortisol level in the evening may indicate evidence for a 
hyperactive HPA axis, the combination with low cortisol in the morning makes 
the overall slope flatter. Such a flattened slope is considered to reflect a failure 
to activate the HPA axis after awakening and to a failure to deactivate it in the 
evening, indicating a hypoactive HPA axis (e.g., Dmitrieva, Almeida, Dmitrieva, 
Loken, & Pieper, 2013; Fries et al., 2005; Heim, Ehlert, & Hellhammer, 2000). 
In addition, a high cortisol level in the evening is regarded to reflect poor 
recovery from stress, which in turn, may be regarded as a major risk factor 
for developing a more severe (clinical) burnout.
4.5.1. Strengths and limitations
An asset of the present research is that we studied cortisol levels in both a 
clinical and non-clinical burnout sample, arguably reflecting two different types 
of burnout. Furthermore, the clinical burnout patients’ high-quality burnout 
diagnosis as assessed by a team of professional clinical psychologists using a 
semi-structured interview, and our clearly described selection criteria, can be 
considered as a strong feature. In addition to our clinical burnout diagnosis, 
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we only included patients without comorbidity, such as, for example, mood 
and anxiety disorders, which enabled us a relatively pure examination of 
burnout in relation to cortisol. Our extensive cortisol collection and the fact 
that we collected cortisol on non-workdays, instead of during workdays (for 
reasons described earlier), is another strength of the study. Moreover, we only 
included cortisol samples that were collected within strict time-limits, which 
contributes to the validity of the cortisol results.
Despite these strengths, the study has limitations as well. For example, 
although we included relatively large groups, we lost power due to excluding 
cortisol samples which were not collected within our strict time limits, or for 
which no sampling time was reported. Nevertheless, we were still able to find 
differences between the groups, although perhaps we would have found even 
more effects if more participants had sampled within our time-limits and if 
more of them had reported the time of sampling. In this framework, in future 
studies, it might be worthwhile to enhance compliance by, for example, using 
electronic devices that remind participants to sample at the correct times 
and/or using motion-sensors to verify participants’ reported sampling times 
whenever participants forget to report the time they sampled. Furthermore, 
the present data are limited by the cross-sectional design of the study, which 
makes it hard to draw causal inferences. Longitudinal studies might address 
this issue of causality, and could furthermore provide information about 
whether these effects are temporary (e.g., can be reversed through therapy) 
or not.
4.5.2. Conclusion
Both burnout groups displayed a similar lower CAR 30 min after awakening 
compared with the healthy control group. Furthermore, we found some 
evidence indicating that the non-clinical burnout group had a flattened cortisol 
pattern during the day. These results suggest that both clinical and non-
clinical burnout are related to lowered cortisol and reflect a hypoactive HPA 
axis in both of these different types of burnout.

CHAPTER 5
Getting better, but not well: A 1.5 year 
follow-up of cognitive performance 
and cortisol levels in clinical 
and non-clinical burnout
This chapter appeared as:
Oosterholt, B. G., Maes, J. H. R., Van der Linden, D., Verbraak, M. J. P. M., & 
Kompier, M. A. J. (2016). Getting better, but not well: A 1.5 year follow-up of 
cognitive performance and cortisol levels in clinical and non-clinical burnout. 
Biological Psychology, 117, 89-99.
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5.1. Abstract
The purpose was to reexamine cognitive performance and cortisol levels 
of initial clinical burnout patients, non-clinical burnout individuals, and 
healthy controls. After 1.5 years of the initial measurement, clinical burnout 
patients showed a reduction of burnout symptoms and general physical and 
psychological complaints, but these were still elevated compared with controls. 
Nonetheless, they continued to report cognitive problems and still showed a 
minor impaired cognitive test performance. However, they no longer reported 
larger subjective costs associated with cognitive test performance and their 
cortisol awakening response (CAR) returned to a normal level. Compared with 
controls, non-clinical burnout individuals still reported the same, elevated, 
level of burnout symptoms, general physical and psychological complaints, 
and cognitive problems. Their cognitive test performance and associated 
subjective costs remained normal. However, they seemed to continue to 
display a lowered CAR. To conclude, after 1.5 years, clinical burnout patients 
got better, but not “well”, and non-clinical burnout individuals remained not 
“well”.
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5.2. Introduction
Employees with burnout frequently report cognitive problems, such as difficulties 
with concentration and memory (e.g., Weber & Jaekel-Reinhard, 2000). Research 
has shown that these self-reported cognitive problems are accompanied by 
actual cognitive impairments as measured with neuropsychological tests (Diestel 
et al., 2013; Jonsdottir et al., 2013; Oosterholt et al., 2012; Österberg et al., 
2009; Sandström et al., 2005; Van Dam et al., 2011; Van der Linden et al., 
2005). Nevertheless, the actual burden of these impairments is still not clear, 
as they range from relatively mild (e.g., Österberg et al., 2009) to profound 
impairments (e.g., Sandström et al., 2005).
It has been hypothesized that the cognitive deficits in burnout are related to 
stress (e.g., Österberg et al., 2009; Sandström et al., 2011). This hypothesis 
is plausible as burnout is generally considered to be a stress-related condition 
(e.g., Cordes & Dougherty, 1993; Maslach et al., 2001) and there is substantial 
evidence that stress can have a detrimental impact on the brain, for example, 
on the hippocampus (e.g., Lupien & Lepage, 2001) and the prefrontal cortex 
(e.g., Arnsten, 2009). These brain structures are, among others, responsible for 
memory consolidation and executive functioning, respectively. The mechanism 
underlying the relationship between stress and cognition is assumed to involve 
the hypothalamic-pituitary-adrenal axis (HPA axis), a part of the neuroendocrine 
system that plays a role in the regulation of stress reactions. Specifically, the 
hormone cortisol, the release of which is regulated by the HPA axis and which 
is considered to be the main stress hormone, is believed to be involved in 
mediating the stress-cognition relation, whereby both high and low levels of 
cortisol can have detrimental effects on cognition (Lupien, Maheu, Tu, Fiocco, & 
Schramek, 2007).
Cortisol levels in relation to burnout have been examined in several studies. The 
results of these studies are mixed (Danhof-Pont et al., 2011). For example, in 
some studies burnout was found to be related to lower levels of cortisol (e.g., 
Marchand et al., 2014; Sonnenschein et al., 2007), whereas in other studies 
higher cortisol levels were found (e.g., De Vente et al., 2003; Melamed et al., 
1999). Moreover, there are also studies in which burnout did not relate to any 
cortisol deviations (e.g., Grossi et al., 2003; Mommersteeg, Keijsers, et al., 
2006).
To gain further insight into the burnout-cognition and burnout-cortisol 
relationships, we recently examined cognitive performance (Oosterholt et al., 
2014) as well as cortisol levels (Oosterholt, Maes, Van der Linden, Verbraak, 
& Kompier, 2015) in a sample of clinical burnout patients (employees seeking 
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treatment for their burnout symptoms and diagnosed as such), non-clinical 
burnout individuals (employees reporting symptoms of a burnout, but neither 
diagnosed as such nor seeking help for these symptoms), and healthy control 
individuals. An asset of these studies was that we examined burnout by including 
both a clinical and a non-clinical burnout group (and a healthy control group). 
Furthermore, compared to the majority of other studies in this area, we used 
relatively large samples, and we used well-validated and extensive measures to 
assess both cognitive performance and cortisol levels. With regard to cognitive 
performance, we found that, although both the clinical burnout patients and 
the non-clinical burnout individuals reported cognitive problems, only clinical 
burnout patients showed a relatively mild impaired cognitive test performance. 
Compared with the healthy controls, they also reported larger subjective costs 
associated with their cognitive test performance. Specifically, they invested 
more effort in completing the tests, and rated the tests as more demanding. As 
regards cortisol levels, we found the cortisol awakening response to be lower 
in both clinical burnout patients and non-clinical burnout individuals compared 
with healthy individuals. In addition, some evidence was found indicating that 
the decline of cortisol during the day was smaller in individuals with a non-
clinical burnout than in healthy controls. These results suggested a hypoactive 
HPA axis in both our clinical and non-clinical burnout group.
Almost all previous research on both the relationship between burnout and 
cognition and burnout and cortisol has been cross-sectional, and has been 
performed in individuals with acute burnout symptoms. However, relatively little 
is known about the longitudinal course of cognitive performance in burnout 
(Beck, Gerber, Brand, Pühse, & Holsboer-Trachsler, 2013; Oosterholt et al., 
2012; Österberg, Skogsliden, & Karlson, 2014; Van Dam, Keijsers, Eling, & 
Becker, 2012; Wahlberg et al., 2009) as well as about the longitudinal course of 
cortisol levels in burnout (Moch et al., 2003; Mommersteeg, Heijnen, Verbraak, & 
Van Doornen, 2006b; Mommersteeg, Keijsers, et al., 2006; Österberg, Karlson, 
Malmberg, & Hansen, 2012; Wahlberg et al., 2009). Moreover, both with regard 
to the burnout-cognition and burnout-cortisol relationship, the results of these 
previous studies are inconsistent (see Discussion for a more detailed review of 
the existing literature). The aim of the present study was to get more insight into 
the time course of cognitive performance and cortisol levels in burnout. To this 
end, we reexamined the initial clinical burnout group, non-clinical burnout group, 
and healthy control group that we reported on previously (Oosterholt et al., 
2014) after a 1.5 year period. As recovery from burnout is a slow process (e.g., 
Sonnenschein et al., 2008), and previous longitudinal studies on the relationship 
between burnout and cognition (e.g., Oosterholt et al., 2012) as well on the 
relationship between burnout and cortisol (e.g., Moch et al., 2003) have shown 
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that a relatively short follow-up period did not result in any positive changes, we 
chose to reexamine our groups after a rather long period of approximately 1.5 
years. In-between the first examination (T1) and the second examination (T2), 
the patients in the clinical burnout group received psychological therapy aimed 
at reducing burnout symptoms. Although we did not have specific expectations 
as regards the non-clinical burnout group, we expected burnout symptoms and 
physical and mental complaints of the clinical burnout group to improve in the 
course of the treatment period. However, the question of interest was whether 
or not cognitive performance would also show any improvements and whether 
cortisol would return to a normal level. If reduced cognitive performance and 
cortisol deviation would result from burnout, it is possible that when burnout 
symptoms decrease this will be accompanied with a return to pre-burnout 
cognitive functioning and cortisol levels. Such changes are to be expected only 
if the prolonged stress, held to underlie the burnout symptoms, did not result in 
any permanent damage (McEwen, 2000).
In sum, the purpose of the present study was to answer two research questions, 
next to assessing the time course of burnout symptoms and general physical and 
psychological complaints. First, what is the course (from T1 to T2) of cognitive 
performance (self-reported cognitive problems, cognitive test performance, 
and subjective costs associated with cognitive test performance) in both clinical 
burnout and non-clinical burnout? Second, what is the course (from T1 to T2) of 
cortisol levels in both clinical and non-clinical burnout?
5.3. Method
5.3.1. Participants
The participants in the present study had been examined previously on both 
cognitive performance and cortisol levels, see Oosterholt et al. (2014), and 
(Oosterholt et al., 2015), respectively. Of the 93 participants examined during 
the first examination (T1), 85 (91 %) agreed to participate in the second 
examination (T2), approximately 1.5 years later. Of these participants, 31 (out 
of 33) belonged to the clinical burnout group, 27 (out of 30) to the non-clinical 
burnout group, and 27 (out of the 30) to the healthy control group. The difference 
between the clinical and non-clinical burnout group was that, at T1, the clinical 
burnout group comprised patients with a clinical burnout diagnosis whereas the 
non-clinical burnout group consisted of individuals who reported symptoms of a 
burnout, but were neither diagnosed as such nor seeking help for these symptoms 
and all still worked. From the reexamined healthy control group, one participant 
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was excluded because he was treated for a burnout during the time between T1 
and T2. The reasons for not participating at T2 ranged from an inability to get in 
contact with the participant, the participant working abroad, being unwilling to 
take off from work, or just being unwilling to participate again. At T2 the three 
groups were still matched on several demographical characteristics (see Table 
5.1. for more detailed information) and had various occupational backgrounds. 
Furthermore, all participants were actively employed, except for one individual 
in the non-clinical burnout group and one in the control group.
In-between T1 and T2, the patients of the clinical burnout group received 
psychological treatment for their burnout symptoms. Treatment was provided by 
professional clinical psychologists according to a treatment protocol for burnout 
(Keijsers et al., 2004) that is commonly used in the Netherlands. Basic modules 
of this treatment include: reduction of complaints, cognitive-behavioral therapy, 
and relapse prevention. Additional therapy modules can be chosen if necessary. 
Although this treatment was aimed at reducing burnout symptoms and was not 
specifically directed at improving cognitive performance or changing cortisol 
levels, it gave us the opportunity to establish any possible changes in cognitive 
performance and or cortisol levels as a result of the treatment (and/or the lapse 
of time). On average, the burnout patients received 14 (SD = 6.24; range 0–23) 
therapy sessions (one patient chose not to go in treatment after the diagnosis, 
and at T2, one patient was still in treatment). A therapy session lasted for 
about 45 min. Important to note is that the treatment was aimed at reducing 
burnout symptoms and it was not specifically directed at improving cognitive 
performance or cortisol levels. The non-clinical burnout group and the healthy 
control group did not receive any form of intervention between T1 and T2.
For a detailed description of the selection procedure of the different groups at 
T1, see Oosterholt et al. (2014) or Oosterholt et al. (2015). In brief, the patients 
of the clinical burnout group were recruited from a large mental health care 
organization in the Netherlands, where they were selected on the basis of their 
burnout diagnosis. A burnout diagnosis was established by a team of two or 
three professional clinical psychologists. At T1, the individuals in the non-clinical 
burnout group and the control group were recruited via local advertisements 
or social networking. Individuals whose scores on the exhaustion subscale of 
the Utrechtse Burnout Scale (UBOS; see Materials for more information about 
this measure) were equal to or higher than the cut-off score (2.20; Schaufeli 
& Van Dierendonck, 2000) were assigned to the non-clinical burnout group, 
and individuals whose scores were lower were assigned to the control group. 
Excluded from participation were individuals with a past history of burnout and 
individuals who had a current psychiatric disorder.
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5.3.2. Materials
5.3.2.1. Self-reports
Utrechtse Burnout Scale. Burnout symptoms were measured with the 
Utrechtse Burnout Scale (UBOS; Schaufeli & Van Dierendonck, 2000), which 
is the Dutch adaptation of the Maslach Burnout Inventory (MBI; Maslach et 
al., 1996). The version for general professions (UBOS-A; Schaufeli & Van 
Dierendonck, 2000) was used. This questionnaire includes 15 items that can 
be scored on a 7-point Likert scale (0 = “never”, 6 = “every day”), and consists 
of three subscales: exhaustion (5 items), cynicism (4 items), and professional 
efficacy (6 items), with cut-off scores of > 2.19, > 1.99, < 3.67, respectively. 
Cronbach’s alpha of the subscales were .95, .86, and .79, respectively, for T1, 
and 87, .84, and .82, respectively, for T2.
Symptom checklist-90-revised. General physical and psychological complaints 
were assessed with the Dutch adaptation (Arrindell & Ettema, 2003) of the 
Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977). The SCL-90-R 
consists of 90 items divided into nine subscales: anxiety (10 items), agoraphobia 
(7 items), depression (16 items), somatization (12 items), insufficiency 
(9 items), sensitivity (18 items), hostility (6 items), and sleeplessness (3 
items), and one subscale with additional questions (9 items). The items can 
be answered on a 5-point Likert scale (1 = “not at all”, 5 = “extremely”). 
The sum of the scores on all items results in a psychoneuroticism score, the 
equivalent of the Global Severity Index in the English version. The mean 
psychoneuroticism score of the healthy Dutch population is 118 (Arrindell & 
Ettema, 2003). Cronbach’s alpha of the questionnaire was .98 for T1, and .97 
for T2. 
Cognitive failure questionnaire. Self-reported cognitive problems were 
measured with a Dutch translation of the Cognitive Failure Questionnaire (CFQ; 
Broadbent et al., 1982). The questionnaire contains 25 items, which assess 
the frequency of everyday cognitive failures. The items can be answered on a 
5-point Likert scale (0 = “never”, 4 = “very often”). Cronbach’s alpha of the 
questionnaire was .92 for T1, and .87 for T2.
Fatigue, motivation, effort, and demands. Prior to the assessment of the 
cognitive test battery, participants rated their fatigue and how motivated 
they were to complete the tests. After each cognitive test, the participants 
scored how demanding the test had been. Furthermore, after the cognitive 
test battery, fatigue was reassessed and the participants were asked how 
much effort they had invested in completing the cognitive tests. All questions 
were assessed on a 10-point Likert scale (1 = “not at all”, 10 = “very much”).
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5.3.2.2. Cognitive tests
The same cognitive test battery was employed as at T1. That is, the executive 
functions updating, inhibition of prepotent responses, inhibition of irrelevant 
information, and switching were measured with the 2-Back Task, STOP-IT, 
Flanker Task, and Matching Task, respectively. In line with Miyake et al. (2000) 
our motive for examining these specific functions follows from a relatively 
large consensus that these are the three most basic and distinctive executive 
functions, which can be clearly and precisely described (contrary to other more 
higher-level constructs of executive functioning, such as planning or abstract 
thinking) and can be operationalized in relatively simple, well-studied, and 
validated cognitive tasks. As regards inhibition, we measured both inhibition 
of prepotent responses and inhibition of irrelevant information, since these 
are considered to be two distinctive types of inhibition, with different neuronal 
substrates (Nigg, 2000). Furthermore, verbal memory, measured with the 
Digit Span Task, and overall task performance on the STOP-IT, Flanker Task, 
and Matching Task were used as indicators of general cognitive processing. 
For more detailed information about the cognitive tests and its measures see 
Oosterholt et al. (2014).
The cognitive tests were performed on a laptop with a 15-inch screen. 
Participants were placed at approximately 50 cm in front of the screen. 
Each test was introduced with a written instruction on the screen as well as 
explained verbally by the experimenter. Prior to the experimental part of a 
test, each test was practiced for about 30 s. Since at T1 the Flanker Task 
data of one participant of the non-clinical burnout group was not stored, the 
analysis of the Flanker Task was based on N = 83.
5.3.2.3. Cortisol
As at T1, salivary cortisol was sampled on two consecutive non-workdays. 
On both days, participants sampled six saliva samples: at awakening, 30 min 
after awakening, 60 min after awakening, at 12:00 hr, 17:00 hr, and 22:00 
hr. Different measures of the cortisol awakening response (CAR) as well as 
of cortisol levels during the day were used as indices of participants’ cortisol 
levels. For both the CAR and the cortisol levels during the day, the area under 
the curve with respect to ground (AUCG) was computed, CAR AUCG and Day 
AUCG , respectively. In addition, the CAR was computed in two ways: until 30 
min after awakening (CAR AUCG30), and until 60 min after awakening (CAR 
AUCG 60). The AUCG measures were computed by the time-dependent formula 
as described in detail by Pruessner et al. (2003). Furthermore, the slope of the 
CAR (CAR slope; the increase of cortisol after awakening) and the slope of the 
Chapter 5 Getting better, but not well
88 89
5
day (Day slope; decrease of cortisol during the day) were computed. The CAR 
slope was computed as the difference in cortisol between the second sample 
(30 min after awakening) and the first sample (at awakening). The Day slope 
was computed as the difference between the first sample (at awakening) and 
the last sample (at 22:00 hr). For more detailed information on the cortisol 
outcome measures see Oosterholt et al. (2015).
Prior to the computation of the different cortisol outcome measures, the 
samples were individually checked for abnormalities. In the non-clinical 
burnout group, one extremely high evening value at T1 (36.19 nmol/l) was 
excluded from one participant, and from another participant, the samples were 
excluded because at T1 sampling was not performed on two consecutive non-
workdays. Furthermore, and in line with Nicolson et al. (1997), we excluded 
the samples of two participants, one from the non-clinical group and one 
from the clinical burnout group, because of extremely high values at T2 (> 60 
nmol/l). Also, the data of one participant of the burnout group and one of the 
control group were not included in the analysis because these participants did 
not fill out the diary at T1 or T2 (see Procedure, for more information about 
the diary). For the computation of the different cortisol outcome variables, 
only the cortisol values of the samples that were sampled at 0–5 min after 
awakening (first sample), at 25–35 after the first sample (second sample), 
at 25–35 after the second sample (third sample), within 31 min prior to or 
after 12:00 hr (fourth sample), within 61 min prior to or after 17:00 hr (fifth 
sample), and within 91 min prior to or after 22:00 hr (sixth sample), were 
used. A cortisol outcome measure was computed separately for each day 
first. If the values of both days were available the values were averaged. 
If not, only the value of a single day was utilized. Except for a marginally 
significant correlation between sample 6 on day 1 on T1 (r = .22, p = .077), 
on both T1 and T2, the correlation between the two days was significant for 
each of the pairs of cortisol samples, and ranged between r = .27 and r = .70 
(calculated with Pearson’s r).
5.3.3. Procedure
Approximately 1.5 years after T1, participants were contacted by telephone or 
email and asked to participate at T2. After participants agreed to participate 
again, the dates were set for the two consecutive non-workday saliva sampling, 
and an appointment was made for a test session. The saliva sampling could 
take place before or after the appointment for the test session (in most of 
the cases it took place before the test session), but both occurred on average 
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within a 7-day period (SD = 5.44; range 1–34). Participants started T2 (the 
test session or the saliva sampling), on average, 20 months (SD = 5.30; 
range 12–30) after the start of T1.
Prior to the saliva sampling, participants received instructions about the 
sampling procedure. Specifically, they were instructed to not brush their 
teeth and to clean their lips (if necessary) before collecting a sample, and to 
refrain from eating or drinking (except water) within 45 min before sampling. 
During the two sampling days, participants registered, in the form of a diary, 
information about variables that are assumed to affect cortisol levels, such as 
time of awakening, exact time of sampling, intake of medication, caffeine and 
alcohol consumption, smoking, and physical activity. Saliva was sampled in 2 
ml Eppendorf tubes, which participants stored in a refrigerator or freezer until 
they returned them. Returned samples were kept in a freezer at −20 ◦C until 
they were analyzed. The samples were analyzed in duplo by a time-resolved 
immunoassay with fluorescence detection (DELFIA method; as described in 
detail by Dressendörfer et al., 1992) at the Biochemical Laboratory of the 
University of Trier in Germany.
A test session took place on a weekday and started around 14:00 hr. A 
test session began with the five cognitive tests, which were presented in 
a counterbalanced order across the participants. Prior to, in-between, and 
after the cognitive tests, participants scored the questions about fatigue, 
motivation, effort, and demands (see Materials for more information). At 
the end of the test session, participants filled out some questions about 
demographical characteristics and potentially confounding variables, and 
scored the questionnaires (UBOS, SCL-90-R, and CFQ). On average, a test 
session lasted 75 min.
All participants gave informed consent to take part in the study, and were paid 
for their participation. The study was approved by the Ethical Committee of 
the Faculty of Social Sciences at the Radboud University in the Netherlands.
5.3.4. Statistical analyses
The demographical characteristics were analyzed with a one-way univariate 
analysis of variance (ANOVA) and Pearson’s chi-square test (for the specific 
analysis/test used for each demographical characteristic, see Table 5.1.). All 
other outcome measures, except those of the Matching Task, Flanker Task, 
and fatigue scores, were analyzed with a 2 × 3 mixed design ANOVA with 
Time (first vs. second) as within-subject factor and Group (clinical burnout 
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vs. non-clinical burnout vs. control) as between-subject factor. The Matching 
and Flanker Task, and fatigue scores were analyzed with a 2 × 2 × 3 mixed 
design ANOVA with Run type (switch vs. repetition) as within-subject factor 
for the Matching Task, Trial type (congruent vs. incongruent) as within-subject 
factor for the Flanker Task, and Moment (prior to vs. after) as within-subject 
factor for the fatigue scores. For each of the latter ANOVA’s, Time (first vs. 
second) served as a second within-subject factor and Group (clinical burnout 
vs. non-clinical burnout vs. control) as between-subject factor. Whenever 
a statistically significant overall Group effect was obtained, post hoc pair-
wise group comparisons using Fisher’s Protected Least Significant Difference 
(FPLSD) tests were performed. Independent samples and paired samples 
t-tests were performed in case of a significant interaction effect, but only if 
relevant for answering one of our research questions, that is when a Group 
effect was involved (see Supplement for the results of all independent samples 
and paired samples t-tests).
For some outcome measures, normality was improved by replacing within-
group outliers with the group mean + or − three standard deviations (five 
outliers in total: one in the cynicism subscale of the UBOS, one in the SSRT 
measure of the STOP-IT, one in the Matching Task, and two in the CAR slope; 
analyses with the outliers removed let to identical conclusions as the analysis 
with the outliers). To improve normality of the data from the SCL-90-R, 
Flanker Task, effort, demands on 2-Back Task, demands on Digit Span Task, 
CAR AUCG 30, CAR AUCG 60, and Day AUCG, the scores of these outcome 
measures were log10-transformed. Due to negatively skewed data, the effort 
scores and demand scores on the 2-Back Task and Digit Span Task were first 
reversed prior to the log10-transformation.
All statistical analyses were performed with two-tailed tests, and an alpha level 
of .05 was used to determine statistical significance. Partial eta-squared (η2) 
was calculated as an effect size estimate. Statistical analyses were conducted 
with SPSS for Microsoft Windows, version 21.0 (SPSS, Inc., Chicago, IL).
5.4. Results
5.4.1. Demographical characteristics
The demographical characteristics of the three groups at T1 as well as T2 are 
displayed in Table 5.1. On both time points, the groups did not significantly 
differ on age, sex, level of education, working irregular working hours, 
tobacco use, and intake of medication (for statistics see Table 5.1.). On T1, 
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the number of contractual working hours per week of the clinical burnout 
group was significantly larger than that of the healthy control group (p = 
.027). Furthermore, on T2, a significantly smaller number of individuals in the 
clinical burnout group did not use any medication compared with those in the 
non-clinical burnout group (p = .025).
5.4.2. Burnout symptoms, and general physical and 
 psychological complaints
The UBOS scores revealed significant main effects of Group and Time, and a 
significant interaction effect between Group and Time for all three subscales 
(see Table 5.2. for the statistics and for an interpretation of the main effects). 
Regarding the exhaustion subscale, t-tests revealed a significant decrease from 
T1 to T2 for the clinical burnout group (p < .001) and a significant increase 
for the healthy control group (p = .018). Despite these different trajectories of 
exhaustion, on both time points the clinical burnout group reported significantly 
more exhaustion than the control group (both p’s < .001). Furthermore, on 
both T1 and T2, non-clinical burnout individuals reported significantly more 
exhaustion compared with healthy controls (both p’s < .001). On T1, the clinical 
burnout group experienced significantly more exhaustion than the non-clinical 
burnout group (p < .001), but this difference was no longer significant at T2.
For the cynicism subscale, all groups differed significantly from each other on 
each time point (all p’s < .001), except for an insignificant difference between 
the clinical and non-clinical burnout group on T2. Specifically, the clinical 
burnout group showed significantly higher scores than the non-clinical burnout 
group, which in turn showed significantly higher scores than the control group. 
From T1 to T2 only the clinical burnout group significantly differed, reflecting 
that this group was less cynical at T2 (p = .001).
Regarding the personal efficacy subscale, on T1, the clinical burnout group 
reported significantly less personal efficacy than both the healthy control group 
(p < .001) and the non-clinical burnout group (p = .004). These differences 
disappeared on T2, which apparently was mainly due to a significant increase in 
professional efficacy in the clinical burnout group (p < .001), whereas the other 
groups did not differ in professional efficacy from T1 to T2.
The SCL-90-R scores revealed significant main effects of Group and Time 
and a significant Group × Time interaction effect (for the statistics and an 
interpretation of the main effects, see Table 5.2.). From T1 to T2, only the 
clinical burnout group showed a significant (p < .001) reduction of general 
physical and psychological complaints. However, on both T1 and T2, the clinical 
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burnout group as well as the non-clinical burnout group reported significantly 
more general physical and psychological complaints than the control group 
(all p’s < .01). Only on T1 did the clinical burnout group report more general 
physical and psychological complaints than the non-clinical burnout group (p 
< .001).
In addition, compared to the norm scores of healthy Dutch individuals, the 
level of exhaustion (norm: 1.00–2.19), and general physical and psychological 
complaints (norm: 113–123) were high on T1 and remained high on T2 for both 
the clinical and non-clinical burnout group. For the clinical burnout group only, 
the level of cynicism (norm: .50–1.99) was high on T1 and remained high on 
T2. The level of personal efficacy (norm: 3.67–4.99) was low for the clinical 
burnout group on T1, but improved to an average level on T2.
5.4.3. Cognitive performance
5.4.3.1. Self-reported cognitive problems
Analysis of the scores of the CFQ revealed significant main effects of Group 
and Time, and a significant Group × Time interaction effect (see Table 5.3. 
for the statistics and for an interpretation of the main effects). A paired t-test 
revealed that the clinical burnout group showed a significant reduction of 
self-reported cognitive problems from T1 to T2 (p < .001). However, despite 
this reduction, independent t-tests indicated that the clinical burnout group 
reported significantly more cognitive problems than the healthy control group 
on both T1 and T2 (p < .001 and p = .042, respectively). Compared with the 
non-clinical burnout group, the clinical burnout group reported more cognitive 
problems only on T1 (p = .001). Similar to the clinical burnout group, the non-
clinical burnout group reported more cognitive problems than the control group 
on both T1 and T2 (p = .002 and p = .003, respectively).
5.4.3.2. Cognitive tests
The results of the different cognitive tests are displayed in Table 5.3. Analysis 
of the number of errors on the 2-Back Task revealed no main effect of Group, 
but a significant main effect of Time, and a significant Group × Time interaction 
effect (for an interpretation of the Time effect for this and the other cognitive 
tests, see Table 5.3.). Subsequent t-tests showed that, although none of the 
groups differed on T1, on T2, the clinical burnout group made significantly 
fewer correct responses on this test than the healthy control group (p = .033). 
This seemed to be mainly due to a significant increase in performance from T1 
to T2 of the control group (p < .001).
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For each of the three performance measures on the STOP-IT, the analysis 
revealed a significant main effect of Time, but no main effect of Group, and 
no Group × Time interaction effect. These results reflected the absence of any 
significant performance differences between the three groups on this test.
Analysis of the number of inhibition errors on the Flanker Task revealed only 
a significant main effect of Time and a significant Trial type × Time interaction 
effect. No other effects were found for this test, which indicated that the three 
groups did not significantly differ with regard to their performance on this test.
For the RT’s of the Matching Task, the analysis revealed significant main effects 
of Run type and Time (for an interpretation of the Run type and Time effects, 
see Table 5.3.). No other effects were found, which indicated that there were 
no group differences on this test.
No significant effects were found on the number of correct recalls of the Digit 
Span Task, reflecting the absence of any significant differences in performance 
between the groups on this test.
5.4.3.3. Subjective costs associated with cognitive test performance
Table 5.4. displays the findings of the subjective costs associated with the 
performance on the cognitive tests. Analysis of the fatigue scores revealed 
significant main effects of Moment and Group, and significant Moment × Time 
and Group × Time interaction effects (for an interpretation of the Moment 
effect, see Table 5.4.). Post hoc tests of the Group main effect showed that, 
overall (thus independent of both Moment and Time), the clinical burnout 
group as well as the non-clinical burnout group were significantly more fatigued 
than the healthy control group (p < .001 and p = .005, respectively). Further 
examination of the Group × Time interaction revealed that, irrespective of 
Moment, the clinical burnout group was significantly more fatigued than both 
the control group and the non-clinical burnout group on T1 only (both p’s < 
.001), and that the non-clinical burnout group was significantly more fatigued 
than the control group on T2 only (p = .010). Furthermore, the clinical as well 
as the non-clinical burnout group were less fatigued on T2 than T1 (p < .001 
and p = .013, respectively).
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The analysis of the motivation and effort scores revealed no significant results. 
All scores were high at both measurement points, reflecting very high levels 
of motivation and effort of this study’s participants. Analysis of the demand 
scores revealed a significant Group × Time interaction effect for the STOP-IT. 
Further examination of this interaction effect showed that, on T1, the burnout 
group rated the STOP-IT test as more demanding than both the control group 
(p = .004) and the non-clinical burnout group (p = .036). However, this was 
no longer the case on T2, apparently mainly due to the fact that the clinical 
burnout group reported a significant reduction of demands for the STOP-IT 
from T1 to T2 (p = .008).
5.4.4. Cortisol
Figure 1 shows, for each of the groups on both T1 and T2, the raw means 
and standard errors of the mean cortisol level on the two consecutive non-
work days. A significant main effect of Group was found for the CAR AUCG 
30, but no main effect of Time, and no interaction effect between Group and 
Time (see Table 5.5. for the statistics). Post hoc tests of the main Group 
effect showed that, averaged across T1 and T2, individuals with a non-clinical 
burnout had a significantly lower (p = .013) CAR 30 min after awakening 
than healthy individuals (see Supplement, Table 5.9., for the specific results 
of the t-tests for both T1 and T2). No significant results were found for each 
of the other cortisol outcome measures (for statistics see Table 5.5.) except 
for a marginally significant Group × Time interaction effect for the CAR slope 
(p = .051). Independent and paired t-tests were performed to explore this 
marginally significant interaction effect between Group and Time for the CAR 
slope. However, these tests revealed no further significant results.
5.5. Discussion
The main aim of the present study was to examine the time course of cognitive 
performance and cortisol levels in burnout. To this aim we reexamined an initial 
clinical burnout group, a non-clinical burnout group, and a healthy control 
group after a 1.5 year period. In-between the first examination (T1)  and the 
second examination (T2) the clinical burnout group received psychological 
treatment.
Regarding burnout symptoms (UBOS), and general physical and psychological 
complaints (SCL-90-R), we found that the clinical burnout group showed 
a significant improvement from T1 to T2. In fact, on T2, their scores on
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Figure 5.1. Raw mean (+SEM) of the cortisol levels on the two consecutive non-work days for 
each sample, separated by group and examination time (T1 vs. T2). On T1 and averaged across 
the groups, the participants woke up at 08:17 hrs (there were no significant differences between 
the three groups). On T2 and averaged across the groups, the participants woke up at 08:04 
hrs (the participants in the clinical burnout group woke up significantly earlier than both the 
participant in the non-clinical burnout group and the participants in the control group, p = .024, 
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these subjective measures were not different from those in the non-clinical 
burnout group. However, it is relevant to note that even on T2, the clinical 
as well as the non-clinical burnout group still scored significantly higher than 
the control group on burnout symptoms (exhaustion and cynicism), and 
on general physical and psychological complaints. In addition, these scores 
of the burnout groups also remained high compared with the norm scores 
(except for the cynicism scores of the non-clinical burnout group). On T2, 
only the scores of both burnout groups on the personal efficacy subscale of 
the UBOS reached a similar level as that of the control group. So, apparently 
the burnout participants had the idea they functioned quite well again after 
1.5 years.
Our results with regard to the clinical burnout group are in line with those 
of Van Dam et al. (2012) and Oosterholt et al. (2012). They also found that 
after a period of psychological treatment, clinical burnout patients showed 
a significant across-time improvement on burnout symptoms (exhaustion), 
and general physical and psychological complaints, but continued to have 
significantly elevated scores on these measures compared to healthy controls 
and norm scores. Our finding that individuals in the non-clinical burnout 
group, who did not receive any psychological treatment, continued to score 
high on burnout symptoms (exhaustion), is in accordance with De Vries et al. 
(2016), who found the level of burnout symptoms to be relatively stable over 
a one-year period.
With regard to cognitive performance, the results of the self-reported 
cognitive problems revealed that only the clinical burnout participants 
showed a significant decrease from the first to the second measure. The 
other two groups did not show a change in self-reported cognitive problems 
over time. However, on T2, both burnout groups still reported significantly 
more cognitive problems than the healthy control group. These findings 
reflected the same pattern of results as we found for the majority of the 
other subjective measures (e.g., exhaustion, cynicism, and general physical 
and psychological complaints). The finding that, on T2, the clinical burnout 
group still reported an elevated level of self-reported cognitive problems is 
in accordance with the results of previous studies of Oosterholt et al. (2012) 
and Österberg et al. (2014). In these studies (initial) clinical burnout patients 
persisted to report cognitive problems after a 10 week and a 2 year period, 
respectively. Although there are no previous follow-up studies about self-
reported cognitive problems in non-clinical burnout samples to compare our 
results with, the continued report of cognitive problems in our non-clinical 
burnout group does not seem remarkable since, at T2, this group was very 
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similar to the clinical burnout group in terms of UBOS and SCL-90 scores, that 
after all also reported cognitive problems.
Regarding cognitive test performance, we found that, although there were no 
Group differences on the 2-Back Task on T1, on T2, the clinical burnout group 
performed worse on this test compared with the healthy control group. This 
seemed to be mainly due to a significant increase in performance from T1 
to T2 of the control group. This might suggest the existence of a somewhat 
compromised cognitive functioning in the clinical burnout group because the 
control group benefited from a stronger learning effect (test-retest) than the 
clinical burnout group. In our previous study (Oosterholt et al., 2014), in 
which the cognitive performance of the present participants was examined 
only at T1, it was reported that the clinical burnout group had a slower overall 
reaction time than the control group on the Matching task. However, in the 
present study this finding was not maintained. This was due to attrition of 
participants at follow-up, which resulted in a decrease of statistical power. 
With regard to the performance on the other cognitive tests (i.e., STOP-IT, 
Flanker Task, and Digit Span Task), we found, similar as to T1, no differences 
between the three groups on T2. All in all, and analogous to T1, on T2, only 
the cognitive test performance of the clinical burnout group (and not that of 
the non-clinical burnout group) revealed a rather minor impairment.
Our finding that after more than 1.5 years the cognitive test performance 
of the clinical burnout group was still mildly impaired (albeit on a different 
cognitive test and rather indirectly in the form of a less strong learning effect), 
is in line with previous research of Oosterholt et al. (2012), Österberg et al. 
(2014), and Van Dam et al. (2012), in which similar results were obtained 
after a 10-week, a 20-months, and a (also) 20-months follow-up period, 
respectively. However, the present findings are in contrast with the studies of 
Beck et al. (2013) and Wahlberg et al. (2009), which showed normalization of 
initially observed impairments in cognitive test performance after a 12-week 
and 12-month follow-up period, respectively. Yet, it has to be noted that the 
“clinical burnout” samples in these two latter studies were less comparable 
with the clinical burnout samples used in our studies and in the studies by 
Oosterholt et al. (2012), Österberg et al. (2014), and Van Dam et al. (2012). 
More specifically, the sample in Beck et al. (2013) was more similar to our 
non-clinical burnout sample (actively employed employees, who reported 
symptoms of a burnout, but were neither diagnosed as such nor seeking 
help for these symptoms). In the study of Wahlberg et al. (2009) the sample 
consisted of depressed women with job-stress related long-term sick-leave.
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We no longer found evidence on T2 that the cognitive test performance of the 
clinical burnout group was associated with larger reported subjective costs. 
Compared with our previous study, which was solely based on T1, in the 
present study, we found only little evidence that, on T1, the clinical burnout 
group reported larger subjective costs. For the same reason as described 
earlier, this was due to attrition of participants, which led to a decrease in 
statistical power.
To the extent that burnout indeed is related to impaired cognitive functioning, 
an effective alternative intervention method might be a treatment specifically 
directed at improving cognitive functioning. Recently, Gavelin, Boraxbekk, 
Stenlund, Jarvholm, and Neely (2015) showed promising results with regard 
to reducing both patients’ burnout symptoms and cognitive problems through 
a process-based cognitive training intervention. These findings fit the results 
of previous research in which cognitive training interventions seemed to be 
beneficial in other clinical populations such as major depression and traumatic 
brain injury (e.g., Iacoviello et al., 2014; Westerberg et al., 2007, respectively). 
However, see, for example, Melby-Lervåg and Hulme (2013) for a critical note 
on the effectiveness of cognitive training interventions.
As already noticed in our previous T1 study (Oosterholt et al., 2014), we 
recommend that in future research more challenging cognitive tests may be 
used to test cognitive performance in burnout. An example is the Executive 
Secretarial Task (Lamberts, Evans, & Spikman, 2010). This test requires 
organization and prioritizing of multiple tasks over a long time span, while 
dealing with delayed intentions. Another advantage of this and other similar 
tests is that these have a better ecological validity and better predict a 
person’s level of functioning in daily life (Lamberts et al., 2010; Shallice & 
Burgess, 1991).
Regarding cortisol levels, we only found a Group effect for the CAR AUCG 30. 
This indicated that, averaged across T1 and T2, individuals with a non-clinical 
burnout had a significantly lower CAR 30 min after awakening than healthy 
individuals. Strictly speaking, the Group × Time interaction for the CAR AUCG 
30 did not reach significance, which would imply that further tests are not 
necessary. However, we considered further examination to be informative. 
Results of the corresponding t-tests revealed that, while on T1 the clinical 
burnout group had a marginally significantly lower CAR 30 min after awakening 
than the control group (p = .085), this difference had disappeared on T2 (p 
= .896). However, 30 min after awakening and compared with the control 
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group, the marginally significantly lower CAR of the non-clinical burnout group 
found on T1 (p = .082), was still significantly lower on T2 (p = .038). Taken 
together, these results suggest that after 1.5 years the CAR 30 min after 
awakening had returned to a normal level for the clinical burnout group but 
not for the non-clinical burnout group. Assuming that the CAR 30 min after 
awakening of individuals with non-clinical burnout does not return to a normal 
level, it is an interesting but at present hard to answer question as to what 
the clinical relevance of this lower cortisol pattern shortly after awaking is. 
Future studies should make it clear whether our findings can be replicated and 
hopefully can disentangle what these mean for (future) health and well-being.
With regard to the findings of the non-clinical burnout sample, there are no 
previous published follow-up studies to compare our results with. In some 
earlier studies the course of cortisol levels in clinical burnout samples have 
been examined (Moch et al., 2003; Mommersteeg, Heijnen, Verbraak, et al., 
2006a; Österberg et al., 2012; Wahlberg et al., 2009), but for several reasons 
it is hard to compare our findings with the results of these studies (or to 
compare the results of the previous studies which each other). For example, 
the cortisol measures which are used vary widely between the studies. 
Furthermore, in two of the five previous studies, the control group was not re-
examined at follow-up (Österberg et al., 2012), and in one study the course of 
cortisol levels was examined solely in a clinical burnout group (Mommersteeg, 
Heijnen, Verbraak, et al., 2006a). Finally, there is a large heterogeneity between 
the studies in terms of the operationalization of the clinical burnout group. 
Less heterogeneity between burnout samples might provide more consistent 
and promising results. A consensus definition of burnout would facilitate this 
challenge. In addition, research has shown that people with burnout do not 
form a homogeneous group (even when using the same operationalization), 
but that there may be different “subgroups” with different symptomatology 
(Demerouti, Verbeke, & Bakker, 2005; Golembiewski & Munzenrider, 1988; 
Tops et al., 2007; Van Dam et al., 2012). It is plausible that this heterogeneity 
within burnout samples may have contributed to the inconsistencies in results 
concerning the relation between burnout and cortisol deviations.
5.5.1. Strengths and limitations
A strong feature of the present study was that we examined the course of 
cognitive performance and cortisol levels in burnout by including both a 
clinical and a non-clinical burnout group, and a healthy control group, whereas 
previous studies compared “only” a burnout group with a control group. In 
Chapter 5 Getting better, but not well
106 107
5
addition, the relatively long follow-up period can be regarded as a strength. 
Another asset is that we systematically examined cognitive performance by 
focusing on three interrelated aspects of cognitive performance, namely, self-
reported cognitive problems, cognitive test performance, and subjective costs 
associated with cognitive test performance. Furthermore, we determined 
cortisol levels by measuring cortisol during multiple days, and by using a full 
range of cortisol indices.
Despite these strengths, our study has some limitations as well. For example, 
one might argue that a diagnosis of burnout with a comorbid depressive or 
anxiety disorder is not rare. Along that line of reasoning, excluding burnout 
patients with a comorbid disorder might limit the generalizability of our results. 
However, this exclusion was considered to be important for the purpose of 
establishing the burnout-cognition and burnout-cortisol relationships while 
preventing contamination by comorbid psychopathologies. Furthermore, 
although we treated clinical and non-clinical burnout as two different groups 
of burnout, it is important to emphasize that there may be some overlap 
between these two burnout groups. It is equally important to note, however, 
that despite such potential overlap, we did find interesting differences between 
these two groups on some measures. Next, the time-interval between T1 and 
T2 differed between the participants. Despite this difference, it is, however, 
important to emphasize that the (average) time-interval only differed between 
the participants and not between groups. This makes it unlikely that the 
former difference differentially affected our between-group results. Moreover, 
it remains unknown to what extent the positive changes that we observed in 
the clinical burnout group were due to treatment, maturation, or both. Hereto, 
we also should have included a wait-list control group, but this would pose 
ethical constraints. Also, one could argue that, although we started the study 
with relatively large groups and lost only a small percentage of participants 
during follow-up, we lost some power in our cortisol analyses due to excluding 
cortisol samples which were not collected within our strict time limits, or for 
which no sampling time was reported.
5.5.2. Conclusion
Despite considerable improvement of burnout symptoms, and general physical 
and psychological complaints after 1.5 years, the initial clinical burnout 
patients continued to report cognitive problems and still revealed a (very 
mildly) impaired cognitive test performance. However, the patients no longer 
reported larger subjective costs associated with cognitive test performance 
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and cortisol returned back to a normal level. After 1.5 years, the non-clinical 
burnout group still reported the same, elevated, level of burnout symptoms, 
general physical and psychological complaints, and cognitive problems. 
Cognitive test performance of this group remained normal and not associated 
with larger subjective costs. However, we found some evidence indicating 
that, 30 min after awakening, the non-clinical burnout group continued to 
display a lowered CAR. Taken together, the results of this study indicate that 
after 1.5 years, the clinical burnout group got better, but not “well”, and the 
non-clinical burnout group remained not “well”.
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6.1. Overview
The purpose of this dissertation was to examine whether burnout is 
accompanied by impaired cognitive functioning and changes in cortisol levels, 
thereby enhancing knowledge about the nature of burnout. More specifically, 
we aimed to:
1. a)  Provide a better understanding of cognitive functioning associated
          with burnout (cross-sectional approach);
b) Gain more insight into the course of cognitive functioning in 
     relation to burnout (longitudinal approach);
2. a) Provide a better understanding of cortisol levels associated with 
          burnout (cross-sectional approach);
   b) Gain more insight into the course of cortisol levels in relation to
          burnout (longitudinal approach).
To these aims we conducted four studies which were reported in Chapters 2 to 
5. In these studies, we examined the burnout-cognition and burnout-cortisol 
relationships by adopting research designs that enabled us to overcome key 
limitations of previous studies: i) large differences in the operationalization of 
burnout and its lack of specificity, ii) heterogeneity and restricted reliability 
of outcome measures, iii) not controlling for important potential confounders, 
and iv) a lack of longitudinal research designs. In this final chapter, we first 
separately portray both relationships (i.e., burnout-cognitive functioning and 
burnout-cortisol levels) by providing a brief introduction into the specific 
relationship, an overview of the main results, and a discussion of the findings 
of our empirical studies. Subsequently, the strengths and limitations of the 
studies reported in this dissertation and directions for future research are 
described. Next, some practical implications are depicted followed by an 
overarching conclusion.
6.2. Burnout and cognitive functioning
6.2.1. Introduction
Employees with burnout often report cognitive problems. For example, 
they frequently complain about difficulties to concentrate and an impaired 
memory. This was already known for several decades (e.g., Maslach et al., 
2001). However, it was not until 2005 that researchers started to empirically 
study cognitive functioning in burnout and test whether these self-reported 
cognitive problems are accompanied by actual cognitive impairments, as 
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measured with cognitive neuropsychological tests (e.g. Österberg et al., 2009; 
Sandström et al., 2005; Van Dam et al., 2011; Van der Linden et al., 2005). 
The results of these initial studies seemed to indicate that the self-reported 
cognitive problems in burnout are indeed accompanied by objective cognitive 
impairments, as measured with neuropsychological tests. More specifically, 
these earlier studies seemed to indicate that burnout is particularly associated 
with impaired executive functioning, whereas individuals with burnout had 
fewer impairments in more lower-order cognitive processes (Sandström et 
al., 2011; Van der Linden et al., 2005)
6.2.2. Main results
Against this background, in our first study (described in Chapter 2), we 
investigated the burnout-cognition relationship by focusing specifically on 
executive functioning. We examined a group of clinical burnout patients and 
a healthy control group on tests measuring the three most basic executive 
functions, namely, updating, inhibition, and task-switching. We also assessed 
the self-reported cognitive problems of both groups. The results of this 
study were mostly in line with the aforementioned initial studies on cognitive 
functioning in relation to burnout. That is, we found clear evidence that the 
burnout patients reported more cognitive problems than healthy individuals. 
Furthermore, burnout patients underperformed the healthy controls on the test 
that measured updating, signifying an impairment in executive functioning. 
In contrast to what was concluded in most of the initial studies (Sandström et 
al., 2005; Van der Linden et al., 2005), our results also showed that burnout 
was associated with an impairment in more lower-order cognitive processing, 
as indicated by a general slowing in reaction time.
A relevant design strength of our first study was that we could also test 
whether these observed cognitive impairments in clinical burnout patients 
would diminish over time. We reexamined both groups after a 10-week period, 
in which the clinical burnout patients received psychological treatment. The 
results revealed that, although still elevated compared with the healthy 
individuals, the clinical burnout patients showed positive changes regarding 
their burnout symptoms, general health, and self-reported cognitive difficulties. 
However, the cognitive test performance of the patients did not improve. 
Important to note is that the time interval between the first and the second 
examination was relatively short and treatment had not been finished for any 
of the clinical burnout patients. Hence, we could not rule out the possibility 
that improvement would occur over longer periods or after finishing therapy.
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In our second study (Chapter 3) we examined the burnout-cognition 
relationship in more detail. In addition to a large sample of clinically 
diagnosed burnout patients and of healthy controls, we now also examined 
a sample of non-clinical burnout individuals. The latter sample consisted of 
individuals who reported to have symptoms of burnout, but were not clinically 
diagnosed and were not seeking help for these symptoms. Again, cognitive 
functioning was assessed by measuring self-reported cognitive problems as 
well as performance on cognitive tests. Inspired by the findings from our 
first study, in Study 2, the three groups were not only compared on their 
performance on cognitive tests assessing the three most basic executive 
functions, but also on their performance on tests that employed more lower-
order cognitive processes. Moreover, we aimed to draw upon a new approach 
by also investigating subjective costs involved in performing these cognitive 
tests. To this aim, we collected information about experienced fatigue, 
motivation, effort, and demands that went together with the performance 
on the cognitive tests. The results of this second study showed that, similar 
to our first study, the clinical burnout patients reported more cognitive 
problems than the individuals with non-clinical burnout, who in turn reported 
more cognitive problems compared with the healthy controls. As regards 
cognitive test performance, we found some evidence that (only) the clinical 
burnout group underperformed the healthy control group. More specifically, 
they showed longer reaction times, reflecting an impairment in more lower-
order cognitive processing. We obtained no results indicating any specific 
impairment in executive functioning. However, cognitive test performance of 
the clinical burnout patients was accomplished with larger subjective costs. 
Taken together, the results of this study indicated that, although both the 
clinical and the non-clinical burnout group reported cognitive problems, 
evidence for a relatively mild impaired cognitive test performance and larger 
reported subjective costs associated with cognitive test performance was only 
found for the clinical burnout group.
In our fourth study, described in Chapter 5, we once more studied the 
longitudinal course of cognitive performance in burnout by reexamining 
the three original groups (i.e., clinical burnout, non-clinical burnout, and 
healthy control group) from our second study (described in Chapter 3). To 
address an important limitation of our first longitudinal study (as described 
in Chapter 2, i.e., the relatively short follow-up period of 10-weeks), this 
time we reexamined the three groups after more than a 1.5 years period. 
Similar to our first longitudinal study, the patients of the clinical burnout 
group received psychological treatment in-between the first and second 
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examination. Importantly and contrary to our first longitudinal study, in 
which all patients were still in treatment at the follow-up measurement, in our 
second longitudinal study, all patients except one were no longer in treatment 
at the time of the reexamination. Yet, despite the differences in time frame 
between the two longitudinal studies, the pattern of results that we found in 
the clinical burnout group was identical to that in our first longitudinal study. 
That is, although still elevated compared with the controls, the clinical burnout 
group revealed a significant reduction of burnout symptoms, general health, 
and self-reported cognitive problems. Overall, the cognitive test performance 
remained the same and still showed signs of a mild impairment. However, 
burnout patients no longer reported larger subjective costs associated with 
cognitive test performance. As regards the non-clinical burnout individuals, 
they still reported the same, elevated, level of burnout symptoms, general 
physical and psychological complaints, and cognitive problems when compared 
with the healthy controls. Their cognitive test performance and associated 
subjective costs remained normal.
6.2.3. Discussion
6.2.3.1.  Research aim 1a: Provide a better understanding of cognitive 
functioning associated with burnout
All in all, the results of our studies (described in Chapter 2 and 3) showed clear 
and compelling evidence that clinical burnout is associated with more self-
reported cognitive problems. These results are in line with those of the other 
studies on this topic (Österberg et al., 2009; Van der Linden et al., 2005). 
Additionally, we found self-reported cognitive problems to be significantly 
different between clinical and non-clinical burnout. That is, clinical burnout 
patients rated their cognition as being significantly worse than individuals 
with non-clinical burnout levels did (the latter group in turn reported more 
cognitive problems than healthy controls did). Thus far, in only one previous 
study (Van der Linden et al., 2005) such a comparison between clinical and 
non-clinical burnout was made. In this latter study, the same pattern of results 
was found as in our study.
Although the studies in this dissertation revealed that individuals with non-
clinical burnout symptoms also reported cognitive problems, we did not find 
evidence that the cognitive test performance of these individuals was impaired. 
We solely found some proof for impaired cognitive test performance in clinical 
burnout patients. More specifically, the results of our studies showed that 
the impaired cognitive test performance in clinical burnout patients reflected 
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both minor deficits in executive functioning and more lower-order cognitive 
processes. It is important to note that the overall degree of the impairments 
was found to be relatively mild compared with the results of many previous 
studies (e.g., Öhman et al., 2007; Sandström et al., 2005; Van der Linden 
et al., 2005). A factor that could be responsible for this discrepancy is that 
we only included burnout patients without comorbid mental disorders in our 
studies. Thus, we were fairly conservative in our “ideal-typical selection” of 
participants. In previous research, patients with comorbid mental disorders 
were not always excluded, or the effects of comorbidity were not always 
controlled for. Consequently, these previous findings might present an 
overestimation of the level of cognitive test performance impairments in 
clinical burnout. This is possible because, for example, there is ample evidence 
that depression is related to substantial deficits in cognitive functioning (e.g., 
Gotlib & Joormann, 2010).
The absence of any cognitive test performance impairments in the non-
clinical burnout group is not in line with the findings of previous studies. 
In these studies non-clinical burnout was found to be associated with: (i) a 
more general cognitive decline (Van der Linden et al., 2005), (ii) deficits in 
executive functions (Diestel et al., 2013), and (iii) even better performance 
on tests that measured executive functioning (Castaneda et al., 2011). Since 
selection criteria differed strongly between these studies, heterogeneity in 
the used burnout samples may possibly explain the inconsistency in these 
previous results. Clearly, more research, using comparable burnout samples 
(i.e., similar inclusion criteria), is required to draw firmer conclusions about 
cognitive test performance in individuals with non-clinical burnout.
We did not only examine the degree and specific nature of cognitive 
impairments in both clinical and non-clinical burnout, but we also evaluated 
the costs associated with test performance. In line with the conclusion of 
Van Dam (2013), we found that individuals with burnout (both clinical and 
non-clinical) are, just as healthy individuals, highly motivated to perform the 
cognitive tests. Yet, we obtained evidence indicating that adequate cognitive 
test performance in clinical burnout comes at relatively large costs, as reflected 
in higher invested effort and experienced task demand scores.
We hypothesize that if these costs exceed a critical value, more significant 
cognitive test performance impairments may emerge. This line of reasoning 
implies that when clinical burnout patients, and possibly also individuals with 
non-clinical burnout symptoms, became challenged to a larger extent (e.g., 
by using longer and/or more (complex) tests) they might well eventually fail 
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(even more) to uphold their test performance. This notion is supported by 
research that demonstrates that mental fatigue appears to affect performance 
to an even larger extent on more challenging tasks (e.g., Holding, 1983; Lorist 
et al., 2000; Van der Linden et al., 2003). Moreover, this notion might also 
provide an explanation for the discrepancy between the level of self-reported 
cognitive problems and the level of cognitive test performance impairments 
found in burnout. This discrepancy could be due to the fact that self-reported 
cognitive problems reflect the cognitive problems experienced in daily life, 
which may be a context that is more challenging and complex than which can 
be established in the relatively short and uncomplicated cognitive tests (e.g., 
Lamberts et al., 2010; Shallice & Burgess, 1991).
6.2.3.2. Research aim 1b: Gain more insight into the course of 
cognitive functioning in relation to burnout
The results of our two longitudinal studies (described in Chapters 2 and 4) 
revealed that although the (initial) clinical burnout patients improved over the 
course of time, even after a period of up to 1.5 years, they still reported more 
burnout symptoms, general health complaints, and self-reported cognitive 
problems compared with healthy controls. With regard to the non-clinical 
burnout individuals (Chapter 5), we found no evidence for a reduction in the 
level of burnout symptoms, general health complaints, and cognitive problems. 
This means that these levels were still elevated compared with those of healthy 
individuals. Furthermore, and analogous to the results of the initial examinations 
(T1’s), our reexaminations showed that only the cognitive test performance of 
clinical burnout patients (and not that of individuals with non-clinical burnout 
symptoms) still revealed mild impairments, even after more than 1.5 years. 
We, however, no longer found evidence that the cognitive test performance 
of the clinical burnout patients went together with larger reported subjective 
costs. Therefore, all in all, we can conclude that after a period of treatment the 
clinical burnout group got better, but not ‘well’, and the non-clinical burnout 
group remained not ‘well’.
These conclusions concur with those of Österberg et al. (2014), and Van Dam 
et al. (2012), who obtained similar results after comparable follow-up periods. 
Nevertheless, our findings deviate from those of Beck et al. (2013), who showed 
a normalization of initially observed impairments in cognitive test performance 
after a 12-week follow-up period. However, the clinical burnout sample in the 
study of Beck et al. (2013) was not comparable with the clinical burnout sample 
used in our study and the samples in the studies of Österberg et al. (2014) and 
Van Dam et al. (2012). It was more similar to our non-clinical burnout sample 
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(actively employed employees, who reported burnout symptoms, but were 
neither diagnosed as such nor seeking help for these symptoms). Yet, even 
when we make this assumption the results of Beck et al. (2013) still do not 
match our finding regarding the non-clinical burnout group. More high quality 
studies with relevant and comparable inclusion (and exclusion) criteria are 
required to draw more definite conclusions about cognitive test performance in 
non-clinical burnout.
6.3. Burnout and cortisol
6.3.1. Introduction
Burnout is a stress-related syndrome and cortisol is considered to be a main 
stress hormone (e.g., Lupien et al., 2007). Therefore, researchers started to 
examine cortisol levels in burnout to acquire valuable information about the 
biological underpinnings of burnout. Studying cortisol levels in relation to burnout 
is also interesting since it has been hypothesized that the cognitive problems 
of individuals with burnout may be related to possible cortisol deviations (e.g., 
Österberg et al., 2009; Sandström et al., 2011). More specifically, cortisol is 
believed to be involved in mediating the stress-cognition relation, whereby 
both high and low levels of cortisol are assumed to have detrimental effects on 
cognition (Lupien et al., 2007).
Although the relationship between burnout and cortisol levels has been 
examined in previous research, it is clear that the results are mixed (see 
Danhof-Pont et al., 2011, for an comprehensive review of the results). For 
instance, some studies showed burnout to be related with lower levels of 
cortisol (e.g., Marchand et al., 2014; Sonnenschein et al., 2007), whereas other 
studies revealed burnout to be associated with higher cortisol levels (e.g.,  De 
Vente et al., 2003; Melamed et al., 1999). To complicate things further, there 
are also studies in which burnout was not found to be related with any cortisol 
deviations (Mommersteeg, Heijnen, Verbraak, et al., 2006a).
As already noted, we believe that several important limitations may be 
held responsible for the inconclusiveness in the existing burnout-cortisol 
literature (i.e., the large variety of operationalizations of burnout and its lack 
of specificity; heterogeneity and limited reliability of the cortisol assessment; 
important potential confounding variables which were not controlled for; the 
lack of longitudinal research designs). By studying the burnout-cortisol relation 
with designs in which we attempted to overcome these important limitations of 
earlier research our aim was to create more insight into this relationship.
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6.3.2. Main results
With our third study, described in Chapter 4, we tried to provide a better 
understanding of cortisol levels associated with burnout. Hereto, we compared 
a clinical burnout group, a non-clinical burnout group, and a healthy control 
group with regard to cortisol levels. These are the same three groups as 
reported on in Chapter 3. In order to examine a state of the art spectrum 
of cortisol indices, including different measures of the CAR and several day-
curve measures, salivary cortisol was collected six times a day during two 
consecutive non-workdays. The results of this study showed that 30 minutes 
after awakening, the CAR of both the clinical and the non-clinical burnout 
group was lower compared with the healthy control group. Furthermore, we 
obtained some evidence that the decline of cortisol during the day was smaller 
in the non-clinical burnout group than in the healthy control group.
In Chapter 6, we studied the course of cortisol levels in burnout by reexamining 
the three samples (i.e., clinical burnout, non-clinical burnout, and healthy 
control group) that we reported on in our third study (described in Chapter 
4). This reexamination took place after a period of 1.5 years. In-between 
the first and second examination the patients of the clinical burnout group 
received psychological treatment. The results of our reexamination showed 
that the lowered CAR 30 minutes after awakening, which was found at the 
first examination in the clinical burnout sample, had returned to normal levels. 
The group with a non-clinical burnout still continued to display a lowered CAR 
30 minutes after awakening. However, we no longer found evidence for a 
smaller decline of cortisol during the day in the non-clinical burnout group 
compared to the control group.
6.3.3. Discussion
6.3.3.1. Research aim 2a: Provide a better understanding of cortisol 
levels associated with burnout
In Chapter 4, the results showed that clinical and non-clinical burnout 
individuals had a similar attenuated cortisol pattern shortly after awakening 
(i.e., CAR 30 min after awakening). These findings are in line with the results 
of previous studies of  Mommersteeg, Keijsers, et al. (2006) and Sonnenschein 
et al. (2007), and those of Marchand et al. (2014) and Moya-Albiol et al. 
(2010b), in which clinical burnout and non-clinical burnout, respectively, were 
also found to be related with a lower level of cortisol shortly after awakening. 
Thus far, no other studies have been published that specifically assessed 
the CAR 30 min after awakening in a non-clinical burnout sample. However, 
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other previous studies showed clinical burnout to be unrelated to any cortisol 
deviation (Mommersteeg, Heijnen, Kavelaars, et al., 2006) as well as to 
be related with higher cortisol (De Vente et al., 2003) with respect to this 
measure. 
In Chapter 4, we found some evidence indicating that the cortisol slope of the 
day was smaller in the non-clinical burnout group than in the control group, 
which may reflect poor recovery from stress. This smaller slope was not only 
the result of a lower cortisol level in the morning directly after awakening, but 
was also due to a relatively high cortisol level in the evening in the non-clinical 
burnout group. A high cortisol level in the evening is sometimes considered to 
reflect poor recovery from stress, which in turn, may be regarded as a major 
risk factor for developing a more severe (clinical) burnout.
As noted in the beginning of this section, earlier results on the relationship 
between burnout and cortisol are mixed. Our results do not change this 
picture. Nevertheless, we do believe that our results contribute to a better 
understanding of the observed differences in earlier studies. For example, one 
possible explanation for why null results or elevated cortisol levels were found 
in some previous studies (both in those using a clinical or non-clinical burnout 
sample), might be due to comorbidity of depression and/or anxiety. There is 
evidence that these latter disorders are related to increased cortisol levels 
(e.g. Abelson et al., 2007; Herbert, 2013). However, it should be noted that 
comorbidity alone does not explain all the variance in the observed cortisol 
levels in burnout (e.g., Sjörs et al., 2012). Another possible explanation 
for the observed null results in some prior clinical burnout research is that 
patients already had been in treatment for a longer period, or that the time 
interval between diagnosis and cortisol sampling was larger than in our study 
(as to both possibilities, often no information is provided in previous research 
to rule out these possibilities). For example, similar to our own longitudinal 
study (Chapter 5), Mommersteeg, Keijsers, et al. (2006)  found that directly 
after diagnosis, clinical burnout patients had lower cortisol levels than 
healthy individuals, but that these differences disappeared during a period 
of psychological treatment. In other words, during treatment (or just in the 
course of time), it may be that the HPA axis recovers resulting in normal 
cortisol levels. A similar explanation might also account for the null results 
of some previous studies in which non-clinical burnout samples were used. 
More precisely, if in these studies the period of time between the assessment 
of burnout symptoms and the collection of cortisol was relatively long (again, 
this information is often not provided) maturation effects may have occurred.
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6.3.3.2. Research aim 2b: Gain more insight into the course of cortisol 
levels in relation to burnout
Our results, described in Chapter 5, showed that the initially observed lowered 
CAR 30 minutes after awakening in clinical burnout patients returned to a 
normal level after a 1.5 years period during which they received psychological 
treatment. Among non-clinical burnout individuals, who did not receive any 
intervention in-between the two examinations, a lower CAR 30 minutes after 
awakening was still observed when compared with healthy individuals. 
With regard to the non-clinical burnout sample, there are no previously 
published follow-up studies to compare our results with. In contrast, the 
course of cortisol levels in clinical burnout samples has been examined in 
some previous studies (Moch et al., 2003; Mommersteeg, Heijnen, Verbraak, 
et al., 2006b; Mommersteeg, Keijsers, et al., 2006; Österberg et al., 2012; 
Wahlberg et al., 2009). Although some of these studies also show cortisol 
levels to be relatively normal at follow-up (Mommersteeg, Heijnen, Verbraak, 
et al., 2006b; Österberg et al., 2012), it is difficult to compare our findings 
with these results (or to compare the results of the previous studies with 
each other). For example, cortisol measures vary widely between the studies. 
Furthermore, the control group was not reexamined at follow-up in two of 
the five prior studies (Mommersteeg, Keijsers, et al., 2006; Österberg et 
al., 2012). In another study, the course of cortisol levels was investigated 
solely in the clinical burnout group (Mommersteeg, Heijnen, Verbraak, et 
al., 2006b). Finally, and most fundamentally, selection criteria varied widely 
between the studies and this resulted in a large heterogeneity in terms of the 
operationalization of the clinical burnout group.
Assuming that the cortisol levels of non-clinical burnout employees (and 
possibly also those of clinical burnout patients) do not return to normal levels, 
it is an interesting but currently hard to answer question as to what the 
clinical relevance of this lower cortisol pattern (shortly after waking up) is. 
Hopefully, future high quality studies will make it clear whether our cortisol 
results can be replicated and paint a more detailed picture as to what these 
mean for (future) health and well-being.
6.4. Strengths of this dissertation
A strength of this dissertation is that, in the same sample, we studied 
both cognitive performance and cortisol levels in relation to burnout with 
research designs that enabled us to overcome four key limitations of previous 
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research: i) large differences in the operationalization of burnout and its 
lack of specificity, ii) heterogeneity (and restricted reliability) of the outcome 
measures, iii) not controlling for important potential confounders, and iv) the 
lack of longitudinal research designs.
We addressed the first limitation by examining cognitive functioning and 
cortisol levels both in a clinical and a non-clinical burnout group. Our clinical 
burnout samples were selected on the basis of a high quality and standardized 
burnout diagnosis, as established by professional clinical psychologists. Our 
non-clinical burnout group consisted of employees who reported symptoms 
of burnout but who were not diagnosed as such and were still working. In 
addition, we described our inclusion criteria very clearly and also included a 
non-burnout reference group.
With regard to the second limitation, we systematically assessed a broad and 
state of the art spectrum of both cognitive functioning and cortisol levels. 
Cognitive functioning was measured both subjectively, by a well-validated 
questionnaire, and objectively, by well-validated cognitive tests that assessed 
executive functioning as well as more lower-order cognitive processes. 
Furthermore, we drew upon a new approach by evaluating the performance 
on the cognitive tests in light of the associated personal costs. The underlying 
principle is that adequately upholding performance may come at larger costs. 
We found this to be the case in clinical burnout patients (Chapter 3). As 
regards the assessment of cortisol we aimed to get a full, valid, and reliable 
assessment of cortisol levels. Hereto, we measured the diurnal cortisol 
pattern, by collecting six salivary cortisol samples during two consecutive 
non-working days. Unlike the majority of previous studies, we collected 
the cortisol samples on non-working days to make sure that the sampling 
conditions were equal between the groups. This matters because research has 
shown that cortisol levels are generally higher on workdays than on days off 
work (e.g., Kunz-Ebrecht et al., 2004; Langelaan et al., 2006; Schlotz et al., 
2004). This probably influenced the results of those previous studies in which 
the burnout group comprised clinical burnout patients who were (largely) 
not working (i.e., on sick leave) and in which the control group consisted of 
healthy individuals who were working during the sampling procedure.
The third limitation was addressed by excluding participants with comorbid 
mental disorders, especially those with mood and anxiety disorders. 
As mentioned before, we believe that this, or controlling for the effect of 
comorbidity, is essential because, for example, major depressive disorder is 
proven to be related both with significant deficits in cognitive functioning 
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and with increased levels of cortisol. Our burnout samples without comorbid 
disorders enabled us to carry out a relatively ‘pure’ assessment of the 
burnout-cognition as well as the burnout-cortisol relationship. Furthermore, 
we examined both relationships by statistically controlling for potentially 
important confounding variables, such as the use of medication, alcohol and 
caffeine intake, time of awakening, sleep duration, and sleep quality.
Finally, we addressed the fourth limitation by conducting two longitudinal 
studies to investigate the course of both cognitive functioning and cortisol 
levels in relation to burnout.
6.5. Limitations of this dissertation
We believe that this dissertation has two main limitations. The first limitation 
relates to the issue of causality. We treated cognitive functioning and cortisol 
levels as outcome variables influenced by burnout. Our findings that burnout 
was associated with cognitive impairments and, to some extent, with lowered 
cortisol, do not rule out the possibility of a reverse relation, nor that of a bi-
directional relationship. In other words, one might argue that both cognitive 
impairments and lowered cortisol may be cause as well as consequence of 
burnout. Such relationships might be plausible. For example, as regards 
the burnout-cognition relation, Van der Linden et al. (2005) already noticed 
in their pioneering work that cognitive deficits might be responsible for, or 
play an important role in the origination of burnout. This is because healthy 
cognitive functioning is considered to be essential in coping effectively with 
stress (Declerck et al., 2006; Williams et al., 2009). Accordingly, when 
confronted with stressors on the job, impaired cognitive functioning might 
lead to inadequate coping strategies, that could result in burnout.
The second issue of this dissertation concerns the identification of possible 
within-group differences. For example, Van Dam (2013) pointed at the 
importance of studying within-group differences, since research has shown 
that people with burnout do not constitute a homogeneous group, but that 
there may be different “subgroups” with different symptomatology (e.g., 
Demerouti et al., 2005; Golembiewski & Munzenrider, 1988; Tops et al., 2007; 
Van Dam, 2013). Although we examined burnout in relation to cognition and 
cortisol by assessing both a clinical and a non-clinical burnout sample, we did 
not examine whether these particular samples formed homogenous groups. 
This could have been investigated by examining possible within-group 
differences, for example, with regard to the recovery process. Van Dam et 
al. (2012), for instance, found that although many of their clinical burnout 
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patients recovered to a large extent, a group of patients could be identified 
who continued to report severe burnout complaints and cognitive impairments. 
This may have also been the case in our studies and a closer examination of 
individual trajectories or subgroups could have provided further information 
about burnout in relation to cognitive functioning and cortisol levels. However, 
the number of participants in our samples (and observed power) was not 
sufficient to further examine such possible within-group differences.
6.6. Future research recommendations
Our most important recommendation for future research relates to the 
concept of burnout. Metaphorically speaking, to reach agreement on the 
meaning of a certain concept one has to talk the same language. Currently 
this is not the case in burnout research, which has led and probably will keep 
leading to inconsistency in results. An important cause for this differentiation 
is the absence of an officially defined diagnosis in the Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric 
Association, 2013). Similarly, burnout is only mentioned without diagnostic 
criteria in the International Classification of Diseases (10th ed.; ICD-10; 
World Health Organisation, 2010). Accordingly, and also due to financial 
reimbursement issues (e.g., in many countries, treatment for burnout is not 
compensated by insurance companies), between countries, and even within 
countries, different diagnoses are used, such as major depressive disorder, 
adjustment disorder, undifferentiated somatoform disorder, (vital) exhaustion, 
or neurasthenia instead of a burnout diagnosis. Therefore, we like to advocate 
more diagnostic research on burnout that hopefully results in a more uniform 
concept of burnout and to an inclusion in the DSM and ICD (with diagnostic 
criteria). Such an endeavor could be structured following the example of  the 
development of clear criteria for insomnia (Edinger et al., 2004), which has 
led to a dramatically improved diagnostic reliability among both clinicians and 
researchers.
Since we were the first to systematically examine personal costs associated 
with the performance on cognitive tests in people with burnout, another 
recommendation that we would like to make for future research is to further 
examine this relationship. In light of the higher subjective costs that we 
found to be associated with the cognitive test performance in clinical burnout 
patients, an interesting question to be addressed in future studies is what would 
happen if individuals with burnout became challenged to a larger extent. We 
expect that if the personal costs exceed a critical value, for example, through 
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the assessment of a more challenging test, more significant cognitive test 
performance impairments might emerge. An example of such a challenging 
test could be the Executive Secretarial Task (Lamberts et al., 2010). This is a 
three-hour test, requiring organization and prioritizing of multiple tasks over 
a long time span, while dealing with delayed intentions. Another advantage of 
this and similar tests is that these have a better ecological validity and may 
better predict a person’s level of functioning in daily life (e.g., Lamberts et al., 
2010; Shallice & Burgess, 1991).
An interesting issue to investigate would be to look into the process of 
recovery in burnout after cognitive test performance. Since we found clinical 
burnout patients to invest more effort in completing the cognitive test and to 
rate the tests as more demanding, it may well be that people suffering from 
burnout (symptoms) need more time to recover after completing a cognitive 
test battery compared with healthy individuals. In future research one might 
consider to examine whether burnout is related to such an extended recovery 
time. This could be studied, for example, by assessing the recovery process 
(both subjectively and objectively, for example, by measuring cortisol levels) 
right after, in the evening after, or even the day after performance on, 
preferably a challenging, cognitive test battery.
Our last recommendation concerns the issue of causality. As noted above, on 
the basis of our results and those of previous research with regard to both 
the burnout-cognition and burnout-cortisol relationship, we cannot rule out 
the possibility of a reverse relation, nor that of a bi-directional relationship. 
As noted before, such relationships are plausible. Future cohort studies or 
studies with more repeated measurements and/or longer follow-up periods, 
in combination with appropriate statistical techniques (e.g., Boudrias, Morin, 
& Lajoie, 2014), are needed to shed more light on the issue of causality in 
both the burnout-cognition and burnout-cortisol relationship. 
6.7. Practical implications
We believe that the results of our studies reported in this dissertation have 
a number of practical implications, especially with respect to clinical practice 
and reintegration to work.
First of all, our findings that burnout symptoms and cognitive impairments 
of burnout patients cannot easily be reversed by “traditional” psychological 
treatment, emphasizes the importance of effective (alternative) intervention 
programs. In the Netherlands, employees who seek help for their burnout 
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complaints are usually treated with psychological therapy, according to a 
treatment protocol for burnout (this was also the case in our studies). This 
type of intervention is mainly focused on individual treatment directed at a 
personal level. Awa, Plaumann, and Walter (2010) conducted an extensive 
review of the literature, and concluded that although treatment directed at 
a personal level can be beneficial for reducing burnout symptoms, generally 
these effects are not lasting and fade away after a period of 6 months. In this 
same review the authors concluded that intervention programs that are both 
person- and organization-directed are more effective and that these effects 
are longer-lasting. In addition, they showed that such intervention programs 
in combination with refresher courses have the longest effects. Therefore, 
we advocate that a standard intervention for the treatment of burnout must 
be directed at both a personal and an organizational level, and preferably 
includes refresher courses.
To the extent that burnout indeed is associated with specific cognitive 
impairments, an effective alternative intervention method may be a treatment 
specifically directed at improving cognitive functioning in general or some 
specific cognitive function in particular. In a recent study, Gavelin et al. (2015) 
showed promising results as regards reducing patients’ burnout symptoms 
as well as cognitive problems through a process-based cognitive training 
intervention. These results fit the findings of previous research showing 
cognitive training interventions to be beneficial in other clinical groups 
such as major depression and traumatic brain injury (e.g., Iacoviello et al., 
2014; Westerberg et al., 2007, respectively). Yet, for a critical note on the 
effectiveness of such training in general, see Melby-Lervåg and Hulme (2013). 
Although additional research, specifically aimed at burnout, is required, 
cognitive training interventions would be an interesting and potentially useful 
method to address burnout symptoms and cognitive impairments associated 
with burnout.
Results that cognitive performance of (initial) burnout patients seems to be 
mildly reduced may also have implications for the reintegration to work. We 
believe that for a successful reintegration to happen, burnout patients may 
adapt their high performance demands to a level that fits their current cognitive 
capability. Employers could facilitate this process by making adjustments in 
task-demands, for example, by temporarily providing these employees with 
tasks that require less cognitive effort (Van Dam, 2013) or to promote the use 
of compensatory techniques that reduce cognitive demands.
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6.8. Conclusion
The purpose of this dissertation was to:
1. a)  Provide a better understanding of cognitive functioning associated
          with burnout;
b) Gain more insight into the course of cognitive functioning in 
     relation to burnout;
2. a) Provide a better understanding of cortisol levels associated with 
          burnout;
   b) Gain more insight into the course of cortisol levels in relation to
          burnout.
Did we accomplish these aims? We believe we did.
In sum and with respect to aim 1a), our results showed that although clinically 
diagnosed burnout patients (clinical burnout group) as well as employees who 
reported elevated burnout symptoms (but who were not clinically diagnosed 
nor seeking help for these symptoms; non-clinical burnout group) reported 
cognitive problems, we only found evidence for an impaired cognitive test 
performance in the clinical burnout group. These impairments were found to be 
relatively mild compared with those of previous research, which we consider to 
be due to our relatively pure assessment of burnout. Yet, our results indicated 
that cognitive test performance of the clinical burnout patients came at relatively 
large costs, as was reflected in higher invested effort and experienced task 
demands scores.
As regards aim 1b), our follow-up measurements revealed that while still 
elevated in comparison to healthy controls, the clinical burnout group displayed 
a significant reduction of burnout symptoms, general health complaints, and 
self-reported cognitive problems after a period of psychological treatment. 
No such improvement was observed in the non-clinical burnout individuals, 
who did not receive treatment. Overall, the cognitive test performance of 
clinical burnout patients remained the same and still showed signs of a mild 
impairment, even after more than 1.5 years. The cognitive test performance of 
these patients no longer went together with larger reported subjective costs.
As to aim 2a), we measured a broad and state of the art range of cortisol 
indices. On one of these measures we observed differences, showing that both 
clinical burnout patients and individuals with non-clinical burnout had a lower 
CAR 30 minutes after awakening. Although our results provided some valuable 
insights, the inconclusiveness on the relationship between burnout and cortisol 
still remains.
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Regarding aim 2b), our results showed that the initially observed lowered 
CAR 30 minutes after awakening in the clinical burnout group returned to a 
normal level after a 1.5-year period during which they received psychological 
treatment. Among non-clinical burnout individuals, not receiving treatment, 
a lower CAR 30 minutes after awakening was still observed after 1.5 years 
when compared to the healthy controls. As regards our cortisol findings, it is 
an interesting, but at the moment hard to answer, question as to what our 
findings mean in terms of clinical relevance.
All in all, we believe that our studies contributed to a better understanding 
of cognitive functioning and cortisol levels in burnout. However, we are 
convinced that still much is to be learned about burnout in relation to cognitive 
functioning and cortisol levels, in particular about the latter relationship. A 
consensus definition of burnout will facilitate this challenge.
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Summary
Introduction
Burnout and cognitive performance
Employees with burnout often report major cognitive problems, such as 
an inability to concentrate and impaired memory. For example, they often 
complain about problems with focusing during meetings or when reading, and 
difficulties in recalling information. It was, however, not until the last decade 
that researchers started to empirically investigate these self-reported cognitive 
problems in burnout. The findings of these initial studies seemed to indicate 
that these self-reported cognitive problems were indeed accompanied by 
actual cognitive impairments, as measured with cognitive-neuropsychological 
tests. Yet, the exact nature of the impairments (i.e., deficits in executive 
functioning and/or a more general cognitive decline), and which specific 
functions are impaired, still remained unclear.
Burnout and cortisol
Since burnout is considered to be a stress-related syndrome, and cortisol 
is considered to be a main stress hormone, researchers started to examine 
cortisol levels in burnout to acquire valuable information about the biological 
underpinnings of burnout. Moreover, studying cortisol levels in relation to 
burnout is also interesting because it has often been hypothesized that the 
cognitive problems that individuals with burnout experience may be related to 
possible cortisol deviations. More precisely, cortisol is believed to be involved 
in mediating the stress-cognition relation, whereby both high and low levels 
of cortisol are assumed to have a negative impact on cognitive functioning. 
Although the relationship between burnout and cortisol has been examined 
in some previous studies, the results of these studies are mixed. In some 
studies burnout was found to be associated with lower-than-normal levels of 
cortisol, whereas in some other studies burnout was found to be associated 
with higher-than-normal levels of cortisol. Moreover, there is also research in 
which burnout was found to be unrelated to any cortisol deviations.
Aim of this dissertation
Against this background, the main aim of this dissertation is twofold:
1. a)  Provide a better understanding of cognitive functioning associated
          with burnout (cross-sectional approach);
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b) Gain more insight into the course of cognitive functioning in 
     relation to burnout (longitudinal approach);
2. a) Provide a better understanding of cortisol levels associated with 
          burnout (cross-sectional approach);
   b) Gain more insight into the course of cortisol levels in relation to
          burnout (longitudinal approach).
In order to investigate these aims we conducted four studies which were 
reported in Chapters 2 to 5. In these studies, we examined both the burnout-
cognition and burnout-cortisol relationships by adopting research designs that 
enabled us to overcome key limitations of previous studies: i) large differences 
in the operationalization of burnout and its lack of specificity, ii) heterogeneity 
and restricted reliability of outcome measures, iii) not controlling for important 
potential confounders, and iv) a lack of longitudinal research designs.
Results
Burnout and cognitive functioning
In Chapter 2, we investigated the burnout-cognition relationship by comparing 
a group of clinical burnout patients and a healthy control group on their self-
reported cognitive problems and on their cognitive test performance. Based 
on the results of the initial studies, we employed a cognitive test battery that 
specifically focused on measuring executive functioning. The results of our 
study were mostly in line with the aforementioned initial studies. That is, we 
found clear evidence that burnout patients reported more cognitive problems 
than healthy controls. Furthermore, burnout patients underperformed 
the healthy individuals on the test that assessed updating, indicating an 
impairment in executive functioning. In contrast to what was concluded in 
the initial research, our findings also showed that burnout was associated 
with an impairment in more lower-order cognitive processing, which was 
indicated by a general slowing in reaction time. In this same study, we also 
investigated the longitudinal course of cognitive performance in burnout. 
Hereto, we reexamined both groups after a 10-week period, during which 
the clinical burnout patients received psychological treatment. Our findings 
showed that, although still elevated compared with the healthy individuals, 
the clinical burnout patients revealed positive changes regarding their 
burnout symptoms, general health, and self-reported cognitive difficulties. 
Nevertheless, the cognitive test performance of the burnout patients did not 
improve.
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Chapter 3 presents a study in which we examined the burnout-cognition 
relationship in more detail. In addition to a sample of clinically diagnosed 
burnout patients and healthy controls, we also studied a sample of non-
clinical burnout individuals. The latter sample comprised individuals who 
reported to have symptoms of burnout but were not clinically diagnosed and 
were not seeking help for these symptoms. Based on the findings of our 
first study (Chapter 2), in this present study, the three groups were not only 
compared on self-reported cognitive problems and cognitive tests assessing 
the three most basic executive functions, but also on their performance on 
tests that assessed more lower-order cognitive processes. Moreover, we 
aimed to draw upon a new approach by also examining the subjective costs 
associated with performing the cognitive tests. The results of this study 
showed that, although both the clinical and the non-clinical burnout group 
reported cognitive problems, evidence for a relatively mild impaired cognitive 
test performance, and for larger reported subjective costs (more invested 
effort and higher experienced task demands) associated with cognitive test 
performance was solely found for the clinical burnout group.
In Chapter 5, we again examined the longitudinal course of cognitive 
performance in burnout by reexamining the three original groups (as we 
reported on in Chapter 3). To address an important limitation (i.e., the 
relatively short follow-up period of 10-weeks) of our first longitudinal study 
(as described in Chapter 2), in this study we reexamined the three groups 
after more than a 1.5 years period. Analogue to our first longitudinal study, 
the patients of the clinical burnout group received psychological treatment in-
between the first and second examination. Yet, despite the difference in time 
frame between the two longitudinal studies, the pattern of results that we found 
in the clinical burnout group was identical to that in our first longitudinal study. 
To be more precise, although still elevated compared with the controls, the 
clinical burnout patients showed a significant reduction of burnout symptoms, 
general health, and self-reported cognitive problems. Overall, the cognitive 
test performance of the burnout patients remained the same and still showed 
signs of a relative mild impairment. However, they no longer reported larger 
subjective costs associated with cognitive test performance. As regards the 
non-clinical burnout individuals, they still reported the same, elevated, level 
of burnout symptoms, general physical and psychological complaints, and 
cognitive problems when compared with the healthy controls. Their cognitive 
test performance and associated subjective costs remained normal.
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Burnout and cortisol
Chapter 4 presents a study in which we aimed to provide a better picture 
of cortisol levels in relation to burnout. To this aim, we compared a clinical 
burnout group, a non-clinical burnout group, and a healthy control group on 
cortisol levels (these are the same three groups as in Chapter 3). In order to 
examine a broad and up-to-date range of cortisol indices, including several 
measures of the cortisol awakening response CAR and different day-curve 
measures, we sampled salivary cortisol six times a day during two consecutive 
non-workdays. Our findings revealed that 30 minutes after awakening, the 
CAR of both the clinical and the non-clinical burnout group was lower than that 
of the healthy control group. Furthermore, we found some evidence indicating 
that the decline of cortisol during the day was smaller in the non-clinical 
burnout group compared with the healthy control group.
In Chapter 5, we investigated the course of cortisol levels in burnout 
by reexamining the three samples that we reported on in Chapter 4. This 
reexamination took place after a period of 1.5 years. In-between the first 
and second examination the patients of the clinical burnout group received 
psychological treatment. Our findings revealed that after 1.5 years the lowered 
CAR 30 minutes after awakening, which was found at the first examination in 
the clinical burnout sample, had returned to a normal level. The non-clinical 
burnout group still continued to display a lowered CAR 30 minutes after 
awakening, but we did not longer found evidence for a smaller decline of 
cortisol during the day in this group of individuals.
Discussion
Burnout and cognitive performance
The results of our studies showed clear and convincing evidence that both 
clinical and non-clinical burnout is associated with more self-reported cognitive 
problems. These results are in line with previous studies. Additionally, we found 
self-reported cognitive problems to be significantly different between clinical 
and non-clinical burnout. More specifically, clinical burnout patients reported 
more cognitive problems than non-clinical burnout individuals.
We did not find evidence that the cognitive test performance of individuals 
with a non-clinical burnout was impaired. We solely found some proof for an 
impaired cognitive test performance in clinical burnout patients. It is important 
to mention, however, that the overall degree of the impairments that we found 
in clinical burnout patients was relatively mild compared with the findings of 
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many previous studies. A factor that could be accountable for this difference 
is that, in our studies, we excluded burnout patients with comorbid mental 
disorders. In former research, burnout patients with comorbid mental disorders 
were not always excluded, or the effects of comorbidity were not always 
controlled for. Since there is ample evidence that, for example, depression is 
related to substantial deficits in cognitive functioning, these previous studies 
may present an overestimation of the degree in which clinical burnout was 
found to be associated with cognitive test performance impairments.
We were the first that systematically assessed the subjective costs associated 
with cognitive test performance in burnout.  The obtained results indicated 
that adequate cognitive test performance of the clinical burnout patients 
came at relatively large costs, as was reflected in higher invested effort and 
experienced task demand scores. We hypothesize that if these costs exceed a 
critical value, even more significant cognitive test performance impairments 
might emerge.
Similar to the results of the initial examinations, our reexaminations revealed 
that only the cognitive test performance of clinical burnout patients (and not 
that of the non-clinical burnout individuals) still showed a mild impairment, 
even after more than 1.5 years. However, we did no longer found evidence that 
the cognitive test performance of the clinical burnout patients was associated 
with larger subjective costs. Taken together, we can conclude that after a 
period of treatment the clinical burnout group got better, but not ‘well’, and the 
non-clinical burnout group remained not ‘well’.
Burnout and cortisol
As mentioned above, previous findings on the relationship between burnout 
and cortisol are mixed. Our findings do not change this picture substantially. 
However, we do believe that our results contribute to a better understanding 
of the observed differences in earlier studies. For instance, one key possible 
explanation for the previous null findings or why in previous studies elevated 
cortisol levels were found could be the result of including burnout patients with 
comorbid depression and/or anxiety. There is ample evidence that these latter 
disorders are related to increased levels of cortisol.
Assuming that the cortisol levels of clinical and non-clinical burnout individuals 
are lowered (shortly after awakening) and do not return to normal levels (in 
case of the non-clinical burnout individuals), it is an interesting but at the 
moment hard to answer question as to what the clinical relevance of this lower 
cortisol pattern is.
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Strengths of this dissertation
A strength of this dissertation is that we examined both cognitive performance 
and cortisol levels in relation to burnout with research designs that allowed us 
to overcome four key limitations of previous research: i) large differences in 
the operationalization of burnout and its lack of specificity, ii) heterogeneity 
(and restricted reliability) of the outcome measures, iii) not controlling for 
important potential confounders, and iv) the lack of longitudinal research 
designs.
Limitations of this dissertation
We treated both cognitive functioning and cortisol levels as outcome variables 
influenced by burnout. However, our results that burnout was related with 
cognitive impairments and, to some extent, with lowered cortisol, do not 
preclude the possibility of a reverse relation, nor that of a bi-directional 
relationship. That is, both cognitive impairments and lowered cortisol could 
be cause and/or consequence of burnout.
Another limitation concerns the identification of possible within group 
differences. Although we examined burnout in relation to cognition and 
cortisol by assessing both a clinical and a non-clinical burnout sample, we 
did not examine whether these specific samples formed homogenous groups. 
Previous research showed that individual with burnout do not always form a 
homogeneous group, but that there may be different “subgroups” with different 
symptomatology. This could have also been the case in our burnout samples. 
Studying these possible within group differences could have provided valuable 
additional information about burnout in relation to cognitive functioning and 
cortisol levels.
Practical implications
Our findings that burnout symptoms and cognitive impairments of burnout 
patients cannot easily be reversed by “traditional” psychological treatment, 
emphasizes the importance of effective (alternative) intervention programs. 
Previous studies revealed that intervention programs that are not only person- 
but also organization-directed are more effective and have longer-lasting 
effects. Therefore, we advocate that a standard intervention for the treatment 
of burnout must be directed at both a personal and an organizational level. 
An effective alternative intervention method for the treatment of burnout may 
be therapy specifically directed at improving cognitive functioning. Recent 
research showed promising results as regards reducing patients’ burnout 
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symptoms as well as cognitive problems through a process-based cognitive 
training intervention. Although additional research is required, cognitive 
training interventions could be an interesting and potentially beneficial method 
to address both burnout symptoms and cognitive impairments associated 
with burnout.
Our results that cognitive performance of burnout patients seems to be mildly 
reduced may also have implications for the reintegration to work. We think 
that for a successful reintegration to happen, burnout patients may adjust 
their high performance demands to a level that fits their current cognitive 
capability. Employers could facilitate this process.
Future research recommendations
Our most significant recommendation for future research relates to the concept 
of burnout. At the present, there is no uniform definition of burnout, which 
has led and probably will keep leading to inconsistency in results on burnout 
research. For this reason, we like to advocate more diagnostic research on 
burnout that hopefully results in a more consensus definition of burnout.
Since we were the first to systematically examine the subjective costs 
associated with cognitive test performance in people with burnout, another 
recommendation that we would like to make for future research is to further 
examine this relationship.
Furthermore, we would recommend looking into the process of recovery in 
burnout after cognitive test performance. As we found evidence that the 
clinical burnout patients invested more effort in conducting the cognitive tests 
and rated the tests as more demanding, it may well be that burnout patients 
need more time to recover after completing a cognitive test battery compared 
with healthy individuals. In future research one might consider to examine 
whether burnout is related to such an extended recovery time.
Our fourth and last recommendation concerns the already aforementioned 
issue of causality. In our studies, but also in previous research, cognitive 
functioning and cortisol levels were treated as outcome variables influenced 
by burnout. Consequently, on the basis of our results and those of previous 
research with regard to both the burnout-cognition and burnout-cortisol 
relationship the possibility of a reverse relation, nor that of a bi-directional 
relationship cannot be ruled out. Future studies are needed to shed more light 
on this issue of causality.
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Conclusion
Taken together, we believe that our studies contributed to a better understanding 
of cognitive functioning and cortisol levels in burnout. Nevertheless, we are 
sure that still much is to be learned about burnout in relation to cognitive 
functioning and cortisol levels, in particular about the latter relationship. A 
more uniform concept of burnout will facilitate this endeavor.
Addendum Samenvatting
156 157
A
Samenvatting
Inleiding
Burn-out en cognitieve prestatie
Werknemers met burn-out rapporteren vaak cognitieve problemen, zoals 
moeilijkheden met concentratie en een slecht geheugen. Zo geven zij 
bijvoorbeeld vaak aan zich niet goed te kunnen concentreren tijdens 
vergaderingen of tijdens het lezen, en dat ze moeite hebben om informatie te 
kunnen onthouden. Pas gedurende het laatste decennium is men begonnen 
met het empirisch onderzoeken van deze zelfgerapporteerde cognitieve 
problemen van personen met burn-out. De resultaten van deze initiële studies 
lieten zien dat deze zelfgerapporteerde cognitieve problemen inderdaad 
gepaard gaan met objectieve cognitieve problemen, zoals gemeten met 
neuropsychologische testen. Over het specifieke karakter van de cognitieve 
problemen (het executief functioneren en/of meer algemene cognitieve 
functies betreffende) en welke functies precies zijn aangedaan, is echter nog 
geen duidelijkheid.
Burn-out en cortisol
Omdat burn-out wordt gezien als een stress-gerelateerd syndroom en 
cortisol beschouwd wordt als één van de belangrijkste stresshormonen, zijn 
onderzoekers zich gaan richten op de mogelijke relatie tussen cortisolniveau 
en burn-out. Naast het verkrijgen van waardevolle biologische inzichten, is de 
studie naar de relatie tussen burn-out en cortisolniveau ook erg interessant 
omdat vaak wordt verondersteld dat de cognitieve problemen die personen 
met burn-out ondervinden gerelateerd zouden kunnen zijn aan mogelijke 
afwijkingen van het cortisolniveau. Gedacht wordt namelijk dat de relatie 
tussen burn-out en cognitie gemedieerd wordt door cortisol, waarbij wordt 
aangenomen dat zowel een te hoog als een te laag cortisolniveau een nadelig 
effect kan hebben op het cognitief functioneren. Hoewel de relatie tussen 
burn-out en cortisolniveau al is onderzocht in enkele eerdere studies, zijn 
de resultaten van deze studies niet eenduidig. Zo laten de bevindingen 
van sommige studies zien dat burn-out geassocieerd is met een verlaagd 
cortisolniveau, terwijl de resultaten van andere studies uitwijzen dat burn-out 
geassocieerd is met een verhoogd cortisolniveau. Tot slot zijn er ook studies 
waarin geen bewijs is gevonden voor een afwijking van het cortisolniveau van 
personen met een burn-out.
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Doel van dit proefschrift
Tegen deze achtergrond is het hoofddoel van dit proefschrift tweeledig:
1. a) Het beter begrijpen van het cognitief functioneren van personen
          met burn-out (cross-sectionele benadering);
b) Het verkrijgen van meer inzicht in het verloop van het cognitief
     functioneren in relatie tot burn-out (longitudinale benadering);
2. a) Het beter begrijpen van het cortisolniveau van personen met
          burn-out (cross-sectionele benadering);
b)  Het verkrijgen van meer inzicht in het verloop van het cortisolniveau 
    in relatie tot burn-out (longitudinale benadering).
Om deze doelen te onderzoeken hebben we vier studies verricht welke 
beschreven staan in de Hoofdstukken 2 tot en met 5. In deze studies hebben 
we zowel de burn-out–cognitie als de burn-out–cortisol relatie onderzocht met 
behulp van onderzoeksdesigns waarmee we geprobeerd hebben om belangrijke 
beperkingen van eerder onderzoek te ondervangen: i) grote verschillen in 
de operationalisatie van burn-out en een gebrekkige omschrijving ervan, ii) 
heterogeniteit en een beperkte betrouwbaarheid van de uitkomstvariabelen, 
iii) het niet controleren voor belangrijke potentieel storende variabelen, en iv) 
het gebrek aan longitudinale onderzoeksdesigns.
Resultaten
Burn-out en cognitief functioneren
In Hoofdstuk 2 is een studie beschreven waarin we de burn-out–cognitie relatie 
hebben onderzocht door een groep klinische burn-out patiënten te vergelijken 
met een groep gezonde controlepersonen op hun zelfgerapporteerde 
cognitief functioneren en op hun cognitieve testprestatie. Gebaseerd op de 
resultaten van de eerder genoemde initiële studies, hebben we in deze studie 
gebruik gemaakt van een cognitieve testbatterij die vooral als doel had om 
het executief functioneren te meten. De resultaten van onze studie waren 
grotendeels in lijn met de resultaten van de initiële studies. Dat wil zeggen, 
we vonden duidelijk bewijs dat burn-out patiënten meer cognitieve problemen 
rapporteerden dan de gezonde controlepersonen. Verder presteerden burn-
out patiënten slechter dan de gezonde controlepersonen op de test die een 
beroep deed op het zogeheten “updating”, wat wees op een verslechtering 
van het executief functioneren. In tegenstelling tot wat geconcludeerd werd in 
de initiële studies, lieten onze resultaten ook zien dat burn-out geassocieerd 
was met een verslechtering van meer lagere-orde cognitieve processen. Dit 
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werd zichtbaar door een algemeen tragere reactietijd van klinische burn-out 
patiënten. In deze zelfde studie hebben we ook het verloop van cognitieve 
prestatie in relatie tot burn-out onderzocht. Hiertoe hebben we beide groepen 
na een periode van 10 weken opnieuw gemeten. Alhoewel klinische burn-out 
patiënten een significante afname rapporteerden van burn-out symptomen, 
algemene lichamelijke en psychologische klachten, en cognitieve problemen, 
waren deze nog wel steeds significant hoger in vergelijking met die van 
de gezonde controlepersonen. De cognitieve testprestatie van de burn-out 
patiënten verbeterde echter niet.
Hoofdstuk 3 beschrijft een studie waarin de burn-out–cognitie relatie in 
meer detail is bestudeerd. Naast een groep met klinisch gediagnostiseerde 
burn-out patiënten en een groep met gezonde controlepersonen is er in deze 
studie ook een niet-klinische burn-out groep onderzocht. De niet-klinische 
burn-out groep bestond uit personen die burn-out klachten rapporteerden, 
maar die niet klinisch waren gediagnostiseerd en niet op zoek waren naar 
hulp voor deze klachten. Gebaseerd op de bevindingen uit onze eerste 
studie (Hoofdstuk 2), hebben we in deze studie de drie groepen niet alleen 
vergeleken op zelfgerapporteerde cognitieve problemen en op de prestatie 
op cognitieve testen die de drie meest basale executieve functies meten, 
maar ook op de prestatie op testen die meer lagere-orde cognitieve processen 
meten. Daarnaast hebben we de subjectieve kosten die gepaard gingen met 
de prestatie op de cognitieve testen onderzocht. De resultaten van deze 
studie lieten zien dat zowel de klinische burn-out groep als de niet-klinische 
burn-out groep cognitieve problemen rapporteerden. We vonden echter alleen 
in de klinische burn-out groep bewijs voor een relatief milde verslechterde 
cognitieve testprestatie en voor daarmee gepaard gaande hogere subjectieve 
kosten (meer inspanning en hogere ervaren taakeisen).
In Hoofdstuk 5 hebben we wederom het verloop van cognitieve prestatie 
in relatie tot burn-out onderzocht door bij de drie groepen, waarover we 
hebben gerapporteerd in Hoofdstuk 3, opnieuw een meting uit te voeren. 
Om een belangrijke beperking (de relatief korte follow-up periode van 10 
weken) van onze eerste longitudinale studie (zoals beschreven in Hoofdstuk 
2) te ondervangen, hebben we in deze studie de drie groepen pas na een 
periode van meer dan 1.5 jaar opnieuw onderzocht. Evenals in onze eerste 
longitudinale studie, kregen de burn-out patiënten ook in deze studie een 
psychologische behandeling tussen de eerste en de tweede meting. Ondanks 
het verschil in tijdsspanne tussen de twee longitudinale studies, waren 
de resultaten van beide studies met betrekking tot de klinische burn-out 
groep met elkaar vergelijkbaar. Specifieker, de klinische burn-out groep 
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rapporteerde een significante afname van burn-out symptomen, algemene 
lichamelijke en psychologische klachten, en cognitieve problemen, al waren 
deze nog wel steeds significant hoger vergeleken met die van de gezonde 
controlegroep. Over het geheel genomen bleef de cognitieve testprestatie van 
de klinische burn-out patiënten hetzelfde, wat betekende dat zij nog steeds 
een relatief milde cognitieve verslechtering lieten zien in vergelijking met 
de gezonde controlepersonen. Hun cognitieve testprestatie ging echter niet 
langer gepaard met hogere subjectieve kosten (meer inspanning en hogere 
ervaren taakeisen). De niet-klinische burn-out groep rapporteerde nog steeds 
dezelfde hoge mate van burn-out symptomen, algemene lichamelijke en 
psychologische klachten, en cognitieve problemen vergeleken met de gezonde 
controlegroep. Hun cognitieve testprestatie en geassocieerde subjectieve 
kosten bleven normaal.
Burn-out en cortisol
Hoofdstuk 4 beschrijft een studie waarin we geprobeerd hebben om een beter 
beeld te geven van het cortisolniveau in relatie tot burn-out. Hiertoe hebben 
we het cortisolniveau van een klinische burn-out groep, een niet-klinische 
burn-out groep, en een gezonde controlegroep met elkaar vergeleken (dit zijn 
dezelfde drie groepen als in Hoofdstuk 3). Om een breed en up-to-date scala 
van cortisol variabelen te meten, waaronder verschillende maten van zowel 
de cortisol awakening response (CAR) als de dag-curve, hebben we zes keer 
per dag gedurende twee opeenvolgende niet-werkdagen speeksel monsters 
verzameld. Onze bevindingen toonden aan dat 30 minuten na het ontwaken, 
de CAR van zowel de klinische als de niet-klinische burn-out groep lager was 
dan die van de gezonde controlegroep. Verder vonden we enig bewijs dat 
erop duidde dat de afname van cortisol gedurende de dag kleiner was in de 
niet klinische burn-out groep vergeleken met de gezonde controlegroep.
In Hoofdstuk 5 hebben we het verloop van het cortisolniveau in relatie tot 
burn-out onderzocht door na 1.5 jaar opnieuw een meting uit te voeren bij 
de drie groepen waarover we hebben gerapporteerd in Hoofdstuk 4. Tussen 
de eerste en de tweede meting kregen de patiënten in de burn-out groep 
een psychologische behandeling. De resultaten van deze studie lieten zien 
dat de CAR 30 minuten na ontwaken van de klinische burn-out groep was 
genormaliseerd. De niet-klinische burn-out groep had 30 minuten na ontwaken 
nog steeds een verlaagde CAR, maar we vonden niet langer bewijs voor een 
kleinere afname van cortisol gedurende de dag in deze burn-out groep.
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Discussie
Burn-out en cognitieve prestatie
De resultaten van onze studies lieten duidelijk bewijs zien dat zowel klinische 
als niet-klinische burn-out geassocieerd zijn met meer zelfgerapporteerde 
cognitieve problemen. Deze resultaten zijn in lijn met de bevindingen 
van eerder onderzoek. Daarnaast vonden we een significant verschil in 
zelfgerapporteerde cognitieve problemen tussen de klinische burn-out en 
niet-klinische burn-out groep. Meer specifiek vonden we dat klinische burn-
out patiënten meer cognitieve problemen rapporteerden dan personen met 
een niet-klinische burn-out.
We hebben geen bewijs gevonden dat de cognitieve testprestatie van 
personen met een niet-klinische burn-out slechter was dan die van gezonde 
controle personen. We vonden alleen enig bewijs voor een relatief slechte 
cognitieve testprestatie in de klinische burn-out groep. Het is echter 
belangrijk om te vermelden dat de mate van deze cognitieve onderprestatie 
relatief mild was in vergelijking met de resultaten uit voorgaande studies. 
Een factor die verantwoordelijk zou kunnen zijn voor dit verschil is dat we 
in onze studies burn-out patiënten met comorbiditeit hebben uitgesloten 
van deelname. In eerdere studies zijn burn-out patiënten met comorbiditeit 
niet altijd uitgesloten van deelname, of is er niet altijd gecontroleerd voor 
het effect van comorbiditeit. Omdat er voldoende bewijs is dat bijvoorbeeld 
depressie gerelateerd is aan cognitieve beperkingen, zouden de resultaten 
van dergelijke voorgaande studies een overschatting kunnen weerspiegelen 
van de mate waarin burn-out geassocieerd werd met een slechtere cognitieve 
testprestatie.
We waren de eersten die systematisch de subjectieve kosten die gepaard gaan 
met de prestatie op de cognitieve testen hebben onderzocht. De verkregen 
resultaten lieten zien dat adequate cognitieve testprestatie van de klinische 
burn-out patiënten geassocieerd was met relatief hoge kosten, zoals tot 
uiting kwam in hogere scores op geleverde inspanning en ervaren taakeisen. 
Onze verwachting is dat als deze kosten een bepaalde kritische waarde 
overschrijden, de cognitieve testprestatie mogelijk verder zal verslechteren.
Gelijk aan de resultaten van onze initiële metingen, lieten de resultaten van 
onze vervolgmetingen zien dat alleen de cognitieve testprestatie van klinische 
burn-out patiënten (en niet die van personen met niet-klinische burn-out) 
iets verslechterd was, zelfs na meer dan 1.5 jaar. We vonden echter niet 
langer bewijs dat de cognitieve testprestatie van klinische burn-out patiënten 
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geassocieerd was met hogere subjectieve kosten. Samengevat kunnen we 
concluderen dat na een periode van behandeling de klinische burn-out groep 
herstelde, maar niet volledig, en bij de niet-klinische burn-out groep zagen 
we geen verandering.
Burn-out en cortisol
Zoals reeds beschreven zijn de resultaten van voorgaande onderzoeken naar de 
relatie tussen burn-out en cortisol tegenstrijdig. Onze bevindingen veranderen 
dit beeld niet wezenlijk. We geloven echter wel dat onze resultaten hebben 
bijgedragen aan het beter kunnen verklaren van de gevonden verschillen 
tussen voorgaande studies. Bijvoorbeeld, een belangrijke mogelijke verklaring 
voor waarom in sommige voorgaande studies geen bewijs voor een afwijking 
van het cortisolniveau of juist een te hoog cortisolniveau is gevonden, zou 
kunnen zijn dat in deze studies burn-out patiënten met comorbide depressie 
zijn geïncludeerd. Er is namelijk voldoende bewijs dat depressie gerelateerd 
is aan een verhoogd cortisolniveau.
Ervan uitgaande dat het cortisolniveau van personen met een klinische en niet-
klinische burn-out verlaagd is (kort na ontwaken) en niet meer normaliseert 
(in het geval van niet-klinische burn-out personen), is het een interessante 
maar op dit moment een moeilijk te beantwoorden vraag wat de klinische 
relevantie is van dit verlaagde cortisol patroon.
Sterke punten van dit proefschrift
Een sterk aspect van dit proefschrift is dat we zowel de burn-out–cognitie 
als de burn-out–cortisol relatie hebben onderzocht met behulp van 
onderzoeksdesigns waarmee we geprobeerd hebben om vier belangrijke 
beperkingen van eerder onderzoek te ondervangen: i) grote verschillen in 
de operationalisatie van burn-out en een gebrekkige omschrijving ervan, ii) 
heterogeniteit en een beperkte betrouwbaarheid van de uitkomstvariabelen, 
iii) het niet controleren voor belangrijke potentieel storende variabelen, en iv) 
het gebrek aan longitudinale onderzoeksdesigns.
Beperkingen van dit proefschrift
We hebben zowel cognitief functioneren als cortisolniveau behandeld als 
uitkomstvariabelen, die mogelijk door burn-out zouden worden beïnvloed. 
Hoewel onze resultaten laten zien burn-out gerelateerd is aan cognitieve 
beperkingen, en enigszins aan een verlaagd cortisolniveau, kunnen we niet 
uitsluiten dat een omgekeerde of een bi-directionele relatie ook mogelijk is.
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Een andere beperking betreft de identificatie van mogelijke individuele 
verschillen. Hoewel we burn-out in relatie tot cognitie en cortisol hebben 
onderzocht door zowel een klinische als een niet-klinische burn-out steekproef 
te bestuderen, hebben we niet onderzocht of deze specifieke steekproeven 
homogene groepen vormden. Voorgaand onderzoek heeft namelijk laten 
zien dat personen met burn-out niet altijd homogene groepen vormen, 
maar dat er mogelijk verschillende “subgroepen” bestaan met verschillende 
symptomatologie.
Praktisch implicaties
Onze bevindingen dat burn-out symptomen en de cognitieve beperkingen 
niet gemakkelijk “ongedaan” kunnen worden gemaakt door de “traditionele” 
psychologische behandeling, benadrukt het belang van effectieve 
(alternatieve) interventie programma’s. Voorgaande studies hebben laten 
zien dat interventie programma’s die niet alleen gericht zijn op de persoon, 
maar ook op de organisatie, veel effectiever zijn en betere lange termijn 
effecten hebben. Daarom pleiten we ervoor dat een standaard interventie 
voor de behandeling van burn-out gericht moet zijn op zowel de persoon als 
de organisatie.
Een effectieve alternatieve interventie methode voor de behandeling van 
burn-out zou kunnen bestaan uit therapie die er direct op is gericht om het 
cognitief functioneren te verbeteren. Recent onderzoek laat veelbelovende 
resultaten zien wat betreft het verminderen van burn-out symptomen en 
cognitieve problemen met behulp van een procesgebaseerde cognitieve 
training interventie. Alhoewel aanvullend onderzoek noodzakelijk is, zouden 
cognitieve training interventies een interessante en potentieel gunstige 
methode kunnen zijn voor de behandeling van zowel burn-out symptomen als 
cognitieve beperkingen welke geassocieerd worden met burn-out.
Onze resultaten dat de cognitieve prestatie van burn-out patiënten iets 
verslechterd lijkt te zijn, heeft mogelijk ook implicaties voor de werkhervatting 
van werknemers met burn-out. Wij zijn van mening dat voor een succesvolle 
werkhervatting het van belang is dat de eisen die burn-out patiënten aan 
zichzelf stellen passen bij hun huidige cognitieve mogelijkheden. Werkgevers 
zouden dit proces moeten faciliteren.
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Aanbevelingen voor toekomstig onderzoek
Onze belangrijkste aanbeveling voor toekomstig onderzoek betreft het concept 
burn-out. Het ontbreken van een uniforme definitie van burn-out heeft geleid 
en zal in de toekomst blijven leiden tot inconsistente onderzoeksresultaten. 
Om deze reden willen we pleiten voor meer diagnostisch onderzoek wat 
hopelijk zal gaan leiden tot meer consensus over de definitie van burn-out.
Omdat wij als eerste systematisch de subjectieve kosten die gepaard gaan met 
de cognitieve testprestatie van personen met burn-out hebben onderzocht, 
is een andere suggestie voor toekomstig onderzoek om deze relatie nader te 
bestuderen.
Daarnaast willen we aanbevelen om het herstel van personen met burn-out 
na een cognitieve testprestatie verder te onderzoeken. Onze resultaten lieten 
zien dat klinische burn-out patiënten aangaven meer inspanning te hebben 
geleverd bij het maken van de cognitieve testen en deze testen als veeleisender 
hadden ervaren dan gezonde controle personen. Het zou daarom zo kunnen 
zijn dat burn-out patiënten meer tijd nodig hebben om te herstellen na het 
maken van een cognitieve testbatterij in vergelijking met gezonde controle 
personen. In toekomstige studies zou men kunnen onderzoeken of burn-out 
gerelateerd is aan een dergelijke langer durende herstelperiode.
Onze vierde en laatste aanbeveling betreft de reeds genoemde kwestie van 
causaliteit. In onze studies, maar ook in voorgaand onderzoek, zijn cognitief 
functioneren en cortisol behandeld als uitkomstvariabelen die door burn-out 
beïnvloed zouden worden. Hierdoor kunnen we op basis van onze resultaten en 
die van voorgaand onderzoek met betrekking tot zowel de burn-out–cognitie 
als de burn-out–cortisol relatie, niet uitsluiten dat een omgekeerde of een bi-
directionele relatie ook mogelijk is. Toekomstige studies zijn noodzakelijk om 
meer licht te laten schijnen op deze kwestie van causaliteit.
Conclusie
Samengevat zijn wij van mening dat onze studies hebben bijgedragen aan het 
beter begrijpen van het cognitief functioneren en cortisolniveau in burn-out. 
Niettemin zijn we ervan overtuigd dat er nog veel te leren valt over burn-out 
in relatie tot zowel cognitief functioneren als cortisol niveau, in het bijzonder 
over de laatstgenoemde relatie. Een eenduidiger concept van burn-out zal 
deze uitdaging faciliteren.
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Dankwoord
Dit proefschrift is niet tot stand gekomen door er alleen zelf aan te werken. 
Ik heb hierbij veel hulp gekregen van anderen. Graag wil ik daarom beginnen 
door in het algemeen iedereen te bedanken die, op welke manier dan ook, een 
bijdrage heeft geleverd aan de totstandkoming van dit proefschrift. Daarnaast 
wil ik graag een aantal mensen met een persoonlijk woord bedanken.
Een speciaal woord van dank gaat naar alle proefpersonen die hebben 
deelgenomen aan de verschillende studies. In het bijzonder aan de personen 
in de verschillende klinische burn-out groepen, die gedurende een lastige 
periode in hun leven toch bereid waren om zich in te zetten voor de wetenschap. 
Zonder jullie medewerking zou dit proefschrift er niet zijn geweest.
Michiel, ik kan me nog goed herinneren dat ik als student bij je in de kamer 
stond om de mogelijkheden met je te bespreken voor een stage bij A&O-
psychologie. In dat gesprek vroeg ik heel brutaal of ik na mijn stage zou 
kunnen beginnen met een promotieonderzoek. Je antwoordde iets in de trant 
van: “Dat zullen we tegen die tijd wel gaan zien”. Uiteindelijk heb je me deze 
kans geboden. Ik ben je hier erg dankbaar voor. Als promotor ben je een 
goede leermeester voor me geweest. Je hebt me wegwijs gemaakt in de 
wetenschap en je hebt me geleerd om kritisch naar mijn eigen werk te kijken. 
Bedankt ook voor je begrip.
Roald, mijn copromotor en dagelijkse begeleider. Je gaf me de ruimte om 
mijn eigen koers te varen en stuurde alleen bij als dat noodzakelijk was. 
Dit heb ik altijd heel erg weten te waarderen. Ik wil je ontzettend bedanken 
voor alle tijd en moeite die je hebt genomen voor mij en de totstandkoming 
van dit proefschrift. In het bijzonder voor de talloze keren dat je feedback 
hebt geleverd op mijn stukken tekst. Jouw verbeteringen kon ik blindelings 
overnemen. 
Dimitri, ik ben deze reis bij jou begonnen. Eerst als jouw stagiair en later 
als jouw promovendus. Net voordat ik begon als promovendus vertrok je 
naar de Erasmus Universiteit Rotterdam. Ondanks de afstand ben je altijd 
nauw betrokken gebleven bij mijn promotieonderzoek. Ik bewonder jouw 
relativeringsvermogen. Dit heeft me vaak geholpen om niet zelf in een burn-
out te verzeilen. Bedankt.
Graag wil ik de medewerkers van HSK Groep bedanken voor alle hulp bij de 
totstandkoming van de dataverzameling. Daarnaast wil ik Marc ook bedanken 
voor het reviseren van de verschillende manuscripten.
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Hanna, Sanneke, Lauke, Lennert, en Carla, ik wil jullie bijzonder bedanken 
voor jullie hulp bij de werving van proefpersonen en de dataverzameling. 
Zonder jullie inzet was dit proefschrift niet geworden wat het nu is.
Moniek, bedankt voor jouw bijdrage aan het vormgeven en het opzetten van 
verschillende studies. Of het nu ging om het schrijven van de aanvraag voor 
de medisch-ethische toetsingscommissie of simpelweg etiketjes plakken, jij 
draaide je hand er niet voor om. 
Hubert, dank voor het programmeren van de verschillende cognitieve taken. 
Jouw hulp is onmisbaar geweest. Edita, bedankt dat ik jouw Matching 
Task paradigma heb mogen gebruiken en voor de tijd die je hiervoor hebt 
vrijgemaakt. Ronny en Meta, dank voor al jullie hulp rondom praktische zaken. 
Toon, ondanks jouw drukke agenda kon ik voor statistische paniekaanvallen 
bij jou terecht. Ik heb onze gesprekjes bij het koffiezetapparaat altijd erg 
weten te waarderen. Bedankt. Bill, dank voor jouw statistische adviezen en 
bovenal jouw humor onder het genot van een sigaretje. Giovanni ten Brink, 
ook jij bedankt voor al je statistische hulp.
Graag wil ik alle collega’s bedanken waarmee ik de afgelopen jaren op de 
afdeling A&O-psychologie heb samengewerkt. Aan enkele van hen wil ik 
een speciaal woord richten. Mirjam, Melanie, Carla, Dorottya, Juriena, 
Michelle, Jessica, Monique, en Alfred, bedankt voor jullie betrokkenheid 
bij de totstandkoming van dit proefschrift en voor de fijne tijd die ik met 
jullie heb mogen delen, op het werk en daarbuiten. Ik kijk terug op een 
hele bijzondere periode. Sabine, bedankt voor jouw betrokkenheid en steun, 
zowel op professioneel als persoonlijk vlak. Debby, ik kon bij jou terecht voor 
serieuze en de wat minder serieuze gesprekken, oftewel bij jou kon ik mezelf 
zijn. Wat heb ik met je kunnen lachen, jouw humor is onevenaarbaar. Ik mis 
onze momenten. Jeroen, in korte tijd hebben we een goede band opgebouwd. 
Ik hoop dat deze nog lang mag blijven bestaan en kijk uit naar ons volgende 
biertje. Dank voor al jouw hulp in de voorbereiding naar de verdediging toe. 
Ik prijs me gelukkig met jou als paranimf. Hylco, met een warm gevoel kijk ik 
terug op de tijd die ik met jou heb doorgebracht op onze kamer. Een fijnere 
kamergenoot had ik me niet kunnen wensen. Ik kon bij jou terecht voor 
zowel werk- als niet-werkgerelateerde zaken. Ik bewonder de rust en kalmte 
waarmee je handelt en die je uitstraalt, en vind het ook daarom erg fijn dat 
je mijn paranimf wilt zijn. Bedankt voor dit alles.
Lieve (schoon)familie en vrienden, in het bijzonder mijn allerliefste zus 
Elsbeth en mijn allerliefste broertje Dick, graag wil ik jullie bedanken voor al 
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die keren dat jullie voor de broodnodige afleiding hebben gezorgd gedurende 
de periode waarin dit proefschrift tot stand is gekomen. Tegelijkertijd wil ik 
deze gelegenheid ook graag gebruiken om me te excuseren voor die keren 
dat ik dit proefschrift verkoos in plaats van een gezellig feestje of gewoon een 
gezellige dag met jullie. Vanaf nu wordt het anders, hoop ik. Els en Dick, weet 
dat jullie me ontzettend dierbaar zijn.
Kleine Maxim en Vince, jullie zullen je deze tijd waarschijnlijk niet meer 
herinneren over enkele jaren, maar op deze manier wil ik graag voor jullie 
vastleggen dat jullie de afgelopen jaren erg veel voor mij hebben betekend. 
Ik ben van jullie gaan houden op een manier zoals ik dat nog niet eerder heb 
ervaren.
Papa en mama, ik ben jullie heel erg dankbaar voor de ruimte die jullie me 
hebben gegeven om mezelf te kunnen ontwikkelen en voor de mogelijkheden 
die jullie hebben geboden om te worden wie ik nu ben. Bedankt ook voor jullie 
warmte en zorg. Ik houd van jullie.
Tot slot, mijn lieve Daphne, jou ben ik het verreweg de meeste dank 
verschuldigd. Bedankt bijvoorbeeld voor al die keren dat je kookte en/of het 
huishouden deed, terwijl ik weer eens aan dit proefschrift zat te werken maar 
eigenlijk aan de beurt was. Bedankt voor die keren dat je me hielp te kiezen 
als ik weer eens twijfelde over een bepaalde zin en voor die keren dat je mijn 
stukken tekst doorlas. Bedankt voor jouw begrip en relativeringsvermogen en 
voor de ruimte die je me gaf. Bedankt voor jouw steun als ik het moeilijk had. 
Bedankt ook voor de vreugde die je me gaf en voor gewoon de fijne tijd die ik 
met jou doorbracht. Dank voor nog zoveel meer! Ich liebe dich.
Bart
Nijmegen, 2 november 2016
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Burned out Cognition and Cortisol?
Burnout in Relation to Cognitive Performance 
and Cortisol Levels
Bart G. Oosterholt
UITNODIGING
U bent van harte welkom 
op de openbare verdediging 
van mijn proefschrift
Burned out 
Cognition and Cortisol?
Burnout in Relation to 
Cognitive Performance and 
Cortisol Levels
op vrijdag 2 december 2016
om 12:30 precies in de aula van 
de Radboud Universiteit, 
Comeniuslaan 2 te Nijmegen.
Na afloop van de verdediging 
bent u tevens van harte welkom 
bij de receptie in de aula.
Bart G. Oosterholt
Paranimfen
Jeroen Barte
j.barte@psych.ru.nl
Hylco Nijp
h.h.nijp@gmail.com
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